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ABSTRACT OF DISSERTATION
THE ROLE OF EXERCISE IN POLYCHLORINATED BIPHENYL-INDUCED
CARDIOVASCULAR DISEASE
Cardiovascular disease remains the leading cause of death in Western societies.
Endothelial dysfunction is one of the initiating steps in the development of
atherosclerosis. While there is a strong correlation with a person’s genetics, lifestyle
factors including smoking, physical activity, and diet can significantly increase a person’s
susceptibility to the development of atherosclerosis. In addition to these lifestyle factors,
there is a strong body of evidence linking exposure to environmental pollutants including
persistent organic pollutants such as polychlorinated biphenyls to increased
cardiovascular disease and mortality. It has been well-established that exercise
protects against cardiovascular disease, but whether exercise can modulate PCBinduced cardiovascular inflammation and dysfunction is unknown.
To investigate the effects of exercise on PCB-induced cardiovascular disease,
two murine models of atherosclerosis, the ApoE-/- and the LDLr-/- mouse were utilized.
Risk factors for cardiovascular disease including adiposity, glucose intolerance,
hyperlipidemia, hypertension, oxidative stress, and inflammation, were assessed in
these two models as well as mean atherosclerotic lesion size. Exercise positively
modulates several risk factors associated with cardiovascular disease including
hypertension, hyperlipidemia, adiposity and obesity, systemic levels of oxidative stress,
inflammation, and glucose tolerance. Exercise significantly reduced mean lesion size in
vehicle-treated animals. To assess the mechanism of protection of exercise in chapter
4, vascular reactivity studies were performed to measure endothelial function after
exposure to PCB 77. Exercise prevented PCB-impaired endothelial function implicating
the role of superoxide as a cause of impairment. Exercise upregulated phase II
antioxidant enzymes. The work in this dissertation demonstrates several protective
properties of exercise against PCB-induced cardiovascular disease; however, additional
studies are needed to determine if exercise enhances metabolism and excretion of these
environmental pollutants.
KEYWORDS: cardiovascular disease (CVD); Polychlorinated biphenyls (PCBs);
exercise, oxidative stress, endothelium dysfunction

Margaret O’Bryan Murphy
Student’s Signature
May 8, 2014
Date

THE ROLE OF EXERCISE IN POLYCHLORINATED BIPHENYL INDUCED
CARDIOVASCULAR DISEASE

By
Margaret O’Bryan Murphy

Dr. Bernhard Hennig
Director of Dissertation
Dr. Howard Glauert
Director of Graduate Studies
May 8, 2014
Date

In dedication to Margaret O’Bryan Fitts

Acknowledgements
I would like to acknowledge several people who assisted me in the completion of this
dissertation. First, I would like to thank my mentor, Dr. Bernhard Hennig who offered me
a position in his laboratory after serving as his teaching assistant. Without your
guidance, none of this could have occurred. Thank you helping me grow not only in my
career as a scientist on a personal level as well.
To my other committee members, thank you for your assistance. Dr. Esser, thank you
for being a strong female scientist and true role model. Additionally, thank you for
collaborating with us by providing running wheel cages. To Dr. Pearson, thank you for
your continued support and enthusiasm about my project and growth as a scientist. To
Dr. Cassis, thank you for encouragement and insights into assisting this project along.
Your expertise has truly been appreciated in developing dosing regimens as well as the
appropriate mouse model to conduct these experiments. Dr. Li, thank you for your
critical thought and advice for continuing my work. Dr. Newman, thank you for serving
as an outside examiner.
To my fellow labmates, current and previous, I thank you for your continued support,
kindness, and advice during this time. Michael Petriello, your academic input has been
thoroughly appreciated and necessary. Dr. Zuzana Makjova and Dr. Sung Gu Han, your
expertise and training has been invaluable. Katryn Eske, thank you for your kindness
and assistance in animal work. To Brad Newsome, thank you for your editing expertise
and friendship. The laboratory of Alan Daugherty allowed me to perform and refine
many experiments within this dissertation. Jess, thank you for setting up the contractility
apparatus and providing me detailed training to conduce these ex vivo experiments.
Deborah, your training on aortic root sectioning has been very helpful, you are truly a

iii

master. I am eternally grateful for the day that you and Jess helped me handle a mouse
without fear. Anju, thank you for blood pressure training and animal assistance. I would
also like to acknowledge Dr. Morris and Manjula Sunkara for their assistance and
availability to analyze PCB 77, its metabolites, and F2-isoprostanes.
To my family and friends, thank you for your continued support, encouragement
and love during this time. I am truly grateful for your love and kindness. To Tom
Gawriluk, thank you for your continued passion for science. I dedicate this work to my
grandmother and namesake, Margaret O’Bryan Fitts, who would have been a brilliant
scientist had she lived in a different generation when women had more opportunities.

iv

Table of Contents
ACKNOWLEDGEMENTS ........................................................................................................................... III
TABLE OF CONTENTS ................................................................................................................................ V
LIST OF FIGURES ....................................................................................................................................VIII
LIST OF TABLES ........................................................................................................................................ IX
CHAPTER 1: INTRODUCTION .................................................................................................................... 1
1.1 CARDIOVASCULAR DISEASES AND PATHOLOGY OF ATHEROSCLEROSIS ...................................................................1
1.1.1 The role of endothelium in atherosclerosis ....................................................................................3
1.1.2. Mechanisms of Atherosclerosis-Shear Stress and Physical Inactivity ...........................................3
1.2. AN OVERVIEW OF PCBS .............................................................................................................................4
1.2.1 Polychlorinated Biphenyls Contribute to Cardiovascular Disease ..................................................7
1.2.2. Modulation of Polychlorinated biphenyl-induced cardiovascular toxicity through nutrition .......8
1.3. EXERCISE .................................................................................................................................................9
1.3.1. The Vascular Response during Acute Exercise ............................................................................10
1.3.2. Vascular response to chronic exercise ........................................................................................12
1.3.3. Exercise Reduces Cardiovascular Risk Factors ............................................................................12
1.4. POTENTIAL MECHANISMS OF EXERCISE THAT PROTECT AGAINST ATHEROSCLEROSIS: AN IMPLICATION FOR THE
VASCULAR ENDOTHELIUM ...............................................................................................................................17
1.4.1. Shear Stress.................................................................................................................................17
1.4.2. Nitric Oxide .................................................................................................................................18
1.4.3. Exercise Reduces Expression of Cellular Adhesion Molecules .....................................................19
1.4.4. Endothelial Progenitor Cells ........................................................................................................20
1.4.5. Exercise is Anti-inflammatory .....................................................................................................20
1.4.6. Exercise Increases the Antioxidant Defense System ...................................................................21
1.4.7. Nuclear factor erythroid 2-related factor 2 (Nrf2) ......................................................................23
1.5 SCOPE OF DISSERTATION ...........................................................................................................................26
1.5.1. Aims of dissertation ....................................................................................................................26
1.5.2. Rationale .....................................................................................................................................26
1.5.3. Hypothesis and Specific Aims: .....................................................................................................27
CHAPTER 2: EFFECT OF EXERCISE ON PCB 77-INDUCED TOXICITY IN LDL-R-/- MICE FED A HIGH-FAT DIET
............................................................................................................................................................... 29
2.1 SYNOPSIS................................................................................................................................................29
2.2. INTRODUCTION .......................................................................................................................................29
2.3. MATERIALS AND METHODS .......................................................................................................................31
2.3.1. Chemicals ....................................................................................................................................31
2.3.2 Animal treatment ........................................................................................................................31
2.3.3. Exercise Protocol .........................................................................................................................32
2.3.4. Echo Magnetic Resonance Imaging ............................................................................................32
2.3.5. Quantification of PCBs ................................................................................................................32
2.3.6. Plasma cholesterol measurement...............................................................................................33
2.3.7. Liver cholesterol measurement ...................................................................................................33
2.3.8. Blood pressure ............................................................................................................................33
2.3.9 Quantification of atherosclerosis .................................................................................................33
2.3.10. Quantification of plasma components .....................................................................................34
2.3.11. Quantification of mRNA using RT-PCR. .....................................................................................34
2.3.12. Statistical analysis.....................................................................................................................34
2.4 RESULTS .................................................................................................................................................35
2.4.1. Exercise decreases body weight and fat mass in PCB 77-treated animals .................................35
2.4.2. Exercise increases liver size relative to body weight in PCB77-treated mice ..............................36

v

2.4.3. Running activity ..........................................................................................................................36
2.4.4. Quantification of PCB77 in exercise and sedentary animals.......................................................36
2.4.5. Exercise reduces atherosclerosis in PCB 77-treated mice ...........................................................37
2.4.6. Exercise reduces total plasma and liver cholesterol in PCB 77-treated mice ..............................37
2.4.7. Exercise does not attenuate PCB 77 increases in systolic blood pressure ...................................38
2.4.8. Exercise increases inflammatory parameters within the plasma of PCB 77-exposed animals ...38
2.4.9. Exercise reduces leptin in PCB 77-treated animals .....................................................................38
2.4.10. PCB 77 exposure significantly increases expression of CYP1A1 ................................................38
2.5 DISCUSSION ............................................................................................................................................39
CHAPTER 3: THE EFFECTS OF PHYSICAL ACTIVITY ON PCB-INDUCED CARDIOVASCULAR DISEASE IN APOE/- MICE ................................................................................................................................................... 55
3.1 SYNOPSIS................................................................................................................................................55
3.2. INTRODUCTION .......................................................................................................................................55
3.3. METHODS..............................................................................................................................................57
3.3.1. Chemicals ....................................................................................................................................57
3.3.2. Animal treatment & sample collection .......................................................................................57
3.3.3. Glucose tolerance test ................................................................................................................58
3.3.4. Quantification of plasma cholesterol, lipoproteins and cytokines/chemokines .........................58
3.3.5. Liver cholesterol measurement ...................................................................................................59
3.3.6. Quantification of atherosclerosis ................................................................................................59
3.3.7. Quantification of PCBs and F2-isoprostanes ...............................................................................59
3.3.8. Gene expression of CYP1A1 and antioxidant enzymes ...............................................................60
3.3.9. Statistical analysis.......................................................................................................................61
3.4. Results ............................................................................................................................................61
3.4.1. Exercise reduces cardiovascular disease and associated risk factors in PCB77-treated mice.....61
3.4.2. Exercise reduces systemic oxidative stress and upregulates antioxidant enzymes ....................63
3.5. DISCUSSION ...........................................................................................................................................63
CHAPTER 4: EFFECT OF EXERCISE ON PCB 77-INDUCED ENDOTHELIAL DYSFUNCTION IN C57BL/6 MICE 82
4.1 SYNOPSIS................................................................................................................................................82
4.2. INTRODUCTION .......................................................................................................................................82
4.3 METHODS...............................................................................................................................................84
4.3.1. Chemicals ....................................................................................................................................84
4.3.2. Animal treatment .......................................................................................................................84
4.3.3. Exercise .......................................................................................................................................85
4.3.4. Ex vivo vascular reactivity studies ...............................................................................................85
4.3.5. Quantification of PCBs and F2- isoprostanes ...............................................................................85
4.3.6. Plasma and liver cholesterol measurement ................................................................................86
4.3.7. Quantification of mRNA using RT-PCR ........................................................................................87
4.3.8. Statistical analysis.......................................................................................................................87
4.4 RESULTS .................................................................................................................................................87
4.4.1. Exercise lowers F2-isoprostane levels ..........................................................................................88
4.4.2. Exercise did not lower plasma and liver cholesterol levels .........................................................88
4.4.3. Exercise restores endothelium-dependent vasodilation in PCB 77-treated mice........................89
4.4.4. Exercise reduces expression of CYP1A1 ......................................................................................89
4.5 DISCUSSION ............................................................................................................................................89
CHAPTER FIVE: GENERAL DISCUSSION .................................................................................................. 102
5.1 DISCUSSION ..........................................................................................................................................102
5.1.1 Summary ....................................................................................................................................102
5.1.2. Effect of Exercise on PCB 77-induced toxicity in LDLr-/- mice ...................................................102
5.1.3 The Effects of Physical Activity on PCB-Induced Cardiovascular Disease in ApoE-/- mice .....105

vi

5.1.4.
Effect of exercise on PCB 77-induced endothelial dysfunction in C57BL6 mice .................110
5.1.5 Implications From Different Mouse Models..............................................................................112
5.2. FUTURE DIRECTIONS ..............................................................................................................................115
5.3 CONCLUSIONS .......................................................................................................................................117
APPENDIX A: VASCULAR REACTIVITY PROTOCOL ................................................................................. 120
BIBLIOGRAPHY ..................................................................................................................................... 124
VITA ..................................................................................................................................................... 153

vii

List of Figures
Figure 1.1 Structure and nomenclature of polychlorinated biphenyls
28
Figure 2-1 Exercise Increases Body Weight in Vehicle-treated Animals
43
Figure 2-2 Exercise Increases Lean Body Mass and Reduces Fat Mass in
PCB-treated Animals
44
Figure 2-3 Exercise increases liver: body weight in PCB77-treated mice
45
Figure 2-4 Voluntary wheel-running performance in control and PCB77-treated
Mice
46
Figure 2-5 Concentrations of PCB in tissues
47
Figure 2-6 Exercise Reduces Mean Aortic Lesion Area
48
Figure 2-7 Exercise reduced total plasma cholesterol and HDL total cholesterol
levels
49
Figure 2-8 Exercise fails to attenuate PCB77 increases in systolic
blood pressure
50
Figure 2-9 Exercise increases serum t-PAI-1 and TNF-α levels in PCB77-treated
Animals
51
Figure 2-10 Exercise increases plasma levels of IL-6 and MCP-1 in PCB77-treated
animals
52
Figure 2-11 Exercise reduces plasma leptin levels in PCB77-treated animals
53
Figure 2-12 Exercise upregulates CYP1A1 in PCB77 treated mice
54
Figure 3-1. Exercise attenuates PCB 77-impaired glucose intolerance
67
Figure 3-2. Exercise reduces systolic blood pressure in PCB 77-treated mice
68
Figure 3.3 Exercise reduces total plasma cholesterol and VLDL and LDL cholesterol
concentrations
69
Figure 3-4. Exercise prevents upregulation of proinflammatory cytokines by
PCB77 exposure
70
Figure 3-5. Exercise reduces atherosclerosis in PCB77-treated mice
71
Figure 3-6. Exercise modulates PCB 77-induced oxidative stress
72
Figure 3-7. Exercise upregulates antioxidant and phase II enzymes
73
Figure 3-8. Exercise decreases level of OH-PCB 77 in feces
74
Figure 3 9. Proposed signaling pathway for PCB detoxification in vivo
75
Supplementary Figure 3-1. Exercise increases body weight and lean body mass 76
Supplementary Figure 3-2 Exercise increases liver: body weight in PCB77treated mice
77
Supplementary Figure 3-3 Voluntary wheel-running performance in control and
PCB77-treated mice
78
Supplementary Figure 3-4 Voluntary wheel-running performance in control and
PCB77-treated mice
79
Supplementary Figure 3-5 Exercise reduces hepatic cholesterol levels
80
Figure 4-1 Voluntary exercise had no effect on body weight
93
Figure 4-2 Voluntary wheel-running performance
94
Figure 4-3 The effect of exercise on PCB 77 and OH-PCB 77 concentration
95
Figure 4-4 PCB 77 induced oxidative stress is reduced in exercised animals
96
Figure 4-5 Exercise does not reduce plasma or liver cholesterol levels
97
Figure 4-6 Confirmation of Tissue Viability
98
Figure 4.7 Exercise restores endothelium-dependent dilation in PCB77 impaired
vessels
99
Figure 4-8 Exercise reduces CYP1A1 and MCP-1 levels in PCB 77-treated
Animals
100
Figure 5-1 Proposed signaling pathway for PCB detoxification in vivo
119
viii

List of Tables

Table 3-1: Primers used for RT-PCR
Table 4-1: Primers used for RT-PCR

ix

81
101

Chapter 1: Introduction
1.1 Cardiovascular Diseases and Pathology of Atherosclerosis
Cardiovascular diseases (CVDs) are currently the leading cause of death in the
1

U.S . Atherosclerosis is characterized by the accumulation of lipids and fibrous debris
within the large arteries2. Early lesions of atherosclerosis consist of cholesterol-laden
macrophages in sub-endothelial spaces, known as foam cells3. These foam cells and
subsequent fatty streaks can be found in the aorta of a human within the first decade of
life. Fatty streaks are the precursors of more advanced lesions characterized by the
accumulation of lipid-rich necrotic debris and smooth muscle cells (SMCs)4. These
types of lesions usually have a fibrous cap made up of SMCs and an extracellular matrix
that encloses the lipid-rich necrotic core. Although advanced lesions can grow
significantly and result in stenosis, the formation of a thrombus or clot is more likely to
form resulting in myocardial infarction or stroke, and ultimately death5.
Epidemiological studies over the past 50 years have revealed several risk
factors for atherosclerosis. The main risk factors for atherosclerosis include increased
total cholesterol levels with high ratios of low-density lipoproteins (LDL) to high-density
lipoproteins (HDL), obesity, diabetes mellitus, and hypertension6. While there is a strong
correlation with a person’s genetics, lifestyle factors including smoking7, physical
inactivity8 and diet9 can significantly increase a person’s susceptibility to the
development of atherosclerosis10. In addition to these lifestyle factors, there is a strong
body of evidence linking exposure to environmental pollutants including persistent
organic pollutants to increased cardiovascular disease and mortality11.
Cholesterol constitutes a major portion of the atherosclerotic plaque and
increased serum levels of cholesterol play a role in the development of atherosclerosis.
In fact, the first observable change in the vessel wall is the accumulation of lipoprotein
particles and their aggregates in the intima4. However, recent evidence has
demonstrated that atherosclerosis is a low-grade inflammatory disease rather than a
lipid storage disease2.

Within days, monocytes can be seen adhering to the surface of

the endothelium and then transmigrate across the endothelial monolayer to the intima,
ultimately forming foam cells12. Furthermore, circulating levels of inflammatory mediators
including C-reactive protein (CRP) are independent risk factors for atherosclerosis3. The
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specific involvement of inflammation in plaque initiation and progression will be
discussed below.
The formation of an atherosclerotic plaque is a complex process involving
several different cell types. A primary initiating event in atherosclerosis is the
accumulation of LDL within the sub-endothelial space of the intima, which stimulates
endothelial cells to produce a number of pro-inflammatory mediators including adhesion
molecules and macrophage colony-stimulating factor (M-CSF)4. LDL diffuses passively
through gap junctions and its retention within the vessel wall involves interactions with
matrix proteoglycans and apolipoprotein B (apoB)13. Trapped LDL undergoes oxidation,
lipolysis, proteolysis and aggregation which further stimulate inflammatory cytokines14.
These mediators recruit monocytes and lymphocytes to the arterial wall. The first step in
adhesion, the “rolling” of leukocytes along the endothelial surface, is mediated by
selectins which bind to carbohydrate moieties on leukocytes15. Firm adhesion of
monocytes and T cells to the endothelium is mediated by the integrin VLA-4 on the EC,
which interacts with both VCAM-1 and the CS-1 splice variant of fibronectin16. Monocyte
chemoattractant protein-1 (MCP-1) is a chemokine produced by endothelial cells. Mice
deficient in monocyte chemoattractant protein (MCP-1) or its receptor CCR2 had
significantly reduced atherosclerosis, suggesting a role for MCP-1/CCR2 in monocyte
recruitment17,18. It has been shown that MCP-1 facilitates monocyte transmigration and
retention into the sub-endothelial space in both humans and mice. The rapid uptake of
oxLDL particles by macrophages is mediated by two scavenger receptors, SR-A and
CD3619,20. The resulting cholesterol uptake by macrophages leads to the conversion of
a foam cell, which makes up the fatty streak, characteristic of early lesion
development21.
Fibrous plaques are formed by a growing mass of extracellular lipid consisting
mainly of cholesterol and its ester, and by the accumulation of SMCs4. SMC migration
and proliferation as well as extracellular matrix production is regulated by cytokines and
growth factors secreted by macrophages and T cells22. SMCs form the fibrous cap that
encases the necrotic core of the lesion.

Additionally, matrix metalloproteinases

(MMPs) are produced by macrophages within the plaque and cleave the extracellular
matrix. Cleavage of the extracellular matrix aids in the migration of SMCs and
contributes to instability of the plaque increasing the risk for thrombosis23.
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1.1.1 The role of endothelium in atherosclerosis
The endothelium is a monolayer which acts as an interface between blood-borne
molecules; including circulating nutrients, environmental pollutants, lipoproteins, and
cytokines. Endothelial integrity is essential for preserving vascular homeostasis,
regulating vascular tone, coagulation, angiogenesis and repair, and inflammatory
processes. Nitric oxide (NO) is produced by endothelial cells and has several important
roles including regulation of vascular tone, inhibition of platelet aggregation, inducing
vasodilation in SMCs, and preventing leukocyte adhesion24–26. Endothelial dysfunction,
including a decrease in bioavailable NO, is an independent risk factor in cardiovascular
disease27. Endothelial dysfunction is a condition that includes the upregulation of
cellular adhesion molecules (CAMs), which recruit blood mononuclear cells, and
increases in endothelial permeability, which facilitates the diffusion of LDL to the
intima28. The transcription factors nuclear factor-KB (NF-KB) and activator protein-1
(AP-1) regulate the expression of adhesion molecules and cytokines29,30 and are
activated in response to increased levels of reactive oxygen species (ROS)31.
Circulating leukocytes do not adhere to endothelium unless the expression of CAMs
(e.g. VCAM-1, ICAM-1) is present on the cell surface32. Similarly, chemoattractant
stimuli produced from ECs promote migration of leukocytes into the intima where M-CSF
stimulates differentiation from monocytes into macrophages. The macrophages express
scavenger receptors which engulf oxidized LDL ultimately forming foam cells. These
lipid-laden macrophages secrete a number of inflammatory mediators including IL-1 and
TNF-a that amplify inflammation within the vessel wall and contribute to additional
leukocyte accumulation, SMC proliferation, and extracellular matrix remodeling2,4,33.
1.1.2. Mechanisms of Atherosclerosis-Shear Stress and Physical Inactivity
Blood flow-induced shear stress has emerged as an essential feature of the
development of atherosclerosis. Shear stress is a biomechanical force that is
determined by blood vessel, vessel shape, and fluid viscosity and is expressed as units
of dynes/cm2 34. Fluid shear stress has effects on EC morphology. Cells in the tubular
regions of arteries are ellipsoid in shape and align in the direction of laminar flow. Cells
in arterial areas of curvature are exposed to “disturbed” flow have polygonal shapes and
no orientation which increase susceptibility to lesion formation35. A sedentary lifestyle
results in disturbed vascular flow including irregular and non-uniform flow. The influence
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of blood flow in atherosclerosis can be deduced from the presence of vascular
inflammation and the distribution of atherosclerotic lesions at lesser curvature of bends
and near side branches, where blood flow rate is relatively low.36 For example,
atherogenesis is promoted by low shear stress i.e. <5 dynes/cm2 because it disrupts
numerous cell functions including a reduction in eNOS synthesis, vasodilation, and
endothelial cell repair. These disruptions in cell function are coupled to an increase in
reactive oxygen species, increased leukocyte adhesion, apoptosis, increased
permeability to lipoproteins, smooth muscle cell proliferation, and collagen deposition35.
A key initial step in this process involves the recruitment and binding of leukocytes to the
endothelium. Leukocytes normally do not adhere to the endothelium; however, if the
endothelium expresses adhesion molecules, the leukocyte “tethers” through interaction
with P- or L-selectin on the microvilli of leukocytes37. Low shear stress or reduced flow
upregulates the expression of leukocyte adhesion receptors such as intercellular
adhesion molecule 1 and vascular cell-adhesion 138 as well as chemokines including
monocyte chemotactic protein 139 under conditions of disturbed flow.
It should be noted that these receptors and signaling molecules initiate and
maintain inflammation within the vessel wall leading to the development of CVD. These
areas of low or disturbed flow do not cause atherosclerosis by itself, rather it is the
systemic inflammation that leads to the development of this disease. Under conditions
of low-flow, circulating leukocytes can adhere to the EC surface, transmigrate across the
endothelial layer, and initiate the development of the atherosclerotic lesion40.
1.2. An Overview of PCBs
Exposure to persistent organic pollutants is a risk factor for the development of
cardiovascular disease (reviewed in11 ). Polychlorinated biphenyls (PCBs) consist of
two benzene rings with 0-10 chlorines attachment sites with the possibility of 209
congeners (Figure 1.1). Most PCB congeners are colorless, odorless crystals. Mass
production of PCBs began in 1929, largely through Monsanto Chemical Company under
the brand name Aroclor. PCBs were commercially produced as complex mixtures
containing multiple isomers at different degrees of chlorination for a variety of
applications, including dielectric fluids for capacitors and transformers, heat transfer
fluids, hydraulic fluids, lubricating and cutting oils, and as additives in pesticides, paints,
carbonless copy paper, adhesives, sealants, and plastics. Their commercial utility was
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based largely on their chemical stability, including low flammability, and desirable
physical properties, including electrical insulating properties. Their chemical and
physical stability has been responsible for their persistence in the environment, despite
their ban in 1979 by the U.S. Environmental Protection Agency (EPA) 41.
As early as 1936, occupational exposure was reported to cause acute toxicity
leading to workplace threshold limits set. PCB-contaminated cooking oil caused a total
of 1,291 “Yusho” patients in Japan. Symptoms of toxicity included low birth weights,
chloracne, and pigmentations42. In 1966, Jensen reported PCBs in eagles, herring, and
other Swedish environmental samples43. PCBs have been shown to be nearly
ubiquitous environmental pollutants occurring in most human and animal adipose
samples, milk, and sediment. PCBs have entered the environment through use and
disposal. Because PCBs do not easily degrade and are lipophilic in nature, they are
persistent and bioaccumulate. Human exposure to PCBs occurs primarily through lowlevel food contamination44,45. PCBs have been found in nearly all marine plant and
animal species including fish, mammals, birds, and humans. Highly PCB-contaminated
populations include Native American tribes, communities on Forae Islands46, and
Canadian Inuits47. There are several reports of occupational exposure as well as
documented cases within communities such as the Monsanto plant in Anniston, AL48
and the upper Hudson River, NY49. Additionally, two cases of accidental ingestion from
rice oil were reported, the previously mentioned Yusho incident as well as Yu-Cheng in
Taiwan in 197950.
PCB levels in human plasma resulting from exposure vary with low ppb
concentrations found in the general U.S. population51. Yu-Cheng patients in Taiwan
were documented to have 99 ppb of PCBs in plasma50 with levels as high as 1 ppm (3
orders of magnitude difference) after occupational exposure52.Canadian Inuits, who
consume large quantities of fish within their diet have 3.4 fold higher levels of PCBs
within their plasma than the U.S. population53. High risk groups within these populations
include breast-fed children which have been documented to have negative cognitive
functions from exposure54,55.
While acute toxicity of PCBs is a rare phenomenon and limited to symptoms
including chloracne56, a large number of scientific studies (>10,000 published44) have
linked PCB exposure to chronic disease in humans. PCBs contribute to a variety of
pathological conditions within humans. PCBs can act as initiators and promoters of
carcinogenesis57, specifically the congener PCB 358,59. PCBs act as endocrine
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disrupters and can alter metabolic processes regulated through the thyroid gland60. In
addition, developmental exposure to PCBs can result in cognitive dysfunction later in
life61,62.
PCBs can be further classified based on their stereochemistry which affects their
biological functions. There are three groups of PCB congeners including non-orthosubstituted coplanar PCBs (e.g. PCB 77 and PCB 126), ortho-substituted non-coplanar
PCBs (e.g. PCB 104 and PCB 153) and mixed-inducers with one or two chlorines in
ortho positions (e.g. PCB 118)63. This dissertation work focuses on the coplanar PCB77,
which is an agonist of the aryl hydrocarbon receptor (AhR). The toxicity of the coplanar
PCBs correlates with their binding affinity for the AhR which has led to the assignment of
a Toxic Equivalency Factor (TEF) for each of the coplanar PCBs. TEF expresses
toxicity relative to the most potent AhR ligand, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD)64. AhR is a cytosolic transcription factor with a basic helix-loop-helix structure
that is bound to chaperone proteins including a dimer of heat shock protein 90 (hsp90),
and the hepatitis B virus-associated protein 2 (XAP2)65. Upon ligand binding (e.g. PCB
77), AhR dissociates from its chaperone proteins and translocates into the nucleus
forming a dimer with the AhR nuclear translocator (ARNT)66. The newly formed
AhR/ARNT complex binds to AhR-response elements (DREs) located in the promoter
region of responsive genes, thus serving to modify transcription of targeted genes66.
There are several targets of the AhR including a family of CYP enzymes and
other phase II enzymes such as uridine 5’diphosphoglucuronosyltransferase (UGT) 1A1,
and glutathione (GSH)-S-transferase67. These gene targets play a role in the
detoxification process of hydrophobic compounds by adding an epoxide molecule or
other hydrophilic moiety to aid in metabolism41. Because AhR upregulates the family of
CYP enzymes, this explains some of the toxicity from PCB 77 exposure. It has been
shown that upregulation of CYP1A1 by AhR due to PCB 77 leads to its uncoupling,
resulting in the production of Reactive Oxygen Species (ROS)68. Phase I metabolism of
PCB77 forms catechol and hydroquinones which are then converted to quinones by
cellular peroxidases69, which can further contribute to cellular oxidative stress70. These
reactive intermediates can directly bind to DNA71 and proteins72 which may explain some
of the toxic effects of PCBs.
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1.2.1 Polychlorinated Biphenyls Contribute to Cardiovascular Disease
PCB exposure can lead to the development of CVD. Swedish capacitor workers
had increased rates of cardiovascular mortality73. In the female population, a National
Health and Nutrition Examination Survey (NHANES) demonstrated an association
between plasma PCB levels and cardiovascular disease74. Within the Yusho patients,
elevated levels of total blood cholesterol and triglycerides were reported50. A recent
report in Hypertension revealed that residents in Anniston, AL had increased rates of
hypertension, a known risk factor for cardiovascular disease48. Exposure to PCBs in
human studies has also demonstrated elevated cardiovascular disease risk factors
including insulin resistance75, metabolic syndrome76, and diabetes77.
Several mechanisms have been suggested to explain the increased rates of
cardiovascular diseases induced by PCB exposure. Yusho patients had elevated
plasma cholesterol78, and similar effects have been reported in animal models after
exposure to coplanar PCBs79,80 including findings reported within this dissertation. Our
laboratory has previously shown that PCB 77exposure reduced liver expression of
CYP7A181, the rate-limiting enzyme in the synthesis of bile acid from cholesterol, which
could explain the elevated cholesterol levels in the plasma. Additionally, coplanar PCBs
promote adipocyte differentiation as well as upregulating proinflammatory mediators
including MCP-1 and TNF-α, thus contributing to the development of obesity and
associated inflammation82 .
However, our laboratory and others have focused on the mechanism of PCBinduced endothelial dysfunction83,84. Specifically coplanar PCBs, including PCB 77 bind
the AhR leading to upregulation of CYP1A1 within the vasculature85. PCB 77 uncouples
CYP1A1 increasing ROS production which activates redox sensitive transcription factors
NFκB and AP-1. Activation of NFκB can upregulate cellular adhesion molecules
including VCAM-183,86. It should be noted that activation of NFκB and AhR through PCB
77 can be reversed with co-treatment of AhR antagonists as well as antioxidants87,88.
Coplanar PCBs have been shown to disrupt the endothelial barrier83 and even induce
endothelial apoptosis89. PCB 77 can phosphorylate eNOS, leading to formation of
peroxynitrite (ONOO-) which further increases oxidative stress and formation of
nitrotyrosine90. Additionally, previous work in our laboratory has investigated the role of
caveolae in PCB-induced endothelial dysfunction. Caveolae are a type of lipid raft found
in endothelial cells that play a role in signal transduction91. PCB 77 exposure increased
the formation of caveolae and caveolin-1 protein levels in endothelial cells and PCB 77
7

was found in the caveolae-rich fraction92. This data suggest that caveolae could be a
major entry for PCBs into the endothelial cell which can lead to activation of downstream
signaling pathways. Cav-1 has been shown to bind AhR, but deletion of Cav-1 prevents
upregulation of CYP1A1 and subsequent ROS production as well as preventing
downstream activation of NFκB92. Furthermore, PCB 77 phosphorylation of eNOS was
Cav-1 dependent90.
1.2.2. Modulation of Polychlorinated biphenyl-induced cardiovascular toxicity
through nutrition
An accumulating body of evidence within the scientific literature implicates the
role of nutrition in the pathology of atherosclerosis. While a positive energy intake can
lead to obesity, an independent risk factor for atherosclerosis93, specific dietary
compounds can modulate cellular signaling in either pro- or anti-atherogenic ways. A
diet rich in polyphenols found in fruits and vegetables as well as fish oil have been
shown to reduce cardiovascular mortality and reduce the risk of developing
cardiovascular disease94,95. Extensive studies have demonstrated omega-3 fatty acids,
which are a type of polyunsaturated fatty acid (PUFA), to be anti-inflammatory compared
to saturated and trans fatty acids which tend to increase cardiovascular risk factors
because of their inflammatory nature96. Eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) are two omega-3 fatty acids primarily found in fish with
high anti-inflammatory properties. A large number of epidemiological studies have
shown that a diet rich in the consumption of fish or fish oil reduces the risk for
cardiovascular disease97.
Nutrition as a modulator of chronic disease accelerated by environmental
pollutant exposure is an exciting area within the field98. A majority of these studies have
been conducted with PCB being the pollutant studied99. Epigallocatechin-3-gallate
(EGCG), a compound found in green tea, reduced PCB 77-induced CYP1A1
upregulation while reducing the generation of ROS87. EGCG acts as an AhR antagonist
by binding to its chaperone protein, hsp90100. Dietary antioxidants e.g. vitamin E can
reduce PCB-induced activation of NFκB and its subsequent pro-inflammatory
signaling88.
Specifically, our lab has demonstrated that certain polyphenols found in fruits and
vegetables can attenuate the PCB-induced pro-inflammatory signaling within cultured
endothelial cells. Co-treatment with quercetin prevented PCB 77 upregulation of
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CYP1A1 as well as VCAM-1 and E-selectin101. Recently, EGCG was shown to protect
endothelial cells against PCB 126 induced-inflammation by inhibiting AhR and its
associated proinflammatory signaling while upregulating the antioxidant transcription
factor, NF-E2-related factor 2 (Nrf2)102. Nrf2 is a transcription factor that upregulates
phase II enzymes including glutathione S transferase and NAD(P)H: quinone
oxidoreductase 1(NQO1)103. Additional studies from our laboratory provide evidence
that the type of dietary fat can modulate the level of inflammation104. Diet enriched with
linoleic acid, an omega-6 fatty acid, exacerbated expression of adhesion molecules in
the aorta; however, diet enriched in olive oil attenuated this response104. Other studies
have examined the role of olestra, a sucrose polyester that is non-absorbable and has
been shown to decrease the absorption of PCB 77105. Fish oil contains a rich source of
omega-3 fatty acids including DHA and EPA; oxidized DHA was shown to ameliorate
PCB 77 induced proinflammatory signaling by upregulating Nrf2-mediated signaling106.
Although there is no quick fix to protect against diseases associated with
exposure to environmental pollutants including coplanar PCBs, there is strong evidence
for the role of nutrition in providing protection against chronic disease associated with
environmental toxic insult. However, additional studies are needed in particular
epidemiological studies that can demonstrate nutrient protection in human while
providing recommendations for an effective dose of nutrient(s). Furthermore, additional
studies examining the effects of lifestyle modifications including physical activity on the
outcome of chronic disease related to chemical exposure should be included. The
second half of this chapter will describe the cardioprotective properties of exercise
leading up to the rationale for this dissertation work.
1.3. Exercise
Physical activity is defined as “any bodily movement produced by skeletal
muscles that results in energy expenditure beyond resting expenditure.” Exercise is a
subset of physical activity that is planned for the purpose of improving one’s physical
fitness. The American College of Sports Medicine defines exercise as “Any and all
activity involving generation of force by the activated muscles that result in disruption of
a homeostatic state”107. Exercise can be classified by the type, intensity, and duration of
activity. Endurance exercise reflects extended and continuous periods of contractile
activity against low resistance compared with resistance exercise (or strength training)
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which involves short periods of contractile activity against a high resistance108. It has
been shown that protection from cardiovascular disease occurs in those who are
regularly physically active, however, beginning an exercise program at any age will
improve cardiovascular health109. Because daily physical activity is considered to be an
effective component in preventing cardiovascular disease, most cardiologists prescribe
physical activity regimens into primary and secondary prevention programs110. Clinical
trials have demonstrated that patients who have had a cardiac event but undergo
cardiac rehabilitation will have decreased rates of mortality111–113. Daily physical aerobic
activity is considered an effective prescription in preventing one’s risk for cardiovascular
disease10. It has been well-established that exercise protects against cardiovascular
disease, but the complex set of metabolic pathways, hemodynamic effects of exercise
on vasculature, and the regulation of genetic expression activated by exercise are not
fully elucidated.
1.3.1. The Vascular Response during Acute Exercise
During resting conditions, the heart provides enough blood or cardiac output to
sustain basal metabolic needs while central cardiovascular reflex systems maintain
blood pressure. Within each tissue, a network of resistance arteries control the amount
of resistance needed in order to receive adequate blood supply to meet metabolic needs
of that tissue. Within the resistance arteries, vascular smooth muscle (VSM) controls the
level of contraction. VSM are also influenced by sympathetic nerve innervation as well
as local factors, thus establishing tone and integrating the many inputs that regulate
constriction114.
Initiation of muscle contraction during exercise increases the body’s requirement
for nutrients and oxygen. Within the skeletal muscle, vascular control mechanisms work
in a linear fashion to increase blood flow, which meets this increased metabolic demand.
Central control processes also lead to a linear increase in heart rate and cardiac output
to match the needs of the contracting skeletal muscle115. The increase in cardiac output
is supplied by an enhanced venous return which is due to a decrease in visceral blood
flow as well as the phenomenon of the muscle pump116. The muscle pump refers to the
compressive effects of muscle contraction on veins within the contracting skeletal
muscle. Vascular resistance is the main control mechanism for blood flow during
exercise, which is controlled at the level of vascular smooth muscle cells in resistance
arteries of the muscle tissue117. There are complex interactions between
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vasoconstricting and vasorelaxing factors in the VSM of resistance arteries in active
skeletal muscles118. The net effect is that central sympathetic stimulation is
counterbalanced by an overall decrease in total peripheral resistance of the skeletal
muscle e.g. even a 5-fold increase in cardiac output during rigorous exercise mildly
increases mean arterial pressure114.
The local control of blood flow during exercise is mediated by the release of
metabolites from the active muscle, the mechanical stimulation of arteries supplying the
muscle, vasodilation within the arterial tree, and paracrine signaling from RBCs and
endothelial cells119. Changes in intravascular pressure during exercise result in the
myogenic response. The myogenic response occurs when arterioles dilate passively
with increasing pressure until a myogenic constriction occurs (range from 20-120
mmHg)120. If pressure continues to increase, the vessel wall will continue to dilate.
Relaxation of VSM can also occur from capillaries releasing vasodilators locally to
increase their blood flow120. An important role of endothelial cells is maintaining vascular
tone in large and small arteries by releasing vasconstricting mediators (e.g. endothelin1) and vasodilating substances (e.g. nitric oxide and prostacyclin). In a healthy
individual, the primary effect of endothelial cells appears to be endothelium-dependent
dilation (EDD) induced by ligands such as Ach and intraluminal flow-mediated dilation
(FMD) of arteries in response to increased blood flow during exercise121. The enhanced
relaxation of VSM during exercise is due to the release of NO from the endothelium.
ECs experience shear stress from the increase in blood flow during exercise which
causes NO release from the phosphorylation of eNOS by Akt. The diffusion of NO from
the ECs to VSM activates cGMP which induces vasodilation by inhibiting calcium entry
into the cell122.
At the central level, blood flow is controlled by cardiac output and vascular
resistance via the autonomic nervous system. Neurons involved in the central control of
blood flow are from both sympathetic and parasympathetic systems. Parasympathetic
control regulates heart rate while sympathetic effects regulate contractility, vascular
resistance and venous compliance through efferent neurons which innervate the
vasculature, heart, renal system, and adrenal medulla123. At maximal exercise,
vasodilation at the active muscle is centrally controlled to prevent overwhelming the
heart. A separate, central control of blood flow is necessary to prevent hypotension
which could occur from an overly vasodilatory response.
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1.3.2. Vascular response to chronic exercise
It has been shown in multiple animal and human models that chronic exposure to
physical activity results in improved cardiovascular function through increased maximal
oxygen consumption, increased maximal cardiac output, and increased blood flow
capacity in skeletal and cardiac muscle. In relation to the prevention of cardiovascular
disease, there is a strong argument that exercise is a natural “anti-atherogenic” activity
by reducing the risk of certain risk factors including hyperlipidemia, glucose intolerance,
and obesity. The molecular pathways responsible for the “anti-atherogenic”
characteristics of physical activity are just beginning to be revealed. Although chronic
exposure to exercise can influence the molecular pathways of several organ systems,
this section will focus on the current findings within the vascular endothelium.
1.3.3. Exercise Reduces Cardiovascular Risk Factors
Over the past thirty years, there has been a rapid increase in caloric intake and
sedentary lifestyle in developed countries. As a result of these changes, there has been
a parallel increase in cardiovascular disease and metabolic disorders including obesity,
type 2 diabetes, and metabolic syndrome. A sedentary lifestyle has been shown to be
an independent risk factor for these metabolic disorders that lead to atherosclerosis and
cardiovascular disease.124 Pedersen hypothesizes that physical inactivity leads to an
accumulation of body fat within the viscera that activates proinflammatory signaling
which promotes the development of these metabolic disorders, described as the “the
diseasome of physical inactivity.”125 On the other hand there is a plethora of scientific
evidence demonstrating that physical activity reduces and prevents atherosclerotic risk
factors as well as the disease itself.
1.3.3.1. Metabolic Disorders
During the late-Paleolithic era (50,000-10,000 BC), hunter-gatherers or ancestors
of the human race depended on physical activity to obtain food or survive during hostile
encounters. It has been suggested that ancient hunter-gatherers had cycles of feast and
famine that required large bouts of physical activity to obtain food because the food
supply was inconsistent. Thus, it is proposed that the human genome evolved to
ensure that metabolic advantage for these oscillating conditions. A thrifty gene adapted
in order to ensure adequate storage of fuel during times of famine including glycogen
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conservation and gluconeogenesis while glycogen storage, triglyceride synthesis, and
carbohydrate oxidation would predominate during times of feast. These metabolic
adaptations enabled our ancestors to hunt for food by performing intense bouts of
physical activity during times of famine.126

Since the late-Paleolithic era, several

revolutions (Neolithic, industrial, and telecommunication) have led to alterations within
the human environment. Since the latter half of the 20th century, a dramatic increase in
sedentary lifestyle has occurred with television viewing, video gaming and employment
involving sitting in front of a computer becoming the major activities of society127.
Furthermore, the food supply is plentiful. These societal changes (sedentary lifestyle
and plentiful food supply) have occurred too rapidly for the human genome to adapt.
The human genome has remained relatively stable since the arrival of Homo sapiens,
suggesting that our genome was not selected for physical inactivity.128 Based on
hypotheses from Booth and Chakravarthy, the combination of physical inactivity and
plentiful food supply has led to metabolic storage disorders since certain metabolic
genes continue to store fuel with it never being utilized through physical activity126.
Scientific evidence suggests that metabolism can be maintained without
modifying dietary restriction if physical activity is performed to match caloric intake.
However, when daily steps are reduced for 2-3 weeks in healthy males, insulin
sensitivity decreases and abdominal fat increases suggesting that calories used to
maintain muscle mass were partitioned to visceral fat129. Previous work has shown that
whole body insulin-sensitivity decreases rapidly in athletes when aerobic training ceases
or detraining occurs in just 7 days.130 These studies demonstrate the negative metabolic
consequences when physical activity is removed, which makes exercise appear to be a
natural regulator of insulin sensitivity. Wild animals do not exhibit metabolic disorders
because their physical activity is maintained. In experimental studies, rodents will
voluntarily run when placed in a cage with a running wheel; however, when the wheel is
removed epididymal fat and abdominal fat mass rapidly increase.131 In a separate study,
cessation of running led to a decrease in insulin sensitivity by reducing expression of the
insulin receptor and GLUT4 in skeletal muscle.132 Collectively, these studies suggest
that low physical activity levels can elicit an undesirable metabolic phenotype
characterized by reduced insulin sensitivity with subsequent increases in body fat and
triacylglycerol levels that lead to the development of cardiovascular disease. A growing
body of evidence shows a direct link between newly adopted sedentary activities such
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as television watching and risk for metabolic and cardiovascular risk factors in both
adolescents and adults133–135.
1.3.3.2. Insulin Resistance and Glucose Intolerance
Physical activity has been shown to reduce insulin resistance and glucose
intolerance in numerous studies. Additionally a review examined 8 studies in patients
with type II diabetes who underwent an exercise training program between 12-18
months found that participants lowered their hemoglobin A1c by 0.5-1% on average136.
The Diabetes Prevention Program has demonstrated the profound effects of exercise
compared to metformin in reducing the incidence of type II diabetes. The lifestyle
intervention which had participants perform 150 minutes of physical activity each week
over 2.8 years had a 58% reduction in incidence compared to 31% in metformin
group137. The Old Order Amish community, which is a conservative Christian sect, has a
low prevalence of type II diabetes. Recent studies have attributed this phenomenon to
the fact that the Old Order Amish maintain a much more physically active lifestyle
compared to non-Amish, communities within the United States138,139.
1.3.3.3. Blood Pressure
More than 40 randomized controlled trials including 2,674 participants have
examined the effect of exercise on resting blood pressure140. The average reduction for
systolic was 3.4 mmHg and 2.4 mmHg for diastolic. Vigorous exercise has been shown
to acutely reduce systolic blood pressure for up to 12 hours141. These studies have not
found a relationship between training frequency, duration, or intensity with reduction in
blood pressure, suggesting that there is not a dose response curve for exercise and
blood pressure; however, exercise may be only therapy needed for mildly hypertensive
patients142.
1.3.3.4. Lipoproteins
The association between serum cholesterol and CVD is well established within
the literature, therefore, reductions in serum lipoproteins that promote atherosclerosis
are thought to be protective and minimize risk. Low-density lipoprotein (LDL) and
apolipoprotein B have been correlated with cardiovascular disease and related events
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while HDL has been correlated with risk reduction. A meta-analysis of 52 aerobic
exercise training studies lasting >3 months demonstrated an average 5.0% reduction in
LDL-C and a 4.6% increase in HDL-C; however, specific dose response relationships
could not be established143. Within the HERITAGE (Health, Risk Factors, Exercise
Training, and Genetics) study, males with low HDL that participated in 5 months of
aerobic training demonstrated an increase in HDL (4.9%)144. Several groups have
reported increases in HDL (e.g. 0.008 mmol/L per mile of running each week145) with
moderate intensity exercise training146,147.
1.3.3.5. Exercise Reduces Atherosclerotic Plaque
Recently, studies have begun to assess the effect of exercise on the
development and progression of atherosclerosis in humans. Measurement of intimamedia thickness (IMT) of the common carotid artery is a common technique used to
quantify generalized atherosclerosis148. A meta-analysis reviewing the current literature
on exercise and carotid intima-media thickness demonstrates that physical inactivity is
associated with increased carotid IMT149. Hambrecht et al found that leisure physical
activity in excess of 1500 kcal/week inhibited the progression of coronary atherosclerotic
lesions measured by angiography in CAD patients150. Regression of lesions was
observed in patients expending greater than 2200 kcal/week. Similarly, another group
found a significant regression of coronary atherosclerotic lesions in seven out of
eighteen patients with angina who followed a 1 year intervention of exercise151.
Rauramaa et al. conducted a 6 year random controlled trial examining the effect of
exercise on atherosclerosis through the measurement of carotid artery IMT (intimamedia thickness). Although the progression of carotid IMT did not differ between the
control and intervention groups, a subgroup of patients not taking statins had a 40%
reduction in progression in the exercise group152. Although these results are promising,
it should be noted that coronary angiography and IMT measurements do not provide a
comprehensive measure of atherosclerotic plaque burden.
Because accurate assessments of coronary plaque composition and plaque
burden remain a challenge, autopsy studies in animal models of cardiovascular disease
provide a more thorough portrayal of the development and progression of
atherosclerosis. The effect of exercise training on atherosclerosis has been directly
measured post-mortem in a variety of animal models including monkeys, pigs, rabbits,
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rats, and mice. In the majority of studies, regardless of the animal model tested, animals
in the exercise group develop less aortic and/or coronary atherosclerosis than their
sedentary counterparts153. For example, a long-term exercise study utilizing pigs found
that 22 months of treadmill exercise reduced diet-induced atherosclerosis in both the
aorta and coronary arteries approximately 10 fold compared with sedentary animals154.
However, there have been a few studies reporting discrepancies in results. Williams et
al. reported no effect of exercise training on the extent of coronary artery atherosclerosis
in monkeys, despite improvements in other cardiovascular risk factors including
improved left ventricular ejection fractions and improved vasodilation of coronary
arteries155. A short term exercise study (8 weeks) utilizing pigs reported no change in
atherosclerosis, however, this could be due to the duration of the study.156
Mice are increasingly being utilized in atherosclerotic studies due to the
development of transgenic strains including LDLr-/- and ApoE-/- which develop
atherosclerosis at an accelerated rate157. More than twenty published studies have
examined the effect of exercise training in mouse models of atherosclerosis. Among
these studies, regardless of exercise intervention utilized (swimming158–163, treadmill
running164–170, or voluntary running171–177) each of these studies reported a decrease in
atherosclerosis following exercise. The implications of each of these studies is profound
in that numerous mechanisms were identified that show how exercise exerts its
protective effects. These potential mechanisms will be discussed below.
1.3.3.6. Exercise promotes plaque stability
Rupture of atherosclerotic plaque leads to acute myocardial infarction and stroke,
two dramatic clinical events that often lead to mortality. In order for plaques to rupture,
they must become vulnerable. A plaque is defined as vulnerable when the fibrous cap
thins, the smooth muscle content is low while the lipid core is enlarged (>50% surface
area), and inflammatory cells have accumulated within the lesion.77 Agents that
promote plaque stabilization are attractive therapeutic strategies in the prevention of
cardiovascular events. In ApoE-/- mice, swimming for six months led to a stabilization of
plaque as evidenced by decreased macrophage content, increased smooth muscle cell
content, thicker cap, and lack of adventitia inflammation159. In another study that utilized
ApoE-/- mice and treadmill running, plaque stabilization occurred with increased
collagen content, decreased macrophage and matrix metalloproteinase-2 content, and
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increased fibrous cap thickness178. Stabilization of plaque composition through exercise
is a desirable option as it could lead to a decrease in cardiovascular mortality.
1.4. Potential Mechanisms of Exercise that Protect Against Atherosclerosis: An
Implication for the Vascular Endothelium
As mentioned above, there is a plethora of clinical and experimental studies that
provide evidence for the cardiovascular protection that exercise provides. These
protective mechanisms include modulating the lipid profile, enhancing carbohydrate
metabolism and insulin sensitivity, reducing blood pressure, and reducing adipose
stores. Chemical signals (e.g. cytokines, metabolites released from muscles, humoral
factors) and hemodynamic signals acting on the endothelium (e.g. shear stress, blood
pressure and stretch, circumferential stress) are likely candidates that modify endothelial
cell (EC) gene expression during bouts of exercise. There is a growing body of evidence
that repeated exercise imposes shear stress and stretch on the artery wall can initiate
altered gene expression in ECs. A group of exercise physiologists would argue that
these gene expression changes induced by exercise training are the “normal” human EC
phenotype from our previous history of being hunters and gatherers124. This “normal”
phenotype is crucial to the maintenance of vascular tone, preventing VSM proliferation
and migration seen in atherosclerosis, inhibiting inflammation, and preventing the prothrombytic state seen in advanced cardiovascular disease179
1.4.1. Shear Stress
The endothelium is exposed to hemodynamic forces including shear stress.
Shear stress is an important stimulus as it has been shown to induce gene expression
changes involved in NO production, vascular remodeling, and angiogenesis34. The
increased shear stress at the endothelial surface can result in distortion of the EC
monolayer likely due to cytoskeleton rearrangement. Steady laminar but not oscillatory
flow increases Na-K-Cl co-transporter mRNA in cultured ECs and also increases the
conductance of K+ and Cl- channels, ultimately leading to vasodilation.180 The authors
propose that this transporter may act as a flow-sensor by upregulating transcription of
co-transporter proteins.

Steady rhythmic flow has impacts on the endothelial lipid

bilayer and increases its fluidity. Acting as a transducer, lipid components of the
membrane can discriminate changes in shear which initiates MAPK activation in the cell.
Prolonged laminar shear stress induced anti-inflammatory gene expression through the
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activation of Kruppel-like factor 2 and nuclear factor erythroid-2, which induce
transcription of the antioxidant heme oxygenase 1 and eNOS.181 Other antioxidant genes
upregulated by laminar shear stress include superoxide dismutase (SOD), glutathione
peroxidase (GPx)182.
Laminar blood flow from exercise regulates the orientation of EC lining the blood
vessels and influences processes such as angiogenesis. These signals from shear
stress move through the cytoskeleton to the intimal region of the basal endothelial
surface. Integrins are then phosphorylated and activate a multiple complex of nonreceptor kinases (FAK, c-Src, Shc, paxillin, and p130CAS) which along with their
adaptor proteins (Grb2, Crk) and guanine nucleotide exchange factors (Sos, C3G)
activate Ras family.183 Active Ras then activates Mitogen-activated protein kinase
(MAPK) which results in shear stress-induced upregulation of atheroprotective genes
that send anti-apoptotic and anti-proliferative signals, by increasing vascular NO
bioavailability and vascular remodeling184. In contrast, in regions with low and disturbed
flow (due to sedentary lifestyle or vessel shape) the atheroprotective genes are
suppressed while pro-atherogenic genes including c-Jun NH2-terminal kinases are
upregulated, thus promoting atherosclerosis.185 The vasodilation and platelet inhibition
of NO and prostacyclin have been studied extensively. Reduced NO and prostacyclin
levels can result in endothelial dysfunction, an initiating step in atherosclerosis186.
1.4.2. Nitric Oxide
Nitric oxide (NO) is a heterodiatomic free radical generated by oxidation of Larginine to L-citrulline by the enzyme, Nitric Oxide Synthase (NOS). NO has an
important role in the regulation of vascular tone, the inhibition of platelet aggregation,
and the control of adhesion molecules187,188. In vessels with atherosclerotic lesions,
there is a reduction of NO bioavailability which is associated with vasoconstriction,
platelet adherence and aggregation, leukocyte adherence to the vascular wall, and
increased proliferation of VSMC189. NO bioavailability can be indirectly measured by the
degree of endothelium-dependent dilation (EDD)190–193. It has been more than 20 years
since it was described that chronic exercise enhances EDD in canine coronary
arteries194. This phenomenon has been confirmed many times in a variety of clinical and
experimental models (reviewed in 195).
Exercise training, especially aerobic training, has been shown to improve
impaired EDD suggesting an increased bioavailability of NO. Regular exercise has also
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been shown to improve endothelial function in patients with CAD196,197 as well as heart
failure198. Specifically a 4 week aerobic exercise intervention improved EDD by 54% in
patients with CAD199. An important study by Hambrecht reported that exercise increased
eNOS mRNA expression 2-fold with a 3.2 increase in phosphorylation of eNOS on
serine 1177 residue after 4 weeks of regular exercise training in CAD patients150. This
study suggests that exercise led to an increase in enzymatic activity of eNOS and
increased bioavailability of NO since EDD improved.190
The increase bioavailability of NO from exercise could result from increased
expression of eNOS or prevented degradation of NO by reduction of ROS. Studies
utilizing cultured endothelial cells suggest that shear stress increases eNOS expression
and activity200,201. Further evidence for the role of NO in exercise capacity was
discovered in studies utilizing eNOS-/- mice. Running capacity in eNOS-/- is diminished
(50-60% less) than age-matched controls202. Other studies have shown that the
beneficial effects of exercise are negated when one allele is knocked out, suggesting
that full eNOS expression is required203,204. Additionally, regular exercise has been
shown to increase the antioxidant defenses, thus reducing NO degradation192.
Production of NO by the endothelium can influence expression of antioxidant enzymes
and cellular inflammation in vascular tissue.200 This increase in expression of antioxidant
enzymes including superoxide dismutase and glutathione peroxidase, could reduce the
NO degradation by reducing the levels of ROS. This increase in antioxidant enzymes
and eNOS seems to result from repetitive exposure to increased laminar shear stress
during acute bouts of training114. In summary, regular exercise increases blood flow and
subsequent shear stress which improves NO bioavailability and increases EDD.
1.4.3. Exercise Reduces Expression of Cellular Adhesion Molecules
The activation of endothelial cells by cytokines, oxidized LDL, and ROS can
induce the endothelial expression of cellular adhesion molecules including ICAM-1,
VCAM-1, E-selectin, and P-selectin which play a major role in the recruitment of
leukocytes to the vessel wall2. These molecules can be measured in the circulation as
soluble adhesion molecules since they are released into the bloodstream and are
considered to be important markers of endothelial cell dysfunction and inflammation205.
In cardiac patients, a 2 week exercise training intervention led to reduced circulating
levels of ICAM-1206. In patients with heart failure, a 12 week exercise training program
decreased the circulating levels of soluble ICAM-1, VCAM-1207, while a 20 week aerobic
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exercise training program decreased circulating levels of P-selectin208. Animal
experiments support this finding as well. Rabbits underwent exercise training on a
treadmill, 5 days per week for 8 weeks and had a significant decrease in circulating
levels of P-selectin and VCAM-1209. By reducing soluble adhesion molecule expression
most likely due to changes in shear stress and downregulation of other proinflammatory
cytokines, exercise training may be considered an effective non-pharmacological
intervention to reduce endothelial adhesiveness.
1.4.4. Endothelial Progenitor Cells
Endothelial function is dependent on the endothelium’s ability to repair after
injury. Endothelial progenitor cells (EPC) are circulating bone marrow-derived stem cells
that have the capability to differentiate into mature endothelial cells210. EPC are
mobilized from the bone marrow into general circulation to assist in regeneration of
damaged endothelium211. Exercise training has been considered one of the most
effective interventions in stimulating EPCs from bone marrow212. In human studies, both
healthy and CAD patients have increased the number of circulating EPCs after an
exercise intervention. A 280% increase in circulating EPCs was reported in one
study213. In an ApoE-/- model, it was found that exercise increased circulating levels of
EPCs as well172. Current literature supports exercise as an effective therapy in
enhancing endothelial regenerative capacity.
1.4.5. Exercise is Anti-inflammatory
Atherosclerosis is recognized as a chronic inflammatory disorder. Because
systemic markers of inflammation are elevated in the plasma in atherosclerosis,
reducing their levels through exercise or another pharmaceutical therapies (e.g. statins)
may be of interest in treating disease. The pathogenesis of atherosclerosis involves
several cytokines including IL-1, -4, -6, -8, -10) and macrophage-associated cytokines
including TNF-a, IFN-y, and colony stimulating factors214. Cytokines are further
categorized into pro-inflammatory or anti-inflammatory. The pro-inflammatory cytokines
have several roles including the induction of other cytokines and chemokines, the
expression of adhesion molecules on EC, the stimulation of cell proliferation and
differentiation, the release of matrix-degrading enzymes, and the regulation of the acutephase reaction214. Anti-inflammatory cytokines inhibit pro-inflammatory responses, thus
having an atheroprotective role.
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The anti-inflammatory effect of exercise has been well-established in human and animal
models (reviewed in215). During acute exercise, skeletal muscle releases IL-6 which
recruits IL-10 and other anti-inflammatory mediators while proinflammatory cytokines
such as IL-1 and TNF-a are not increased216. Several studies have demonstrated
chronic exercise training reduces vascular wall inflammation while increasing levels of
IL-10, and reducing levels of proinflammatory cytokines217–220. Consistent with these
findings, another study reported a 58% reduction in the production of the proinflammatory cytokines IFN-y, TNF-a, and IL-1B in cultured mononuclear cells as well
as circulating levels of CRP from patients who underwent a 6 month intervention of
exercise training221.
C-reactive protein is an acute phase protein produced by the liver in response to
inflammatory cytokines including IL-6222. CRP is a biomarker used by clinicians to
indicate a person’s chronic vascular inflammation223. There is evidence that CRP is a
proinflammatory mediator that contributes to atherosclerosis by increasing LDL uptake
by macrophages224, increased expression of MCP-1 and cellular adhesion molecules225,
and decreased production of NO by endothelial cells226. Several prospective studies
have examined the effects of exercise training on CRP level and suggest an antiinflammatory effect; however, none of these studies were RCTs. In a RCT study, 101
patients with stable CAD were assigned to percutaneous intervention with a stent or to
aerobic exercise training. After 24 months of training, there was a 41% reduction in CRP
levels217. These results were independent from statin therapy In a different study,
patients underwent 7 weeks of aerobic physical activity, but the 17.4% reduction in CRP
failed to reach statistical significance227. These studies suggest that duration of
intervention is important to the reduction of inflammation. It has been suggested that
exercise reduces CRP levels because of its overall effect on cytokine production
(primarily reductions in IL-1 and TNFa228). Additionally, reductions in obesity lead to a
decrease in adipocyte production of proinflammatory cytokines229. The decreased
production of cytokines in other tissues could be a potential mechanism as well.
1.4.6. Exercise Increases the Antioxidant Defense System
Under physiological conditions, ROS is removed by the cellular antioxidant
systems which include antioxidant vitamins, protein and non-protein thiols, and
antioxidant enzymes. Acute aerobic and anaerobic exercise increase vascular oxidative
stress and damage cellular proteins, lipids, and nucleic acids. In 1982, Davies et al.
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demonstrated that rat skeletal muscle produced free radical after exhaustive exercise230.
A small study of Tour de France participants were found to have tissue damage induced
by xanthine oxidase (XO) from exhaustive exercise231. This data was confirmed in
marathon runners and demonstrates that XO is a source of free radicals during aerobic
exercise. Although high levels of oxidative stress are damaging to cellular function,
“mild” levels of oxidative stress such as those produced during endurance exercise, may
be beneficial for cellular adaptation. Low to moderate amounts of ROS produced during
endurance exercise may be described as a “hormesis,” which is characterized by a
dose-response relationship in which a low dose is stimulatory and a high dose is
inhibitory232. In this context, free radicals can be seen as beneficial since they act as
signals to increase the antioxidative and defense systems.
Animals exposed to chronic training show less oxidative damage after exhaustive
exercise compared to trained animals. This protection occurs because endogenous
antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase,
and gamma-glutamylcysteine synthetase (GCS) are upregulated233. Another study in
Yucatan miniature pigs reported upregulation of SOD1 in the aortic endothelium
following exercise training234. In a study with C57Bl/6 mice , 3 weeks of exercise training
had a 3-fold increase in SOD-3192.

Upregulation of vascular SOD by exercise

provides an efficient way to detoxify superoxide and reduces the generation of
peroxynitrite, a potent ROS formed from NO and superoxide184. A recent clinical trial
examined the effects of exercise training in male patients with stable CAD. This study
found a significant reduction in NADPH oxidase which is a ROS-producing enzyme.
These changes in gene expression were accompanied with a reduced generation of
ROS and an improvement in EDD. These results suggest that exercise training
increases vascular levels of eNOS and SOD1 while decreasing levels of pro-oxidant
enzymes including NOX235. Exercise training initially increases levels of oxidative stress
but contributes to beneficial changes in vascular gene expression observed after several
weeks of exercise training.
There is a growing body of evidence that antioxidant supplementation prevents
the hormesis effect of aerobic exercise. In 1971, it was reported that vitamin E reduced
athletic performance in swimmers236. In triathletes receiving antioxidant supplementation
of coenzyme Q10, Vitamin C and E, there were no improvements on maximal oxygen
uptake, muscle fatigue, or muscle energy metabolism237. In runners receiving Vitamin C
supplementation, delayed muscle onset soreness (DOMS) persisted failed to decrease

22

the recovery process238. Within marathon runners, supplementation of Vitamin C
decreased improvements in running capacity239. In a study utilizing LDLr-/- mice,
supplementation with Vitamin E prevented the beneficial effects of exercise by
preventing upregulation of catalase and eNOS which led to increased atherosclerotic
lesions167. These studies indicate that ROS generated by exercise signal to increase the
expression and activity of antioxidant enzymes. Furthermore, supplementation with
antioxidants has been shown to blunt these cellular adaptations. Because ROS
generated from exercise leads to these adaptations, exercise can be considered as an
antioxidant.
1.4.7. Nuclear factor erythroid 2-related factor 2 (Nrf2)
Oxidative stress has been implicated in the development of atherosclerosis,
particularly within endothelial cells240. While the use of direct antioxidant
supplementation has been largely unsuccessful in reducing cardiovascular
mortality241,242, physical activity or bioactive metabolites that activate the antioxidant
response within the cell may be a non-invasive strategy for protecting against
cardiovascular disease. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a
transcription factor that responds to increased oxidative stress within the cell. Nrf2 binds
to cis-enhance sequence known as antioxidant-response elements (AREs) in the
promoters of target genes243. Target genes for Nrf2 include a diverse set of antioxidant
enzymes and cytoprotective genes and such as heme oxygenase 1 (HO-1),
NAD(P)H:quinone oxidoreductase-1 (NQO1), thioredoxin, glutathione metabolism genes
including glutathione peroxidase 2 (Gpx2), glutathione S-transferases (GSTs), as well
as genes involved in cell survival244.
Under normal physiological conditions, Nrf2 is located in the cytosol and kept
dormant by the inhibitory protein, Kelch-like ECH-associated protein 1 (Keap 1), which is
a substrate adaptor protein that associates with cullin3 to form a functional E3 ubiquitin
ligase complex, which targets Nrf2 for ubiquitination at the proteasome245. In response
to oxidative stress or other inducers, Nrf2 dissociates from Keap1, translocates to the
nucleus, and binds to antioxidant-response elements (AREs) in the promoter region of
target genes. Known Nrf2 inducers include flavonoids (e.g. epigallocatechin gallate and
quercetin), stilbenes (e.g. resveratrol and piceatannol), diferuloylmethanes (e.g.
curcumin) and organosulfur compounds (e.g. allilcin and diallyl trisulfide) which are
considered “xenohormetic” phytochemicals246.
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Nrf2 activation can provide protection against a variety of chemical insults. Nrf2
activation has been considered in chemoprevention because electrophilic insult by
environmental carcinogenesis is a hallmark of initiation of cancer. Zerumbone, a
sesquiterpene derived from tropical ginger and activator of Nrf2, suppressed chemically
induced papilloma formation in mouse skin247. Another class of electrophilic
phytochemicals include isothiocyanates such as sulforaphane, which has been shown to
strongly induce carcinogen detoxifying enzymes through activation of Nrf2248.
Nrf2 signaling is recognized as an adaptive response to environmental stressors,
thus it can provide protection against a variety of toxicants including persistent organic
pollutants. PCB exposure leads to proinflammatory signaling which is mediated by
increased cellular levels of ROS83 and can be exacerbated by glutathione depletion89.
Because Nrf2 activation upregulates several genes involved in glutathione metabolism
including gamma-glutamylcysteine synthetase, Nrf2 activation might provide protection
from PCB and its deleterious effects on the vasculature. Previous studies from our
laboratory have shown a reduction in proinflammatory signaling when endothelial cells102
or C57BL/6 mice249 were exposed to EGCG, a known Nrf2 inducer. Oxidized DHA
prevents pro-inflammatory signaling in endothelial cells exposed to PCB77 due to Nrf2
activation and induction of NQO1, a downstream target106. Additionally, PCB
metabolism often produces toxic quinones. NQO1, a downstream target of Nrf2, could
provide protection from PCB toxicity by detoxifying quinone metabolites250.
Although high levels of oxidative stress are damaging to cellular function, “mild”
levels of oxidative stress such as those produced during endurance exercise, may be
beneficial for cellular adaptation. In fact, when redox signaling is blunted through
exogenous antioxidant supplementation, many beneficial exercise adaptations including
lesion regression167 are blunted239. Low to moderate amounts of ROS produced during
endurance exercise are a part of “hormesis”, or a generally favorable biological response
to low exposure to toxins and other stressors. Exercise results in increased levels of
oxidative stress, thus upregulating antioxidant enzymes in various tissues (described
above), including GSH. In response to exercise-induced oxidative stress, Nrf2
dissociates from Keap1 and translocates to the nucleus, and binds to antioxidant
response elemends (AREs). There is a growing body of literature suggesting that Nrf2
activation occurs during exercise251–254. Research from animal studies have shown a
56% increase in Nrf2 expression in mice after an acute bout of swimming255. Nrf2 levels
increased 5-fold in skeletal muscle cells of trained male cyclists after an acute bout of
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cycling256. Moderate intensity exercise in aged C57BL/6 mice led to increased
expression of several Nrf2 target genes including GST, GCLC, HO-1, and NQO1 in heart
tissue suggesting that moderate exercise training can prevent some of the age-induced
ROS that leads to heart disease252. In a recent study, Nrf2-/- mice had increased levels
of ROS in cardiac tissue that were not reversed with exercise training. The authors
suggest that disruption of Nrf2 increased the heart’s vulnerability to oxidative damage
thus increasing risk for cardiovascular diseases257.
Since atherosclerosis is a low-grade inflammatory disorder characterized by
increased levels of oxidative stress2, Nrf2 has recently been explored as a
pharmacological target in cardiovascular disease. Several studies have demonstrated in
cultured endothelial cells exposed to laminar shear stress, an activation of Nrf2 and
subsequent upregulation of its target genes, which was implicated to be the cause for
reduction in atheroma in these areas of “atheroprotective” flow.103,258–261 Overexpression
of Nrf2 in endothelial cells prevented ROS-induced cytotoxicity and MCP-1
upregulation262. Nrf2 activation by pharmacological agents such as phytochemicals and
now endurance exercise, are emerging as promising therapies to reduce cardiovascular
disease.
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1.5 Scope of Dissertation
1.5.1. Aims of dissertation
The main purpose of this project was to determine if voluntary exercise could
protect against polychlorinated biphenyl-induced cardiovascular disease. The
secondary purpose of this project was to evaluate the mechanism of protection by
assessing the role of nitric oxide and Nrf2-mediated signaling pathways.
1.5.2. Rationale
PCB exposure is associated with hyperlipidemia, type II diabetes, obesity,
hypertension and cardiovascular mortality. It has become well-established that
individuals who engage in regular exercise have a reduced risk of developing chronic
disease including atherosclerosis. Exercise is considered a ‘natural” anti-atherogenic
activity because it prevents atherosclerotic plaque development, decreases inflammation
and adiposity, reduces hypertension, improves insulin sensitivity, and preserves
endothelial function. Previous findings in our laboratory have positioned nutrition as a
non-invasive therapy against polychlorinated biphenyl exposure within the vascular
endothelium. Administration of EGCG, a catechin found in green tea, upregulates the
antioxidant response through a Nrf2-dependent mechanism. Signaling pathways that
are modulated through nutrition intervention are also upregulated during exercise.
However, no one has yet examined whether exercise could protect against PCB-induced
cardiovascular disease. Furthermore, no studies have examined whether those who
engage in regular physical activity have lower body burdens of PCBs and other
persistent organic pollutants.
Determining the effects of exercise on PCB exposure will provide insight into
signaling pathways mediated by exercise within the vascular endothelium. Additionally,
these findings could encourage humans to remain or become physically active in order
to prevent the deleterious effects of pollutant exposure. Physicians and registered
dietitians maybe more likely to recommend exercise regimens to their patient at high risk
for environmental pollutant exposure as more studies reveal the link between
environmental exposure and chronic disease.
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1.5.3. Hypothesis and Specific Aims:
In the following studies, we have selected PCB 77 as an example of a coplanar
PCB that exhibits dioxin-like activity. The general hypothesis of the research described
in this dissertation is that exercise will protect against PCB-induced cardiovascular
disease Furthermore, we hypothesized that this mechanism of protection is mediated
within the vascular endothelium through an increase in bioavailability of nitric oxide. To
test these hypotheses the specific aims were proposed:
:
Specific Aim 1: To define PCB-induced cardiovascular disease and to
demonstrate that exercise protects against this pathology.
Specific Aim 2: To demonstrate that PCB toxicity leads to endothelial cell
dysfunction and that exercise prevents endothelial dysfunction through NO
signaling and redox status.
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Figure 1.1. Structure and nomenclature of polychlorinated biphenyls.
A) A biphenyl molecule showing the numbering and substitution (ortho, meta, para)
system that consists of 209 congeners.
B) Specific structure of PCB77 (3, 3’, 4, 4’-tetrachlorobiphenyl) that is studied
throughout this dissertation.
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Chapter 2: Effect of exercise on PCB 77-induced toxicity in LDL-R-/- mice
fed a high-fat diet
2.1 Synopsis
Atherosclerosis, the primary cause of heart disease and stroke, is initiated at the
vascular endothelium; and risk factors include exposure to environmental pollutants.
Polychlorinated biphenyls (PCBs) are persistent environmental pollutants that promote
proinflammatory signaling in the vascular endothelium. Previous work in our laboratory
has examined the potential role of nutrition in modulating the toxicity of PCBs in vascular
endothelial cells. It has been well-established that exercise can reduce the risk of
cardiovascular disease; however, it has not been examined whether or not exercise can
modulate PCB-induced cardiovascular inflammation and dysfunction. In the current
study, LDLr-/- mice were fed a Western diet (42% fat, 0.02% cholesterol) for 12 weeks to
promote an atherogenic phenotype and were divided into sedentary and exercise groups
at week 4. Mice in the exercise group were individually housed with a running wheel
while their sedentary counterparts were individually housed with no wheel. The mice
were further divided into two groups which were intraperitoneally injected with PCB77 at
a dose of 170 µM/kg mouse or safflower oil vehicle during weeks 6, 8, 10, and 12. The
major finding of this study was that 8 weeks of voluntary exercise led to a reduction in
plasma and hepatic cholesterol levels in PCB 77-treated animals as well as a trend
towards reduction in atherosclerotic lesions. A surprising finding was that exercise
appears to accelerate the inflammatory response in PCB-treated animals and increases
liver: body weight ratio suggesting that exercise may accelerate PCB toxicity. Results
from this study suggest that exercise has minimal effects on PCB-induced vascular
dysfunction using the LDL-R-/- mouse model.
2.2. Introduction
Cardiovascular disease remains the leading cause of death the in developed
world. Atherosclerosis is complex disease characterized by chronic low-grade
inflammation within the vascular wall2. Mouse models of atherosclerosis provide useful
tools for studying the development and progression of this disease157. Low density
lipoprotein receptor-deficient (LDLr-/-) mice are a model of familial hypercholesterolemia
with plasma lipoprotein levels mimicking that of humans263. There is an accumulating
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body of evidence that exposure to environmental pollution (e.g. polychlorinated
biphenyls (PCBs) is linked to the development of cardiovascular disease. For example,
workers exposed to phenoxy herbicides and PCBs in waste transformer oil had a much
higher incidence of cardiovascular mortality264. Yusho patients whom accidentally
ingested contaminated rice-bran oil had elevated levels of triglycerides and plasma
cholesterol, which are risk factors for CVD. A major route of PCB exposure for humans
is dietary intake of contaminated food primarily from animal sources265.
Research from our laboratory and others have shown that PCBs initiate
endothelial dysfunction, which is characterized by increased permeability, upregulation
cytokines and cellular adhesion molecules which recruit blood mononuclear cells,
proinflammatory signaling, and a decreased bioavailability of nitric oxide (NO)266.
Endothelial dysfunction is an independent risk factor for cardiovascular disease27.
Coplanar PCBs (e.g. PCB 77) bind to the aryl hydrocarbon receptor (AhR) which is a
transcription factor that binds to xenobiotic response elements (XREs) within the
promoters of downstream target genes66. Target genes of the AhR include cytochrome
P450 1A1 (CYP1A1), a phase I enzyme that becomes uncoupled during the metabolism
of coplanar PCBs68, thus producing oxidative stress within the endothelium and
subsequent endothelial dysfunction267.
Research from our laboratory and other groups has shown that nutrition can
modulate the toxicity of coplanar PCBs86,87,102,104,106,249. Specifically, our lab has
demonstrated that certain polyphenols found in fruits and vegetables including
quercetin101 and EGCG102 can attenuate PCB-induced pro-inflammatory signaling within
cultured endothelial cells. Diets high in polyphenols are associated with a reduction in
cardiovascular mortality268. In addition to diet, it has been highly documented that
exercise is an effective prevention against cardiovascular disease. The American Heart
Association publishes guidelines for prescribing exercise as primary and secondary
interventions in patients with CVD10. Exercise improves traditional risk factors of CVD
including hyperlipidemia144, hypertension142, adiposity269, inflammation152, and endothelial
function174. In LDLr-/- mice, treadmill running for 12 weeks led to a regression of the
disease166.
By using LDLr-/- mice, a well-documented model of atherosclerosis, we studied
the relationship between exercise and PCB 77 exposure. We chose a voluntary running
model to reduce potential stress of forced activity and the C57BL/6 background
possesses a high capacity for nocturnal running activity270. Our results indicate that
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exercise may protect against PCB 77-induced CVD by reducing atherosclerosis and
adiposity. Exercise failed to reduce PCB 77-associated risk factors of CVD including
hypertension, elevated LDL levels, and inflammation. Additionally, exercise further
upregulated CYP1A1 in PCB 77 exposed animals suggesting enhanced exposure to
PCBs as evidenced by higher plasma levels.
2.3. Materials and Methods
2.3.1. Chemicals
PCB77 was purchased from Accustandard, Inc. (New Haven, CT).

Tocopherol-

stripped safflower oil (vehicle) was obtained from Dyets (Bethlehem, PA). Reverse
transcriptase reagents were purchased from Fisher Scientific (Waltham, MA). Reagents
used for mRNA isolation and qPCR were purchased from Life Technologies (Grand
Island, NY).
2.3.2 Animal treatment
All experimental procedures were approved by the Animal Care and Use
Committee of the University of Kentucky. Animals were treated humanely with regard for
alleviation of pain. Male LDLr-/- mice (2 months of age, The Jackson Laboratory, Bar
Harbor, ME) were given ad libitum access to food and water and housed in a pathogenfree environment with a 12 h light: 12 h dark cycle for 12 weeks. Mice were fed the
Western Diet (Harlan TD.88137) for the length of the study. The Western diet is a
purified diet wit 21% anhydrous milkfat (butterfat), 34% sucrose, and 0.2% cholesterol.
Body weight was measured weekly. Mice were administered vehicle (tocopherolstripped safflower oil, 0.2 mL)), or PCB-77 (170 µM/kg) by intraperitoneal injection as
separate doses during weeks 6, 8, 10, and 12. IP injection administers PCB 77 directly
into the peritoneal cavity, thus bypassing potential gut microbiome and intestional
absorption effects. At the study end point, mice were euthanized with CO2 and
exsanguinated. Mice were not fasted before euthanasia. Ethylenediaminetetraacetic
acid (EDTA) was added to collected blood samples, briefly mixed, and centrifuged at
5000g for 5 min at 4o C to separate plasma. Plasma and tissue samples were frozen in
liquid nitrogen and stored at -80 o C.
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2.3.3. Exercise Protocol
Our model of exercise was the widely used voluntary running-wheel model,
previously described271. Each mouse randomized to exercise was placed in a modified
cage with wheel attached to a magnetic sensing mechanism. This allowed the running
activity of each mouse to be tracked by a computer, from which the corresponding
distance, speed, and amount of time spent running were obtained via ClockLab software
(Actimetrics, Wilmette, IL). The bout threshold was set at 20 rotations/min to measure
activity. This meant that any time the mouse was on the wheel and the rate of rotation
exceeded 20 r/min the data were included in the analysis. Exercise was completely
voluntary; mice were not forced in any way to exercise. The mice predominantly ran at
night for a total of 8 weeks. Individually caged sedentary controls were handled for the
same procedures and amount of time as the exercised mice.
2.3.4. Echo Magnetic Resonance Imaging
Fat mass and lean body mass were measured during week 12 by an echo
nuclear magnetic resonance imaging system (Echo-MRI; Echo Medical Systems,
Houston, TX, USA). This system uses the distinct resonance frequency of protons in
lipid and water to determine body mass. This system was available through the support
of the Center of Obesity and Cardiovascular Disease (COCVD) Center for Biomedical
Research Excellence (COBRE) grant from the National Institute of General Medical
Sciences (8 P20 GM103527-05) of the National Institutes of Health.
2.3.5. Quantification of PCBs
Tissue samples and serum were flash frozen and stored at -80C until analysis.
For the separation of analytes, we used a fully automated Dionex ASE 200 system
(Dionex Corporation, Sunnyvale, CA) for assisted solvent extraction and gel permeability
chromatography/mass spectrometry. Hexane is pumped into the top of an
electrochemical detection cell, which contains the sample and any in-cell cleanup
options. The cell is brought to elevated pressure and temperature, and then the extract
is forced out of the bottom of the cell and collected in a vial for additional cleanup if
necessary. Detection was performed with two microelectron capture detectors; we used
Chemstation software (Agilent, Palo Alto, CA) to run the system and interpret the
chromatograms. An external standard mixture of PCBs, at known concentrations was
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used to test for recovery of the extraction and quantification of PCBs. The limits for
detection for PCBs were 0.1 ng/g of tissue (or 0.05 ppm), with coefficient of variability
<3.5% and accuracy (error <1.5%).
2.3.6. Plasma cholesterol measurement
Plasma cholesterol concentrations were measured using an enzymatic kit (Wako
Chemicals USA, Richmond, VA, USA). Plasma lipoprotein distribution (n=6) was
resolved by fast performance liquid chromatography. Eluted fractions of samples from
individual mice were collected and measured to determine lipoprotein cholesterol
distribution. Lipoprotein cholesterol distribution of very low density (VLDL), low density
(LDL), and high density lipoproteins (HDL) was analyzed using Peak-Fit Software 4.1
version (Seasolve Software Inc., San Jose, CA, USA).
2.3.7. Liver cholesterol measurement
Liver cholesterol was measured as previously described272. Briefly, livers were
homogenized in Krebs-Ringer Solution through repeated low speed sonication for 30
seconds, 10 times. Liver cholesterol concentrations were measured using the enzymatic
kit described above. Data are expressed as cholesterol per mg wet tissue weight.
2.3.8. Blood pressure
Systolic blood pressure was measured using a non-invasive tail cuff method
(Kent Scientific) as described previously273. Briefly, mice were measured on a heated
platform at the same time of day for five consecutive days. Twenty measurements for
each mouse were obtained each day.
2.3.9 Quantification of atherosclerosis
Frozen aortic root tissues from mice in each treatment group were sequentially
sectioned from the origin of the aortic values to the region in the ascending aortic arch.
In our studies, we cut 10 um frozen sections of the aortic root. Nine tissue sections of
aortic sinus at 80 µm intervals were placed on a single slide. This creates serial sections
from the entire aortic root. Lesions were then stained with oil red O and quantified by
image analysis software (Image Pro, version 7.) We orientated the section relative to
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the disappearance of the aortic valve cusps and represented the lesion throughout the
root274.
2.3.10. Quantification of plasma components
For cytokine and chemokine measurement, blood samples were collected from
anesthetized mice by right ventricular puncture. Clotted blood was treated with EDTA
and spun at 1,200 g for 5 minutes, and the plasma was obtained and flash frozen and
stored at -80C. At analysis, all samples were thawed and multiple cytokines were
measured simultaneously by using an 18-plex kit (Millipore, St. Charles, MO) by
following the manufacturer’s instructions.
2.3.11. Quantification of mRNA using RT-PCR.
Total RNA was extracted from tissues using the TRIZOL reagent (Invitrogen Life
Technologies, Carlsbad, CA) according to the manufacturer’s protocol. Reverse
transcription was performed using the AMV reverse transcription system (Promega,
Madison, WI). The levels of mRNA expression were then assessed by RT-PCR using
7300 Real Time PCR System (Applied Biosystems, Foster City, CA) and SYBR Green
master mix (Applied Biosystems). Data analysis was performed using the relative
quantification method (ΔΔCt), in which relative mRNA expression for target mRNAs (i.e.,
VCAM-1 and MCP-1) was compared to a constitutively expressed gene (i.e., β-actin) in
the mRNA samples from tissues. β-Actin, CYP1A1, and catalase primer sequences for
SYBR Green chemistry were designed using the Primer Express Software 3.0 for RTPCR (Applied Biosystems) and synthesized by Integrated DNA Technologies, Inc.
(Coralville, IA). β-actin sequences were Forward: TGTCCACCTTCCAGCAGATGT,
Reverse: GCTCAGTAACAGTCCGCCTAGAA; CYP1A1: Forward:
TGGAGCTTCCCCGATCCT, Reverse: CATACATGGCATGATCTAGGT.
2.3.12. Statistical analysis
Data are represented as mean ± SEM. Two-way ANOVA was used, followed by
a post-hoc Tukey’s test to measure differences using SigmaPlot (version 12) software.
A student’s t-test was performed to measure differences among PCB concentrations
between sedentary and exercise groups. Differences with a value of p<0.05 were
considered statistically significant.
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2.4 Results
2.4.1. Exercise decreases body weight and fat mass in PCB 77-treated animals
All mice were weighted weekly throughout the study. At baseline, there were no
statistical differences among groups. During the first week, all mice were switched to the
Western diet and statistical differences were noted among groups (control, exercise
versus PCB, exercise; p<0.05) after the first week even though no exercise or PCBs had
been administered. These trends continued for weeks 2-3 with additional groups being
significantly different from each other (vehicle control, exercise compared to vehicle
control sedentary; p<0.05). At the beginning of week 4, half of the mice began the
voluntary wheel intervention. Mice from the control exercise group weighed significantly
more than other groups (p<0.05) which could be attributed to an increase in lean body
mass as Echo-MRI revealed. This trend continued through week 6. At week 6, mice
were dosed with 170 µM/kg of PCB 77 or vehicle.

At week 7, all groups lost weight

most likely due to the intraperitoneal injection; however, there were no statistical
differences noted among groups suggesting that the injection itself and not the
administration of PCB 77 led to weight loss. During the 8th week, all groups gained
weight suggesting recovery from the injection with no statistical differences among
groups noted. Another injection was given at week 8 with no observed weight loss. At
week 9 exercise groups continued to gain weight with the vehicle control having a
significant weight gain compared to PCB77-treated, exercised animals (p<0.05). At
week 10, all groups continued to gain weight with no statistical differences among each
other. During week 10, another injection was administered. Both groups treated with
PCB77 lost weight during this week with significant differences between vehicle control,
exercised mice noted (p<0.05).

This trend continued through week 12 with vehicle

control, exercise group weighing significantly more than PCB-exercise group and
sedentary groups (p<0.05). During week 12, an additional dose of 170 µM/kg PCB 77 or
vehicle was administered. At the conclusion of the study, vehicle control exercise mice
weighed significantly more than PCB 77-treated exercise mice and sedentary groups.
Body weight was quite varied throughout the study suggesting potential confounders
including Western diet and intraperitoneal injection. It should be noted that 3 mice in the
PCB, sedentary group died during the experiment. Autopsy revealed inflammation
around surrounding peritoneal injection. Exercise may have protected the PCB 77
group since no deaths occurred in this group during the study.
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Body composition was measured using an Echo-MRI system during week 12 of
the study. Two-way ANOVA revealed a statistical interaction between PCB77 and
exercise. A significant increase in lean mass was found among the exercise groups
(p<0.001, Figure 2-2A).

Among the exercise groups, mice treated with PCB 77 had

significantly less fat mass (p<0.001) Figure 2-2B). Compared to sedentary animals,
animals exposed to voluntary wheel running and PCB 77 had significantly less fat mass
as well (p<0.05).
2.4.2. Exercise increases liver size relative to body weight in PCB77-treated mice
Liver weights were weighed at the conclusion of the study. Statistical differences
were not found among liver weights in different groups; however, when liver size was
normalized to body weight, a significant difference was found between PCB77-treated
mice who exercised compared to vehicle control, exercised animals as well as
sedentary, PCB77-treated mice (p<0.05, Figure 2-3).
2.4.3. Running activity
After 4 weeks, 12 week-old male LDLr-/- mice were divided into 2 groups:
sedentary and exercise. Wheel-running activity was monitored continuously during the
entire 8 weeks of the exercise intervention. The results in Figure 2-3 show that control
mice ran approximately 7.2 km/day compared to 6.99 km/day for PCB77-treated mice.
Consistent with running distance, control mice ran at higher speeds (0.98 km/hour)
compared to PCB77-treated mice (0.87 km/hour). Interestingly, PCB77-treated mice
spent more time on average running (7.73 hours/day) compared to control mice (6.84
hours/day). Lerman et al. reported C57Bl/6 mice run approximately 7.5 km/day for
approximately 5 hours each day with a speed of 1.32 km/hour. LDLr-/- mice are bred on
the C57Bl6 background, but when exposed to PCBs, two aspects of voluntary wheel
running were reduced with average daily running distance of 93% and daily running
speed of 65% despite a 154% increase in time spent running. Further examination of
running data demonstrated no differences in distance or time run on a weekly basis, but
PCB-exposed mice did run significantly slower during weeks 4 and 5 (Figure 2-4).
2.4.4. Quantification of PCB77 in exercise and sedentary animals
PCB 77 was quantified through gas chromatography (GC)-mass spectrometry
system on frozen tissue samples including liver, soleus, and plasma. Plasma samples
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were pooled from 3 animals for each group. PCB 77 levels were undetectable in tissues
or plasma from vehicle-treated mice. PCB77 levels in liver and soleus samples did not
differ among sedentary or exercise groups. PCB 77 levels were tended to be elevated in
the exercise group compared to sedentary (Figure 2-5) suggesting that exercise leads to
mobilization of PCB from other tissues into the plasma. These results are consistent with
human findings which demonstrated that plasma concentrations of PCBs increased in
obese subjects who underwent weight loss.
2.4.5. Exercise reduces atherosclerosis in PCB 77-treated mice
Atherosclerotic lesion area was measured in the aortic root. Due to technical
difficulties, a sample size of 3 was examined in all groups. In control, sedentary animals
a mean lesion area of 0.206 mm^2 was determined. In sedentary animals administered
PCB 77, mean lesion area was 43% higher compared to control, sedentary animals
(0.206 mm^2 versus 0.294 mm^2 p=0.06). In control, exercise animals, mean lesion area
was 0.137 mm^2 (33% reduction compared to control sedentary, 53% reduction
compared to PCB, sedentary). In PCB 77, exercise animals, mean lesion area was
0.200 which is comparable to control, sedentary animals and approximately 32% smaller
than PCB, sedentary animals (p=0.051). Exercise led to a significant reduction in mean
lesion size regardless of PCB exposure. Due to a small sample size, only trends can be
noted.
2.4.6. Exercise reduces total plasma and liver cholesterol in PCB 77-treated mice
Because hypercholesterolemia is associated with PCB 77 exposure in both
human and animal studies and exercise has been shown to lower cholesterol, plasma
cholesterol concentrations were measured at 12 weeks. Exercise lowered plasma
cholesterol concentrations in both control and PCB77-treated animals (Figure 2-7A,
p=0.058). Resolution of lipoproteins through size exclusion chromatography followed by
nonlinear curve fitting analysis determined that exercise significantly decreased the HDL
concentration (Figure 2-7C, p<0.05). Exercise lowered LDL fraction in PCB 77-treated
mice, however, the results were not statistically significant. PCB 77 exposure
significantly elevated hepatic cholesterol; however, exercised animals had significantly
lower levels of hepatic cholesterol (Figure 2-7D, p<0.05).
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2.4.7. Exercise does not attenuate PCB 77 increases in systolic blood pressure
Systolic blood pressure at baseline in all study groups was similar. Although
exercise reduced systolic blood pressure in vehicle control-treated animals (Figure 2-8,
p=0.07), exercise did not lower systolic blood pressure in PCB 77-treated animals.
2.4.8. Exercise increases inflammatory parameters within the plasma of PCB 77exposed animals
To investigate the effect of exercise on inflammatory parameters in PCB 77treated mice, a mouse adipokine LINCOPLEX kit was utilized. In mice exposed to both
PCB 77 and exercise, significantly higher levels of t-PAI-1, TNF-α, IL-6, and MCP-1 were
seen compared to control, sedentary mice (Figure 2-9, p<0.05). TNF-a is an acute
phase reactant protein and risk factor for cardiovascular disease275. T-PAI-1 is a serine
protease inhibitor that prevents fibrinolysis and has been shown to accelerate
atherosclerosis276. IL-6 is a member of the interleukin family and has also been
implicated as a risk factor for cardiovascular disease214. MCP-1 is a chemokine involved
in the recruitment of monocytes from the bloodstream to the intima, a hallmark of the
initiation of atherosclerosis30. These data suggest that exercise accelerates PCB 77induced inflammation.
2.4.9. Exercise reduces leptin in PCB 77-treated animals
Leptin is an adipokine that plays a role in regulating energy intake and
expenditure and is proportionate to the level of adiposity. Leptin was measured in the
plasma and was found to be significantly lower in PCB, exercised animals in comparison
to the remaining groups (Figure 2-10, p<0,05). Leptin has been shown to be chronically
reduced during physical training and is proportional to body adiposity277.
2.4.10. PCB 77 exposure significantly increases expression of CYP1A1
To examine the effect of exercise on gene expression, CYP1A1 was measured in
livers using RT-PCR. CYP1A1 exposure was significantly elevated in PCB, sedentary
animals compared to control counterparts (Figure 2-11, p<0.05) and even more elevated
in PCB, exercise animals compared to PCB, control (p<0.01). These findings suggest
that exercise may have accelerated phase I metabolism as seen by the elevated
expression of CYP1A1 within the liver of these mice.
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2.5 Discussion
Exercise has been shown to have a positive effect on primary and secondary
prevention of cardiovascular disease. However, the effect of exercise on PCB-induced
cardiovascular disease has not been examined. In the current study, we propose that
exercise will protect against PCB-induced cardiovascular disease. To test this
hypothesis, we utilized male LDLr-/- mice fed a Western diet that were exposed to a
chronic dosing of PCB 77 with voluntary wheel running as an intervention. The major
finding of this study was that 8 weeks of voluntary exercise led to a reduction in plasma
and hepatic cholesterol levels with a trend toward a reduction in atherosclerotic lesion
size. A surprising finding was that exercise appears to accelerate the inflammatory
response in PCB-treated animals, increases liver: body weight ratio, and elevates
CYP1A1, thus suggesting that exercise accelerated PCB toxicity.
When LDLr-/- mice were exposed to PCBs, two aspects of voluntary wheel
running were reduced including an average daily running distance daily running speed of
65%. In a previous study it was reported that male LDLr-/- mice ran progressively less
throughout the study (6.4 hours and 10 km/day verus 5.5 km/day and 4 hours at end of
study173. Despite a reduction in average daily running distance, PCB-treated animals
had lower levels of plasma cholesterol and lesion size.
To the best of our knowledge, this is the first study to report the effects of
exercise against PCB-induced cardiovascular disease. We report a 32% reduction in
atherosclerotic lesion size in exercise, PCB-exposed animals compared to sedentary
counterparts. Previous studies in LDLr-/- mice have reported a 33% reduction in lesion
size173 compared to a 40% reduction in LDLr-/- mice that underwent forced exercise (i.e.,
treadmill running167 or swimming162.) Additionally, studies in other hypercholesterolemic
mice (e.g., the ApoE-/-) report lesion reductions between 30-54%. Because
hypercholesterolemia is a risk factor for atherosclerosis10, we examined hepatic and
plasma cholesterol levels. Running led to a small but significant reduction in plasma
levels of cholesterol. Additionally exercise reduced hepatic cholesterol content in PCB
77-exposed animals. Few studies are available that describe the effects of voluntary
exercise on hepatic lipids in hypercholesterolemic mouse models. It has recently been
reported that voluntary exercise reduces plasma levels of cholesterol including VLDL
and LDL sized lipoproteins while increasing hepatic lipoprotein lipase with lower hepatic
cholesterol storage in LDLr-/- mice173.

Another group reported reduction in hepatic

39

triglycerides after treadmill exercise 278. Control LDLR-/- fed a Western diet have 2.5
times greater hepatic triglyceride and cholesterol contents than chow-fed wild type
mice279. These previous studies along with our study suggest favorable effects on
hepatic lipid storage through exercise.
The protective effects of exercise on cholesterol turnover are not fully
understood. In one study, 12 weeks of aerobic exercise led to increase expression of
SRBI, LDLr, and Cyp27 within the liver suggesting that exercise could increase
cholesterol metabolism280. LDLr clears ApoB-containing lipoproteins from circulation281;
SRB1 promotes selective uptake of HDL-cholesterol within the liver282, and Cyp27 is the
rate limiting enzyme in the conversion of cholesterol to bile acids283. This study suggests
that a potential mechanism for exercise training is improvement in cholesterol clearance
which supports our findings of lower hepatic and plasma cholesterol levels. Increasing
cholesterol excretion within the feces is a strategy for preventing atherosclerosis
because it reduces plasma cholesterol. Surprisingly, studies describing the effect of
physical activity on enterohepatic circulation in humans and animal models are lacking,
however there are some early studies in humans demonstrating that exercise increases
sterol output and feces production284. Interrupting intestinal reabsorption during
enterohepatic circulation which causes enhanced excretion of PCB 77 and its polar
metabolites is another strategy that has been proposed to reduce body burden and
deleterious effects of PCB toxicity105. Because these animals were not orally gavaged,
initial metabolism was bypassed in the intestine, thus oral gavage may be more
appropriate model to investigate whether exercise may have an effect on intestinal
reabsorption and excretion of PCB 77.
Because atherosclerosis is an inflammatory disorder2, we examined the effects
of exercise on pro-inflammatory cytokines within the plasma. Circulating levels of IL-6,
TNF-α, t-PAI-1, and MCP-1 have emerged as independent risk factors for CVD275. The
anti-inflammatory effects of exercise have been well-documented in a number of studies
(reviewed in 215); however, few studies have been conducted within the LDLr-/- model.
Specifically, 8 weeks of voluntary exercise in the ApoE-/- model demonstrated a
significant reduction in the proinflammatory cytokines IL-6, TNF -α, and MCP-1172. In
another study, aged ApoE-/- mice fed a high fat diet for 4.5 months followed by 12
weeks of voluntary exercise had an 8-fold reduction in circulating IL-6 levels176. A recent
study reported that 12 weeks of voluntary exercise in LDLr-/- mice had no effect on
plasma levels of TNF-α, IFNγ, MCP-1, IL-6, IL-10173. This may indicate that within this
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model, voluntary exercise will not reduce inflammation even though atherosclerosis
lesion size was reduced. Our lab has previously reported that administration of PCB 77
(2 doses of 170 μM/kg body weight at days 1 and 7) upregulates MCP-1 and IL-6 in
male LDLr-/- mice fed a standardized diet containing 20% calories from fat285. Previous
studies have shown that administration of PCB 77 increases aortic expression of
vascular cellular adhesion molecule-1 (VCAM-1)104.
A surprising finding from this study was that exercised animals exposed to PCBs
had an increase liver: body fat ratio. Exercise suppresses accumulation of lipids within
organs and has been reported to reduce liver weight286 suggesting that the increase in
liver: body weight are due to PCB administration. Our lab reported PCB 77 exposure
significantly increased liver-to-body weight ratio in animals on a high fat diet and a
concurrent reduction in PPARα signalling81.
Other groups have reported that exposure to PCB 77 causes lipid peroxidation,
hepatomegaly, and increased oxidative stress within the liver58,287. Additionally,
reduction in PPARα signaling has been linked fatty acid accumulation and cirrhosis288.
Epidemiological studies from the 2003-2004 NHANES data have demonstrated an
association between PCB exposure and nonalcoholic liver disease289.
commonly used in studies assessing nonalcoholic steatohepatitis
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LDLr-/- mice are

and it has been

recently demonstrated that administration of PCBs can accelerate nonalcoholic fatty liver
disease in mice fed a high fat diet (42% milk fat)291. Inflammation is a hallmark of
nonalcoholic fatty liver disease with a number of proinflammatory signaling pathways
upregulated including NOD-like receptors, DAMPs as well as the cytokines IL-6, TNF α,
and MCP-1292. Exercised animals exposed to PCB 77 had much higher levels of
inflammation including t-PAI-1, TNF- α, IL-6, and MCP-1 which could indicate
steatohepatitis. This suggests that exercise may not overcome the proinflammatory
effects of PCB 77 exposure within the LDLr-/- model of atherosclerosis. Additionally,
exercise led to a significant upregulation of hepatic CYP1A1 in PCB 77 exposed
animals. Although no group has examined the effect of exercise on CYP1A1
expression, flavonoids including quercetin and EGCG have been shown to downregulate
PCB 77 induced expression of CYP1A1. A potential explanation for this phenomenon
could be the dosing regimen (animals were exposed to PCB 77 24 hours before
euthanasia) and enhanced lipolysis from exercise which could have led to increased
plasma concentrations of PCB 77 and its metabolites. In obese individuals who
underwent gastric bypass surgery, increased serum levels of persistent organic
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pollutants were observed. Before weight loss, POP body burden and induction of AhRtarget genes including CYP1A1 were elevated as well as deteriorating liver function, and
hyperlipidemia. Weight loss led to gradual increases in concentration of POPs, but
within 6-12 months of drastic weight loss, the overall body burden of such compounds
was significantly reduced by 10-15%293.
There are several limitations within this study. We found that voluntary exercise
reduced adiposity in PCB-treated animals despite consumption of a HFD. Although we
did not monitor food consumption, others have reported that exercise leads to an
increase in food consumption with a reduction in adiposity likely due to increased energy
expenditure from voluntary exercise269. Since PCB- treated animals exposed to
exercise had a reduction in adiposity but vehicle-treated animals did not, food
consumption should be examined in future studies to determine if PCB administration in
conjunction with HFD affects appetite. Because of small sample size in atherosclerotic
lesion analysis, additional studies are required to substantiate these initial findings.
Because sedentary animals gained a considerable amount of weight compared to the
exercised animals, we cannot conclude that these findings were caused by exercise
alone. Although we observed a reduction in hepatic cholesterol levels, we did not
measure total hepatic lipid content or cirrhosis. Future studies should assess the extent
of liver cirrhosis as well as monitoring changes in biliary excretion and overall body
burden. Although inflammation was not prevented, exercise may decrease overall body
burden of these environmental pollutants over time. Future studies should examine the
effect of exercise on PCB metabolism/excretion and overall body burden over an
extended length of time. An additional limitation could be the potential confounder of
high fat feeding. The majority of in vivo work within the fields of exercise and
cardiovascular disease utilize the ApoE-/- model and demonstrate positive outcomes in
exercised animals related to cardiovascular disease and its associated risk factors.
Additionally, the ApoE-/- model does not require high fat feeding for induction of
atherosclerosis, which would limit the confounder of high fat feeding. Future studies
should examine whether exercise can prevent PCB-induced cardiovascular risk factors
including glucose intolerance, endothelial function, antioxidative potential, and
hypertension within the ApoE-/- model. This work warrants additional studies to
substantiate a new role for exercise.

42

Figure 2-1 Exercise Increases Body Weight in Vehicle-treated Animals
Body weights were measured weekly. Data represent the mean ± SEM. Two-way
ANOVA revealed a statistical difference between vehicle control and PCB groups for
body weight. (*p<0.05 compared to vehicle control for body weight).
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Figure 2-2 Exercise Increases Lean Body Mass and Reduces Fat Mass in PCBtreated animals
A) Lean Mass and B) fat mass were measured through Echo-MRI. Two-way ANOVA
revealed a statistical difference between exercise and sedentary groups for lean body
mass (#p<0.001.) Two-way ANOVA revealed a significant interaction between PCB77
and exercise. *Significantly different compared to PCB77-treated sedentary animals.
#Significantly different compared to vehicle control exercise animals.
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Figure 2-3 Exercise increases liver: body weight in PCB77-treated mice
Liver and body weights were weighed at conclusion of the study. Data represent mean
± SEM. Two-way ANOVA revealed a statistical interaction between PCB77 and
exercise. *Significantly different from control, exercise (p<0.05) #Significantly different
from sedentary, PCB77-treated animals (p<0.05).
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Figure 2-4 Voluntary wheel-running performance in control and PCB77-treated
mice
Male LDLr-/- mice were housed singly in cages mounted with a running wheel with one
week of acclimation. Wheel-running activity was monitored continuously and analyzed
using a Clock-Lab Analysis program. A) Mean daily running distance B) Mean weekly
running time C) Mean running velocity (km/h) during the 9 weeks of observation. A
student’s t-test demonstrated that PCB77-treated mice spent more time running at lower
speeds during week 5 and 6 (p<0.05).
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Figure 2-5 Concentrations of PCB in tissues
PCB77 was quantified through gas chromatography (GC)-mass spectrometry system on
frozen tissue samples (liver, soleus, plasma). Data are mean ± SEM from 5 animals.
Plasma samples were pooled from 3 animals
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Figure 2-6 Exercise Reduces Mean Aortic Lesion Area.
The aortic root was serially sectioned on a cryostat with 10 µm sections. Lesions were
quantified through oil red O. The average lesion area spanning -240 to 240 µm is
depicted. Data represent the mean ± SEM (n=3). * compared to vehicle control,
sedentary (p=0.061). # compared to PCB77-treated sedentary mice (p=0.051).

48

Figure 2-7 Exercise reduced total plasma cholesterol and HDL total cholesterol
levels
Liver and plasma cholesterol concentrations were measured at termination. A) Liver B)
Plasma cholesterol was measured through enzymatic kit (p=.058 compared to PCB77treated sedentary mice). C) Lipoproteins were resolved by size exclusion
chromatography. D) Plasma cholesterol concentrations of Lipoprotein fractions were
calculated using a nonlinear curve fitting approach. Data represent the mean ± SEM of
5 animals. Two-way ANOVA revealed a statistically significant interaction between
exercise and PCB77 for HDL total cholesterol levels. * Significantly different compared to
vehicle control, exercise (p<0.05).# Significantly different compared to PCB77-treated
sedentary mice (p<0.05).
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Figure 2-8 Exercise fails to attenuate PCB77 increases in systolic blood pressure
Blood pressure was measured non-invasively through tail-cuff method (Coda). Data
represent mean ± SEM of 4 animals. (*p=0.07 compared to control, sedentary).
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Figure 2-9 Exercise increases serum t-PAI-1 and TNF-α levels in PCB77-treated
animals
Plasma samples were analyzed for t-PAI-1 and TNF-α levels using mouse adipokine
LINCOPLEX kit. Two-way ANOVA revealed a statistically significant interaction between
exercise and PCB77. *Significantly different between PCB, sedentary animals. (p<0.05)
# Significantly different from control, exercise animals (p<0.05)
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Figure 2-10 Exercise increases plasma levels of IL-6 and MCP-1 in PCB77-treated
animals
Plasma samples were analyzed for IL-6 and MCP-1 levels using mouse adipokine
LINCOPLEX kit. Two-way ANOVA revealed a statistically significant difference between
PCB and Control groups. *Significantly different between PCB, sedentary animals.
(p<0.05)
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Figure 2-11 Exercise reduces plasma leptin levels in PCB77-treated animals
Plasma samples were analyzed for leptin levels using mouse adipokine LINCOPLEX kit.
Two-way ANOVA revealed a statistically significant interaction between exercise and
PCB77. * Significantly different compared to control, exercise.
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Figure 2-12 Exercise upregulates CYP1A1 in PCB77 treated mice.
Liver mRNA was Isolated and CYP1A1 m RNA levels were measured using RT-PCR.
Two-way ANOVA revealed a statistically significant interaction between exercise and
PCB77. *Significantly different compared to vehicle control, sedentary (p<0.05)
#Significantly different compared to PCB77-treated sedentary mice (p<0.01)
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Chapter 3: The Effects of Physical Activity on PCB-Induced Cardiovascular
Disease in ApoE-/- mice
3.1 Synopsis
Cardiovascular disease is the leading cause of mortality in developed countries.
Polychlorinated biphenyls (PCBs) are persistent environmental pollutants that contribute
to the initiation of cardiovascular disease. There is strong evidence that exercise can
reduce the risk of cardiovascular disease; however, whether exercise can modulate
PCB-induced inflammation, endothelial dysfunction and atherosclerosis is unknown. In
this study we examined the in vivo effects of exercise on coplanar PCB- induced
cardiovascular disease and associated risk factors including impaired glucose tolerance,
hypercholesteremia, oxidative stress, inflammation and endothelium-dependent
vasodilation. Male ApoE-/- mice were divided into sedentary and exercise groups
(voluntary wheel running) over a 12 week period. Half of each group was exposed to
vehicle or PCB 77 (170 µM/kg) at weeks 1, 2, 9, and 10. Exposure to coplanar PCB
increased atherosclerosis and several risk factors associated with cardiovascular
disease, including glucose intolerance, hyperlipidemia, oxidative stress and systemic
inflammation. The 12 week exercise intervention significantly reduced several of these
pro-atherogenic parameters induced by PCB exposure. Exercise also lowered PCBinduced oxidative stress and upregulated some antioxidant enzymes including phase II
enzymes. There was a trend towards induction of atherosclerotic lesions and protection
by exercise.
3.2. Introduction
Cardiovascular disease remains the leading cause of death in developed nations.
A number of different factors including environmental and chemical exposures are
contributors to cardiovascular diseases. An accumulating body of evidence from
epidemiological, in vitro, and in vivo studies link cardiovascular disease to environmental
pollution, including exposure to persistent organic pollutants such as dioxins and
polychlorinated biphenyls (PCBs) 11. Dioxin exposure appears to be associated with
mortality from cardiovascular disease 294. Furthermore, residing near sites contaminated
with PCBs is associated with increased rates of hospitalization for coronary heart
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disease and acute myocardial infarction 295, and circulating levels of PCBs were
associated with atherosclerotic plaques in humans 296.
Because the endothelium is in immediate contact with blood, endothelial cells are
particularly vulnerable to environmental contaminants present in the circulation and
which can induce inflammation and endothelial dysfunction 83,297. The majority of proinflammatory effects from coplanar PCBs are mediated through the aryl hydrocarbon
receptor (AhR) (reviewed in 298). Activation of the AhR leads to transcription of the
detoxifying enzyme cytochrome p450 1A1 (CYP1A1) which when in the presence of
PCB can increase the levels of cellular reactive oxygen species (ROS), leading to
induction of pro-inflammatory genes and subsequent vascular dysfunction 267. Our
laboratory has demonstrated previously that exposure to PCB 77 increases the
expression of vascular cell adhesion molecule-1 (VCAM-1) 299, endothelial-derived
monocyte chemoattractant protein-1 (MCP-1) 285, and interleukin-6 (IL-6). Other groups
have shown that PCBs impair endothelium-dependent dilation 84 and promote obesityassociated atherosclerosis 82.
As pollutant emissions continue to increase (i.e., manufacturing and agriculture),
human exposure to these pollutants will rise, thus leading to the need for physiological
buffers to protect against pollutant-induced adverse health effects such as
cardiovascular disease. Data from our laboratory and other groups have provided
strong evidence that nutrition can modulate cardiovascular toxicity of environmental
pollutants 86,87,102,106,300; however, the effect of other lifestyle modifications such as
exercise on health risks associated with exposure to persistent organic pollutants
remains relatively unexplored. One such PCB study examined the effects of exercise on
the gut microbiome and found that 5 weeks of voluntary exercise attenuated PCBinduced alterations in proteobacteria 301. Exercise has been well-established as an
effective primary and secondary intervention for atherosclerotic cardiovascular disease.
Studies in both human and animal models have provided evidence that exercise exerts
beneficial effects on atherogenesis and coronary artery disease (reviewed in 302–304).
Exercise improves traditional cardiovascular disease risk factors including,
hyperlipidemia, obesity, insulin sensitivity and hypertension, as well as vascular function
affected by changes in redox status and inflammation 114. It has been shown that
aerobic exercise decreases atherosclerotic plaque formation 163,213,305 and reduces
neointima formation after carotid artery injury 168. Exercise has also been shown to
reduce proinflammatory cytokines in humans with coronary artery disease 218 and in
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animal models of cardiovascular disease 209. In ApoE-/- mice, exercise improves
endothelium-dependent vasodilation or relaxation in isolated aortas and decreases
vascular oxidative stress 172,174.
By using ApoE-/- mice, a well-documented model of atherosclerosis 157, we
studied the relationship between exercise and PCB 77 exposure. Our results indicate
that exposure to a coplanar PCB increased cardiovascular disease-related risk factors
including oxidative stress, vascular inflammation, hyperlipidemia, and glucose
intolerance, which may have contributed to the observed increase in atherosclerosis in
mice exposed to PCB. Exercise reduced atherosclerotic lesions as well as associated
risk factors in PCB-treated animals.
3.3. Methods
3.3.1. Chemicals
PCB 77 was purchased from Accustandard Inc. (New Haven, CT). Acetonitrile,
Oil Red O and other chemicals utilized were obtained from Sigma Aldrich (St. Louis,
MO).
3.3.2. Animal treatment & sample collection
Male ApoE-/- mice were obtained from the Jackson Laboratories (Bar Harbor,
ME). Each mouse was individually caged, handled, and used in compliance w3ith the
Animal Care and Use Committee of the University of Kentucky. Mice were given ad
libitum access to food (rodent standard chow) and water and housed in a pathogen-free
environment for 12 weeks. Body weight was measured weekly. Mice were administered
vehicle (0.2 mL tocopherol-stripped safflower oil, Dyets, Inc. Bethlehem, PA), or PCB 77
(170 µM/kg) by oral gavage as separate doses during weeks 1, 2, 9, and 10, and the
dosage was based on earlier studies demonstrating glucose intolerance306. Our model
of exercise was the widely used voluntary running-wheel model, previously described271.
We chose a voluntary running model to avoid the potential stressor of forced activity,
and the C57BL/6 background has been shown to have a high capacity for nocturnal
running activity. Each mouse randomized to exercise was placed in a modified cage
with the wheel attached to a magnetic sensing mechanism. This allowed the running
activity of each mouse to be tracked by a computer, from which the corresponding
distance, speed, and amount of time spent running were obtained via ClockLab software
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(Actimetrics, Wilmette, IL). Individually caged sedentary controls were handled for the
same procedures and amount of time as the exercised mice. Food intake was recorded
for 12 weeks. Mice were placed in a metabolic cage system (Techniplast, Inc.,
Philadelphia, PA) during week 12 to collect urine and feces. Fat mass and lean body
mass were measured by an echo magnetic resonance imaging system (Echo-MRI; Echo
Medical Systems, Houston, TX). At the study end point, mice were euthanized with CO2
and exsanguinated. Ethylenediaminetetraacetic acid (EDTA) was added to collected
blood samples, briefly mixed, and centrifuged at 5000g for 5 min at 4o C to separate
plasma. Plasma and tissue samples were frozen in liquid nitrogen and stored at -80 o C.
3.3.3. Glucose tolerance test
Mice were individually housed and fasted for 6 hours prior to the glucose
tolerance test performed during week 6 of the study. Blood was collected from the tail
vein and tested for glucose concentration with a glucometer (Freedom Freestyle Lite;
Abbott Laboratories, Abbott Park, IL). Mice were administered D-glucose (20% in saline,
oral gavage) and blood glucose was quantified at the following time points: 0 min, 15
min, 30 min, 60 min, 90 min, and 120 min. Total area under the curve (AUC; arbitrary
units) calculates the area below the observed concentrations without the presence of a
baseline value306.
3.3.4. Quantification of plasma cholesterol, lipoproteins and
cytokines/chemokines
We determined plasma cholesterol concentrations using an enzymatic kit (Wako
Chemicals USA, Richmond, VA, USA). Plasma lipoprotein distribution was resolved by
fast performance liquid chromatography. Eluted fractions of samples from individual
mice were collected and measured to determine lipoprotein cholesterol distribution.
Lipoprotein cholesterol distribution of very low density (VLDL), low density (LDL), and
high density lipoproteins (HDL) was analyzed using Peak-Fit Software 4.1 version
(Seasolve Software Inc., San Jose, CA, USA)273. Cytokines and chemokines were
measured simultaneously by using an 18-plex kit (Millipore, St. Charles, MO)285. Briefly,
analytes were read with a Luminex-200 machine (Invitrogen) according to
manufacturer’s instructions.
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3.3.5. Liver cholesterol measurement
Liver cholesterol was measured as previously described272. Briefly, livers were
homogenized in Krebs-Ringer Solution through repeated low speed sonication for 30
seconds, 10 times. Liver cholesterol concentrations were measured using the enzymatic
kit described above. Data are expressed as cholesterol per mg wet tissue weight.
3.3.6. Quantification of atherosclerosis
Frozen aortic root tissues from ApoE-/- mice within each treatment group were
sequentially sectioned from the origin of the aortic values to the region in the ascending
aortic arch as previously described274. Briefly, 10 μm frozen sections of the aortic root
were cut. Nine tissue sections of aortic sinus at 80 μm intervals were placed on a single
slide (Probe-On Plus; Fisher Scientific, Pittsburgh, PA). This created serial sections for
the entire length of the aortic root. Lesions were then stained with oil red O (Sigma
Aldrich, St. Louis, MO) and quantified by image analysis software (Image Pro, version
7). Sections were orientated relative to the disappearance of the aortic valve cusps and
represented the lesion throughout the root.
3.3.7. Quantification of PCBs and F2-isoprostanes
To determine systemic PCB and metabolite concentrations, PCB 77 and its
hydroxyl metabolites were isolated from plasma and tissue samples. Briefly, tissues
were homogenized (GenoGrinder, Thomas Scientific, Swedesboro, NJ) in deionized
water. Homogenates were extracted in acetonitrile with the following internal standards:
10 μM 13C12-labeled PCB126 internal standard (IS) and d6-PCB77 (Cambridge Isotope
Laboratories, Tewksbury, MA). Samples underwent sonication and centrifugation at
15,000 rpm for 5 min to remove plasma and tissue debris and repeated twice.
Supernatants (3 mL) were dried under N2 and reconstituted in 99:1 methanol: dl H2O
solvent mixture with 0.5% formic acid and 0.1% 5 M ammonium formate249.
Measurement of urinary F2-Isoprostanes (F2-IsoPs) is considered the gold
standard for assessment of in vivo oxidative stress307, and the assay was performed as
described by us elsewhere249. Briefly, Ethyl acetate:methanol (5:1) + 0.5% acetic acid
(v/v) + 10μM 8-iso-PGF2α-D4 (internal standard, Cayman Chemical, Ann Arbor, MI) was
added to urinary samples, vortexed, and centrifuged at 15,000 rpm for 5 min.
Supernatants were dried under N2 and reconstituted in methanol and acetic acid before
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solid phase extraction (SPE). Supel-Select HLB SPE columns (Sigma-Aldrich, St.
Louis, MO) were preconditioned with methanol and 0.5% acetic acid. Reconstituted F2IsoP samples were loaded onto Supel-Select HLB SPE columns (Sigma-Aldrich, St.
Louis, MO) and washed with 0.5% acetic acid followed by a wash containing 0.5% acetic
acid and 20% methanol. Analytes were eluted with methanol and dried under N2 before
reconstitution with 50:50 methanol: dl H2O.
After extractions were performed, plasma, tissue, and urinary levels of PCB 77
and its metabolites were analyzed using a Shimadzu ultra fast liquid chromatography
system coupled with an AB Sciex 4000-Qtrap hybrid linear ion trap triple quadrupole
mass spectrometer in multiple reaction monitoring (MRM) mode249. MRM transitions
monitored included 291.9/ 222.1 and 291.9/220 for PCB 77; 338/268.1 and 338/196.1 for
13C12 PCB 126 and 297.9/228.1 and 297.9/226.2 for d6-PCB77. In the MRM ion
transition the precursor ion represents the M⁺∙ and the product ion represents either [MCl] ⁺ or [M-2Cl] ⁺. MRM transitions monitored for PCB 77 metabolites: 352.8/306.9 for
hydroxy PCB77 and 368.8/322.9 for dihydroxy PCB 77. The precursor ion of the ion

transition is a formic acid adduct [M+FA-H]-, and product ion is [M-H]-. F2-IsoPs were

analyzed by integrating peak area i.e., area under the curve, AUC, relative to known
internal standard concentrations (AUC/IS). All values were normalized to urinary
creatinine values (Cayman Chemical, Ann Arbor, MI) and compared to ion transitions of
the internal standard (13C12 PCB126) with known concentration to calculate PCB
parent and metabolite pmol concentrations.
3.3.8. Gene expression of CYP1A1 and antioxidant enzymes
Total RNA was extracted from tissues using the TRIZOL reagent (Invitrogen Life
Technologies, Carlsbad, CA) according to the manufacturer’s protoco249. RNA
concentrations were quantified via the NanoDrop 2000 spectrophotometer (Thermo
Scientific, Waltham, MA) and reverse transcription was performed using the AMV
reverse transcription system (Promega, Madison, WI). The levels of mRNA expression
were assessed by quantitative real-time PCR using 7300 Real Time PCR System
(Applied Biosystems, Foster City, CA) and SYBR Green master mix (Applied
Biosystems). Data analysis was performed using the relative quantification method
(ΔΔCt), in which relative mRNA expression for target mRNAs was compared to a
constitutively expressed gene (i.e., β-actin) within mRNA samples from tissues. Primer
sequences (see Table 1) for SYBR Green chemistry were designed using the Primer
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Express Software 3.0 for RT-PCR (Applied Biosystems) and procured from Integrated
DNA Technologies, Inc. (Coralville, IA).
3.3.9. Statistical analysis
Data are represented as mean ± SEM. Two-way ANOVA was used, followed by
a post-hoc Tukey’s test to measure differences using SigmaStat software (Systat
Software, Point Richmond, CA). Differences with a value of p<0.05 were considered
statistically significant.
3.4. Results
3.4.1. Exercise reduces cardiovascular disease and associated risk factors in
PCB77-treated mice
We examined the effects of exercise on specific risk factors associated with
cardiovascular disease including obesity, glucose tolerance, hypertension, and
hypercholesterolemia. All groups gained weight during the study with sedentary groups
gaining approximately 3 grams of body weight and exercise groups gaining 5 grams of
body weight during the 12 week study, independently of PCB exposure (p<0.05,
Supplementary Figure 1A). Body composition was measured using an Echo-MRI
during week 12 of the study and a trend was seen in the exercise, PCB-treated group as
they exhibited less fat mass than sedentary counterparts (p=0.053) with a significant
increase in lean mass among exercise groups independent of treatment (p<.001
Supplementary Figure 1B). Because all treatment groups gained weight specifically in
lean body mass, this dosing regimen did not produce signs of PCB toxicity. Control mice
ran approximately 5 km/day for approximately 7 hours per day at a speed of 0.65
km/hour. PCB-treated mice ran less distance during weeks 10 and 11 for a shorter
period of time (approximately 6 hours per day and 5 km/day). Speed was not different
among groups. The running capacity in ApoE-/- mice is less than that of the LDLr-/mice. During weeks 10 and 11, both groups had significantly lower distance and time
spent running. Actogram analysis revealed disturbances in circadian rhythm which
could indicate interrupted light: dark cycles within the facility. Sedentary animals treated
with PCB 77 (170 µM/kg) showed a significant increase in blood glucose concentrations,
compared with vehicle control and exercise groups, in response to a bolus of
administered glucose (Figure 1A, p<0.05). The total AUC for blood glucose was
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significantly increased in sedentary mice treated with PCB 77 (Figure 1B, p<0.05) but
exercise attenuated this response (p<0.05)
Because hypercholesterolemia and hypertension82,308,309 are associated with PCB
77 exposure and exercise has been shown by several groups to lower cholesterol as
well as hypertension117,310,311, plasma cholesterol and systolic blood pressure were
measured. Exercise significantly reduced plasma cholesterol levels in PCB 77-treated
mice (Figure 3-2A, p<0.001). Resolution of lipoproteins through size exclusion
chromatography followed by nonlinear curve fitting analysis determined that exercise
significantly decreased both the VLDL (Figure 3-2b p<0.001) and I/LDL cholesterol
concentrations (p<0.01) in PCB 77-treated mice compared to sedentary counterparts.
No differences in HDL concentrations were found among groups. Similarly, exercise
significantly reduced hepatic levels of cholesterol in PCB 77-treated mice
(Supplementary Figure 4, p<0.05). Among sedentary animals, PCB 77 significantly
increased systolic blood pressure at the end of the study (Figure 3-3, p<0.001).
Exercised animals exposed to vehicle treatment displayed significantly lower systolic
blood pressure compared to vehicle-treated sedentary animals while animals exposed to
PCB 77 during exercise displayed significantly lower blood pressure than PCB-treated
sedentary animals (138 mmHg versus 149 mmHg, p<0.001) but remained comparable to
vehicle, sedentary levels (139 mmHg). Because atherosclerosis is recognized as an
inflammatory disease2, selected inflammatory parameters were investigated. To
determine the effect of exercise on inflammation, we measured an array of plasma
cytokine and adipokine concentrations. Significant decreases in interleukin 6 (IL-6),
monocyte chemoattractant protein 1 (MCP-1), chemokine (C-X-C motif) ligan1 (CXC1 or
KC), macrophage colony stimulating factor (M-CSF), and (monokine induced by gamma
interferon) MIG were detected in exercised mice exposed to PCB 77 compared to
sedentary counterparts (Figure 3-4A-E, p<0.05).
Administration of PCB77 tended to increase atherosclerosis more in both
sedentary than exercised animals (Figure 3-5). Exercised animals administered vehicle
had significantly lower levels of atherosclerosis compared to sedentary animals which
supports others’ findings (p<0.05; 17739.5 μm2 versus 48511.6 μm2). Exercise did not
significantly reduce mean atherosclerotic lesion size compared to sedentary animals in
PCB-treated animals (p=0.392) although the mean lesion size was reduced in these
animals. Due to the limited sample size within this study, a repeated study with more
power would better delineate the effect of exercise on mean atherosclerotic lesion size.
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3.4.2. Exercise reduces systemic oxidative stress and upregulates antioxidant
enzymes
Because inflammatory diseases, such as atherosclerosis, are redox sensitive, we
also assessed in vivo systemic oxidative stress. F2-isoprostanes (F2-IsoPs),
prostaglandin-like eicosanoids formed during fatty acid peroxidation, were measured in
urinary samples from all treatment groups. In PCB-treated animals, exercised mice had
significantly lower levels of 8-iPF2 α and iPF2 α-VI (p<0.05) compared to sedentary
animals. Because of an 8-fold reduction of oxidative stress in exercised animals, we
next examined expression of antioxidant genes. Overall, exercise significantly
upregulated the expression of catalase, glutathione peroxidase (Gpx), glutathione Sreductase (GSR) and glutathione S-transferase (GST) and led to downregulation of the
inhibitor of Nrf2, Keap1 (Figure 7).
Additionally, exercised groups exposed to PCB 77 had a significant
downregulation of CYP1A1 compared to sedentary counterparts, which could contribute
to the lower levels of oxidative stress. To assess whether exercise had an effect on
body burden, PCB 77 and its hydroxyl metabolite OH-PCB 77 were quantified in the
plasma and several tissues including liver, lungs, soleus, kidney, retroperitoneal white
adipose tissue, epididymal white adipose tissue, and subcutaneous white adipose
tissue. PCB 77 and OH-PCB 77 levels were undetectable in tissues or serum from
vehicle-treated mice or PCB 77 treated mice at the conclusion of the study. OH-PCB 77
levels in feces from sedentary mice were approximately 4 fold higher than those from
exercised mice, (Figure 8, p<0.05).
3.5. Discussion
There is substantial evidence that exposure to persistent organic pollutants
including dioxin and PCBs are linked to the incidence of cardiovascular disease and
heart failure which remain the leading cause of death in developed nations294,296,312
Dioxin and coplanar PCBs exhibit their toxicity by binding to the aryl hydrocarbon
receptor (AhR) which causes the upregulation of CYP1A1 expression which leads to an
increase in oxidative stress due to the uncoupling of CYP1A1 68. We have shown
previously that coplanar PCBs, including PCB 77 and PCB 126 are proinflammatory and
atherogenic in vascular endothelial cells 83,313. Coplanar PCBs have also been shown to
promote obesity 82, atherosclerosis 79, and diabetes 306,314.
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In most people, body burdens of environmental pollutants are prevalent, and
prevention against environmental chemical-induced disease pathologies remains a
challenge. Positive lifestyle changes such as healthful nutrition and an increase in
physical activity tend to protect against the development of inflammatory diseases such
as atherosclerosis, obesity and diabetes315–317. Evidence from our laboratory suggests
that antioxidant nutrients and related bioactive compounds found in fruits and vegetables
protect against environmental toxic insult to the vascular endothelium by increasing
antioxidant defense and by down-regulation of proinflammatory signaling 98,249; however,
the role of exercise remains largely unknown.
Data from this study provide evidence for the protective properties of physical
activity against cardiovascular disease. Exposure to PCB 77 in sedentary animals
elevated several risk factors associated with cardiovascular disease including glucose
intolerance, hypercholesteremia, hypertension, systemic inflammation, oxidative stress,
as well as increased atherosclerosis. Baker et al. have previously reported that coplanar
PCBs induce rapid and sustained glucose intolerance in an AhR-dependent manner306.
We demonstrate glucose intolerance in sedentary, PCB-treated animals that is
prevented in exercised animals. In the current study, sedentary, PCB-treated animals
had significantly higher levels of liver and plasma cholesterol, predominately in the VLDL
and LDL fractions. Our results extend previous findings which have shown that dietary
exposure to PCB77 significantly increases hypercholesteremia specifically within the
VLDL fraction that is associated with increased atherosclerosis82. Voluntary exercise
attenuated the hypercholesteremia but failed to significantly reduce the subsequent
increase in atherosclerosis. Within this study, voluntary running reduced lesion size by
22% compared to sedentary, PCB-treated animals. In vehicle-treated animals, exercise
reduced lesion size by 68% which supports previous findings159,169. These findings
suggest that exercise can prevent and/or delay the development of atherosclerosis in
vehicle-treated animals only. Additional studies that utilize a greater sample size are
needed to determine if exercise can prevent PCB-induced atherosclerosis.
Low-grade inflammation is a hallmark of endothelial dysfunction and
atherosclerosis2. We have demonstrated previously that coplanar PCBs can cause
endothelial dysfunction as evidenced by an upregulation of inflammatory mediators
including the cytokines IL-6 and MCP-183,102,285,297. In fact, PCB 77-treated animals that
were exposed to exercise had levels of inflammation that were similar to control,
sedentary animals. Exercise attenuated the PCB 77-mediated induction of inflammatory
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cytokines and chemokines including MCP-1, IL-6, and M-CSF (Figure 6). Because
inflammation is sensitive to redox changes or an increase in oxidative stress, we also
assessed in vivo systemic oxidative stress. Results from our study indicate that
exposure to PCB 77 leads to a dramatic increase in F2-isoprostanes in sedentary mice,
with much lower levels (8-fold) found in exercised animals, suggesting that exercise
protects against systemic oxidative stress associated with PCB 77 exposure.
Mechanisms of protective properties of physical exercise such as voluntary
exercise are not simple and may involve induction of phase II antioxidant enzymes254.
Under normal physiological conditions, Nuclear factor erythroid 2 like 2 (Nrf2) is dormant
within the cytoplasm while bound to its inhibitor, Kelch-like ECH-associated protein 1
(Keap1)245. In response to oxidative stress, Nrf2 dissociates from Keap1, translocates to
the nucleus, and binds to antioxidant response elements (AREs) to upregulate cellular
defense genes including GSH-dependent antioxidant enzymes (glutathione peroxidases
and glutathione S-transferases)244. Exercise training results in increased levels of
oxidative stress, which upregulates antioxidant defense mechanisms in various tissues
including the liver318. This phenomenon is known as hormesis, defined as a generally
favorable biological response to low exposure of toxins or other environmental
stressors.319 Our findings demonstrate a downregulation of the inhibitor protein Keap1
with an upregulation of several Nrf2 target genes including phase II antioxidant enzymes
Gpx1, GST, and GSR. Additionally, our results show a downregulation of the phase I
enzyme, CYP1A1, which has been implicated in contributing to oxidative stress in the
presence of coplanar PCBs68. Superoxide can uncouple eNOS320, the enzyme
responsible for the production of the potent dilator nitric oxide, thus producing
peroxynitrite and reducing endothelial-dependent dilation. We have previously shown in
cultured endothelial cells, exposure to PCB 77 leads to an increase in peroxynitrite.90
In addition to well-established protective mechanisms of exercise, including
down-regulation of inflammation through upregulation of antioxidant genes, our data with
PCBs also implicate increased metabolism of lipophilic compounds such as PCBs.
Compared to sedentary animals, we found that exercised animals exposed to PCB 77
had significantly less OH-PCB 77 metabolites within their feces. This suggests indirectly
that exercise increased drug metabolism and that most of the PCB 77 may have been
metabolized and/or excreted prior to the time of measurements (at the end of study).
Exercise can alter pharmacokinetics by affecting drug absorption and hepatic and renal
clearance of drugs 321. Four weeks of voluntary exercise in C57Bl/6 mice led to an
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upregulation of CYP7A1 and CYP27 which could aid in the secretion of cholesterol into
bile acids322. Our findings warrant further investigation to determine the effect of
exercise on coplanar PCB metabolism and excretion.
Although this is the first study to examine the effect of exercise on metabolism
and overall body burden of PCBs, other groups have investigated the role of bioactive
nutrients such as olestra105 and chitosan323 on excretion of toxicants including coplanar
PCBs. These studies demonstrate that these nutrients including charcoal and choric
acid324 inhibit the body from absorbing these compounds while chlolella325 and
chlorophyll326 promote its excretion from the body by disrupting gastrointestinal
absorption. To our knowledge, there is no published work examining the effect of
exercise on the metabolism, absorption, and excretion of environmental toxicants;
however, other groups have studied flavanones metabolism. Triathletes excrete
flavanones five-fold, which the authors propose occurs because of the overactivation of
the microbiota metabolism caused by physical exercise327. Future studies will
investigate levels of PCB 77 and its metabolites in a time course study in an attempt to
determine if exercise interferes with the absorption through overactivation of gut
microbiome or if exercise accelerates excretion, thus reducing body burden. We
propose that exercise may enhance the clearance of coplanar PCBs through an Nrf2dependent mechanism resulting in upregulation of phase II enzymes leading to
enhanced metabolism (Figure 9).
In summary, our study provides experimental evidence that exercise is beneficial
for protecting the vasculature against PCB-induced oxidative stress and inflammation.
Coplanar PCBs are persistent and a significant risk factor for endothelial injury and
associated cardiovascular disease. This is the first study to suggest that exercise can
increase the metabolism and clearance of environmental pollutants, thus implying the
need for additional studies to determine an effective regimen for protection. More
studies are needed to determine if exercise can delay or prevent adverse health effects
including atherosclerosis associated with PCB exposure.
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Figure 3-1. Exercise attenuates PCB 77-impaired glucose intolerance.
A) Blood glucose concentrations were examined in mice administered vehicle or PCB
77 (50 mg/kg). B) Total area under the curve (AUC) calculates the area below the
observed concentrations. Data present mean ± SEM (n=8). *Significantly different
compared to vehicle control, sedentary (p<0.05) # Significantly different compared to
PCB 77-treated, sedentary mice (p<0.05)
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Figure 3-2. Exercise reduces systolic blood pressure in PCB 77-treated mice.
Blood pressure was measured non-invasively via the tail cuff method (Coda). Data
represent mean±SEM (n=8). *Significantly different compared to vehicle control,
sedentary (p<0.05)# Significantly different compared to PCB 77-treated, sedentary mice
(p<0.05)
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Figure 3-3. Exercise reduces total plasma cholesterol and VLDL and LDL
cholesterol concentrations.
(A) Plasma cholesterol concentrations were measured at termination (B) Lipoproteins
were resolved by size exclusion chromatography. Circles of each point represent mean
values of each fraction from six individual mice of each group, and bars are SEMs. (C)
Plasma cholesterol concentrations of lipoprotein fractions were calculated using a
nonlinear curve fitting approach. Data represent the mean±SEM of 6 animals. Two-way
ANOVA revealed a statistically significant interaction between exercise and PCB77. *
Significantly different compared to vehicle control, sedentary (p<0.05). # Significantly
different compared to PCB77-treated sedentary mice (p<0.01).
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Figure 3-4. Exercise prevents upregulation of proinflammatory cytokines by
PCB77 exposure.
Plasma samples were analyzed for IL-6, MCP-1, and M-CSF levels using mouse
adipokine LINCOplex kit. Data represent the mean± SEM (n=5). * Significantly different
compared to vehicle control, sedentary (p<0.05). # Significantly different compared to
PCB77-treated sedentary mice (p<0.05)
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Figure 3-5. Exercise reduces atherosclerosis in PCB77-treated mice.
The aortic root was serially sectioned on a cryostat with 10 µm sections. Lesions were
quantified through oil red O. The average lesion area spanning -240 to 240 µm is
depicted. Data represent the mean ± SEM (n=6-8). Scale bar represents 500 µm
* Significantly different compared to vehicle control, sedentary (p<0.05).
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Figure 3-6. Exercise modulates PCB 77-induced oxidative stress.
Urine F2-isoprostane levels were measured by HPLC/MS MS to assess in vivo oxidative
stress induced by PCB77. All values were normalized to urine creatinine levels and for
IS recovery. Data are represented as mean± SEM (n=5). *Significantly different
compared to vehicle control, sedentary (p<0.05). # Significantly different compared to
PCB77-treated sedentary mice (p<0.05).
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Figure 3-7. Exercise upregulates antioxidant and phase II enzymes.
mRNA levels were measured using RT-PCR. Two-way ANOVA revealed a statistically
significant interaction between exercise and PCB77. Data are represented as mean
±SEM (n=8). *Significantly different compared to vehicle control, sedentary (p<0.05)
#Significantly different compared to PCB77-treated sedentary mice (p<0.05)
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Figure 3-8. Exercise decreases level of OH-PCB 77 in feces
PCB 77 and its hydroxy metabolites were measured in plasma and liver by UFLC/MS
MS and normalized to IS recovery.

Data are mean ± SEM (n=5). A student’s t-test

revealed statistical differences compared to sedentary animals (*p<0.05).
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Figure 3-9. Proposed signaling pathway for PCB detoxification in vivo.
PCB 77 is an AhR ligand and causes CYP1A1 upregulation, which when in the
presence of PCB 77 leads to superoxide production. Exercise effectively upregulates
the antioxidant response in the presence of PCB77 which allows for a more efficient
antioxidant response to environmental insult. (Adapted from Newsome et al JNB, 2013)
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Supplementary Figure 1. Exercise increases body weight and lean body mass.
A) Body weights were measured weekly. B) Food consumption was measured weekly.
C) Lean mass and D) fat mass were measured through Echo-MRI. Data represent the
mean ± SEM. Two-way ANOVA revealed a statistically significant interaction between
exercise and sedentary groups. * Significantly different compared to vehicle sedentary
groups (p<0.05).# Significantly different compared to sedentary groups (p<0.001)
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Supplementary Figure 3-2 Exercise increases liver: body weight in PCB77-treated
mice
Liver and body weights were weighed at conclusion of the study. Data represent mean

± SEM. Two-way ANOVA revealed a statistical interaction between PCB 77 and
exercise. *Significantly different from control, sedentary (p<0.05) #Significantly different
from sedentary, PCB77-treated animals and control, exercise animals (p<0.001).
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Supplementary Figure 3-3 Voluntary wheel-running performance in control and
PCB77 treated mice
8 week old male ApoE-/- mice were housed singly in cages mounted with a running
wheel. Wheel-running activity was monitored continuously and analyzed using a ClockLab Analysis program. A) Mean daily running distance B) Mean weekly running time
C) Mean running velocity (km/h) during the 12 weeks of observation. A student’s t test
demonstrated a trend that PCB77-treated mice spent less time running (p<0.05).
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Supplementary Figure 3-4 Voluntary wheel-running performance in control and
PCB77-treated mice
Male ApoE-/- mice were housed singly in cages mounted with a running wheel. Wheel
lrunning activity was monitored continuously and analyzed using a Clock-Lab Analysis
program.A) Mean daily running distance B) Mean weekly running time C) Mean running
velocity(km/h) during the experiment. A student’s t-test demonstrated that PCB77treated mice spent less time running during weeks 7, 9, 10, and 11 and covered less
distance during weeks 10 and 11 (p<0.05).
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Supplementary Figure 3-5 Exercise reduces hepatic cholesterol levels.
Data represent mean ± SEM. Two-way ANOVA revealed a statistical interaction
between PCB 77 and exercise. *Significantly different from control, sedentary (p<0.05)
#Significantly different from sedentary, PCB77-treated animals and control, exercise
animals (p<0.05).
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Table 3-1
Primers used for qRT-PCR
Gene name
Forward Primer
Reverse Primer 5’-3’
Fragment size
______________________________________________________________________________________
CYP1A1
TGGAGCTTCCCCGATCCT
CATACATGGAAGGCATGATCTAGGT
100 bp
Nrf2
GAGTCGCTTGCCCTGGATATC TCATGGCTGCCTCCAGAGAA
100 bp
Catalase
CAGAGAGCGGATTCCTGAGAGA CTTTGCCTTGGAGTATCTGGTGAT
100 bp
GSR
TCGGAATTCATGCACGATCA
GGCTCACATAGGCATCCCTTT
100 bp
GSTm2
ACACCCGCATACAGTTGGC
TGCTTGCCCAGAAACTCAGAG
118 bp
Gpx1
GTGGCGTCACTCTGAGGAACA CAGTTCTCCTGATGTCCGAACTG
125 bp

Copyright © Margaret O’Bryan Murphy 2014
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Chapter 4: Effect of exercise on PCB 77-induced endothelial dysfunction in
C57BL/6 mice
4.1 Synopsis
Polychlorinated biphenyls (PCBs) are persistent environmental chemicals, and
coplanar PCBs can induce oxidative stress and activate pro-inflammatory signaling
cascades which are associated with atherosclerosis. Physical inactivity is considered an
independent risk factor for CVD and has been shown to cause endothelial dysfunction.
Numerous studies in both humans and animal models have demonstrated a beneficial
role for exercise in the prevention and treatment of CVD. Thus, we hypothesized that
voluntary exercise can modulate PCB-induced endothelial dysfunction. To test this
hypothesis, C57BL/6 mice were placed on a voluntary exercise regimen for 5 weeks
before administration of PCB 77, 24 hours before euthanasia. Ex vivo vascular reactivity
studies were performed to measure endothelial function. Sedentary animals exposed to
PCB77 exhibited endothelial dysfunction as demonstrated by significant impairment of
endothelium-dependent-dilation (EDD), which was prevented in exercised animals.
Administration of tempol, a superoxide dismutase (SOD) mimetic restored endotheliumdependent vasodilation implicating increased superoxide levels as a cause of endothelial
dysfunction in these animals. Voluntary exercise decreased plasma F2-isoprostane
levels, an in vivo marker of oxidative stress. Furthermore, CYP1A1, a phase I detoxifying
enzyme was downregulated in exercised animals although liver and plasma levels of
PCB 77 were not different between groups. These data suggest that voluntary exercise
provides vascular protection by preventing PCB 77-induced endothelial dysfunction.
4.2. Introduction
Polychlorinated biphenyls (PCBs) are environmental pollutants that were
manufactured for use in dielectric and coolant fluids, lubricants, and flame retardants
due to their chemical stability. PCB production was banned in the United States in 1979
due to their carcinogenic nature41. Because of their chemical stability, PCBs continue to
persist in the environment. Human exposure occurs primarily through dietary intake of
contaminated food and continues to bioaccumulate within individuals328.
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The toxicity of coplanar PCBs is similar to dioxin and is mediated through
activation of the aryl hydrocarbon receptor (AhR), an orphan receptor that is classified as
a basic helix-loop-helix Per-ARNT-Sim transcription factor65. Upon ligand binding (e.g.,
PCB 77), AhR translocates to the nucleus and binds to xenobiotic response elements
(XREs) within the promoters of downstream target genes66. Coplanar PCBs increase
cellular oxidative stress through an uncoupling of cytochrome P450 (CYP1A1)-mediated
uncoupling mechanism68.
Human exposure to coplanar PCBs has been associated with cardiovascular
disease and its associated risk factors including diabetes77, hypertension48,
dyslipidemia329, and endothelial dysfunction84,313,330. Endothelial dysfunction is an
independent risk factor for cardiovascular disease27 and precedes the development of
atherosclerosis331.

Endothelial dysfunction is very common in patients with

atherosclerosis and hypertension332. Nitric oxide (NO) is a key regulator of normal
endothelial function. NO is produced by endothelial nitric oxide synthase (eNOS) during
the conversion of L-arginine to L-citrulline through receptor activation (e.g., muscarinic
receptors) or mechanical force (e.g., shear stress)320. NO relaxes blood vessels,
prevents platelet aggregation and adhesion, limits oxidation of low-density lipoprotein
(LDL) cholesterol, inhibits proliferation of vascular smooth muscle cells, and decreases
expression of proinflammatory cytokines187.
Oxidative stress is regulated by mechanisms that keep a tight balance between reactive
oxygen species and antioxidant enzymes that remove ROS. Excessive ROS leads to
cellular damage of DNA, lipid, and proteins333. We have previously shown in cultured
porcine aortic endothelial cells, administration of PCB 77 leads to an increase in reactive
oxygen species (ROS)313 and subsequent dysfunctional eNOS signaling90. eNOS
becomes uncoupled and produces superoxide instead of NO which reacts very rapidly
with existing NO to form peroxynitrite leading to endothelial dysfunction and subsequent
NFκB-mediated proinflammatory signaling. Endothelial dysfunction is most commonly
assessed by vascular reactivity studies that measure the vasodilator response in
isolated vessels to various pharmacological agonists334. Acetylcholine (ACh) is
commonly used to assess endothelial dependent vasodilation because it acts via
muscarinic membrane receptors with signal transduction through adaptor proteins that
lead to the release of NO. NO diffuses from the endothelial cell to smooth muscle cells
where it activates guanylate cyclase to produce cyclic GMP leading to smooth muscle
relaxation335. Ex vivo studies have demonstrated impaired acetylcholine-induced
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endothelium-dependent vasorelaxation in hypercholesterolemic animals158 as well as
C57BL/6 mice exposed to dioxin336. However, numerous studies have demonstrated the
benefits of exercise in restoring endothelial function d158,164,171,174,337. This likely occurs
by increasing NO bioavailability; however, the mechanisms are not fully understood.
Because ApoE-/- mice do not undergo endothelial dysfunction until later in life338
and LDL-/- mice require high fat feeding339, we utilized C57BL/6 mice to avoid such
confounders including age and diet. In this study, we hypothesize that exercise will
prevent PCB-induced endothelium-dependent dilation by reducing systemic oxidative
stress and increasing the bioavailability of NO.
4.3 Methods
4.3.1. Chemicals
We purchased PCB 77 from Accustandard Inc. (New Haven,
CT). Phenylephrine, Sodium Nitroprusside, Acetylcholine, Tempol, and L-NGNitroarginine Methyl Ester (L-NAME) were obtained from Sigma Aldrich (St. Louis, MO).
4.3.2. Animal treatment
Male C57BL/6 mice were obtained from the Jackson Laboratories. (Bar Harbor,
ME). C57BL/6 mice have been shown to exhibit high running behavior340. Each mouse
was individually caged, handled, and used in compliance with the Animal Care and Use
Committee of the University of Kentucky. Mice were given ad libitum access to food
(rodent standard chow) and water and housed in a pathogen-free environment for 5
weeks. Body weight was measured weekly. Urine and fecal samples were not obtained
in order to minimize stress within these animals. Mice were administered a single dose
of vehicle (tocopherol-stripped safflower oil, 0.2 mL)), or PCB 77 (170 µM/kg) by
intraperitoneal injection 24 hours before euthanasia. This dose has been shown to
produce endothelial dysfunction as measured by impaired endothelial-dependent
vasodilation (data not shown). At the study end point, mice were euthanized with
ketamine/xylene and exsanguinated. Ethylenediaminetetraacetic acid (EDTA) was
added to collected blood samples, briefly mixed, and centrifuged at 5000g for 5 min at 4o
C to separate plasma. Plasma and tissue samples were frozen in liquid nitrogen and
stored at -80 o C.
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4.3.3. Exercise
Our model of exercise was the widely used voluntary running-wheel model,
previously described271. Each mouse randomized to exercise was placed in a modified
cage with wheel attached to a magnetic sensing mechanism. This allowed the running
activity of each mouse to be tracked by a computer with Clock lab and Mat lab software
(Actimetrics, Wilmette, IL) from which the corresponding distance, speed, and amount of
time spent running were obtained.
4.3.4. Ex vivo vascular reactivity studies
Forty Male C57BL/6 mice were randomized to exercise or sedentary groups for
five weeks based on previous findings implicating a beneficial role of exercise when
exposed to PCB 301. Mice were anesthetized with ketamine/xylene. Aortas from each
mouse were perfused with Krebs Henseleit solution via the left ventricle and then
removed. Adventitia was carefully dissected free. Measurement of contractile activity
was performed using aortic rings as described previously341. Briefly, ascending (3 mm)
aortic segments were mounted by passing two tungsten wires through the arterial lumen
while immersed in Krebs Henseleit solution. Tension (1g) was maintained continuously
and recorded on a Micro-Med instrument. Krebs Henseleit solution was refreshed in
tissue baths every 10 min. After 30 min of equilibration, tissue viability was tested with
80 mM potassium chloride for 5 min. For dilation studies, vessels were pre-constricted
for 3 minutes with 10-6 M Phenylephrine and then exposed to a cumulative dose of
Acetylcholine (10-9 to 10-5 M). For endothelium independent studies, vessels were preconstricted with 10-6 M PE and exposed to a cumulative dose of SNP (10-9 to 10-5M).
Following a 30 min washout period, aortas were pre-incubated with TEMPOL (1 mM) or
L-NAME (10 μM) for 3 min prior to repeating the ACh dose response in pre-constricted
vessels.
4.3.5. Quantification of PCBs and F2- isoprostanes
PCB 77 and its hydroxyl metabolites were extracted from plasma and tissue
samples to determine systemic PCB and metabolite concentrations. PCB 77 and its
hydroxyl metabolites were isolated from plasma and liver samples (plus 10 μM 13C12labeled PCB126 internal standard (IS) and d6-PCB77, Cambridge Isotope Laboratories,
Tewksbury, MA) through extraction with acetonitrile and subsequent sonication and
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centrifugation at 15,000 rpm for 5 min to pellet plasma and tissue debris. Supernatants
were dried under N2 and reconstituted in 99:1 methanol: dl H2O solvent mixture with
0.5% formic acid and 0.1% 5M ammonium formate249.
Measurement of urinary F2-Isoprostanes (F2-IsoPs) is considered the gold
standard for assessment of in vivo oxidative stress307. We did not collect urine samples
for this study, however, plasma was obtained and has been shown to be a reliable index
for in vivo oxidative stress249.For F2-IsoP analysis, plasma samples were added to 5:1
ethyl acetate:methanol + 0.5% acetic acid (v/v) + 10μM 8-iso-PGF2α-D4 (internal
standard, Cayman Chemical, Ann Arbor, MI), vortexed briefly, and centrifuged to pellet
debris. Supernatants were transferred and dried under N2 and reconstituted in methanol
and acetic acid before solid phase extraction (SPE). Reconstituted F2-IsoP samples
were loaded onto pre-conditioned Supel-Select HLB SPE columns (Sigma-Aldrich, St.
Louis, MO) and washed with 0.5% acetic acid followed by washing with 0.5% acetic acid
containing 20% methanol. Columns were eluted with methanol, eluent was dried under
N2 and samples were reconstituted with 50:50 methanol: dl H2O.
Plasma and tissue levels of PCB77 and its hydroxyl metabolites as well as
plasmaF2-IsoPs were analyzed using a Shimadzu ultrafast liquid chromatography
(UFLC) coupled with an AB Sciex 4000-Qtrap hybrid linear ion trap triple quadrupole
mass spectrometer in multiple reaction monitoring (MRM) mode. MRM transitions
monitored: 291.9/ 222.1 and 291.9/220 for PCB 77; 338/268.1 and 338/196.1 for 13C12
PCB 126 and 297.9/228.1 and 297.9/226.2 for d6-PCB77. In the MRM ion transition the
precursor ion represents the M⁺∙ and the product ion represents either [M-Cl] ⁺ or [M-2Cl]
⁺.MRM transitions monitored for PCB77 metabolites: 352.8/306.9 for hydroxy PCB77
and 368.8/322.9 for dihydroxy PCB77. Precursor ion of the ion transition is a formic

acid adduct: [M+FA-H]- and product ion is [M-H]-. F2-IsoPs were analyzed by integrating
peak area (area under the curve, AUC) with regard to known internal standard
concentrations (AUC/IS). All values were subsequently normalized according to plasma
volume and compared to ion transitions of internal standard (13C12 PCB126) with
known concentration to determine PCB parent and metabolite concentrations (pmol/μL
plasma).
4.3.6. Plasma and liver cholesterol measurement
Plasma cholesterol concentrations were measured using an enzymatic kit (Wako
Chemicals USA, Richmond, VA.). Liver cholesterol was measured as previously
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described272. Briefly, liver tissue (30-50 mg) was homogenized in Krebs-Ringer Solution
through repeated low speed sonication for 30 seconds, 10 times. Liver cholesterol
concentrations were measured using the enzymatic kit described above. Data are
expressed as cholesterol per mg wet tissue weight.
4.3.7. Quantification of mRNA using RT-PCR
Total RNA was extracted from tissues using the TRIZOL reagent (Invitrogen Life
Technologies, Carlsbad, CA) according to the manufacturer’s protocol249. mRNA
concentrations were determined using a NanoDrop 2000 spectrophotometer (Thermo
Scientific, Waltham, MA). Reverse transcription was performed using the AMV reverse
transcription system (Promega, Madison, WI). The levels of mRNA expression were then
assessed by quantitative real-time PCR using 7300 Real Time PCR System (Applied
Biosystems, Foster City, CA) and SYBR Green master mix (Applied Biosystems). Data
analysis was performed using the relative quantification method (ΔΔCt), in which relative
mRNA expression for target mRNAs was compared to a constitutively expressed gene
(i.e., β-actin) in the mRNA samples from tissues. Primer sequences (see Table 1) for
SYBR Green chemistry were designed using the Primer Express Software 3.0 for RTPCR (Applied Biosystems) and synthesized by Integrated DNA Technologies, Inc.
(Coralville, IA).
4.3.8. Statistical analysis
Data are represented as mean ± SEM. Two-way ANOVA was used, followed by
a post-hoc Tukey’s test to measure differences using SigmaStat software (Systat
Software, Point Richmond, CA). Differences with a value of p<0.05 were considered
statistically significant. For vascular function studies, Two-way Repeated Measures
ANOVA was performed.
4.4 Results
Exercise training did not significantly change body weight among groups during
the study nor did an acute dose of 170 µM/kg of PCB 77 24 hours before euthanasia
(Figure 1). After one week of acclimation, mice ran predominantly at night for a total of 5
weeks for 6.2 h/day on average. The average speed of mice was 0.89 km/hour with
average distance 6.34 km/day (Figure 2). No differences were noted between
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experimental groups. PCB 77 concentration in plasma and liver samples were
examined to determine the systemic body burden and to determine whether acute
exercise would have an effect on metabolism and excretion of this toxicant. As seen in
Figure 3, plasma and liver levels of PCB 77 were much lower than its hydroxyl
metabolites. Sedentary animals had approximately 113 pmoles PCB 77 within the liver
compared to 118 pmoles in exercised animals. Exercise did not significantly change the
amount of parent compound in either liver or plasma levels; however, there was a trend
towards less OH-PCB 77 within the plasma compared to sedentary animals (64.6
pmoles in sedentary animals versus 42.4 pmoles in exercised animals; p=0.09). The
exercised animals had higher levels of hydroxyl metabolites within the liver (996 pmoles)
compared to sedentary animals (609 pmoles). Although there were not significant
differences among parent compound, the increase in hydroxyl metabolites within the
liver could suggest enhanced metabolism within exercised animals.
4.4.1. Exercise lowers F2-isoprostane levels
Analysis of F2-isoprostanes, prostaglandin-like eicosanoids derived from
arachadonic acid metabolism, is considered the most reliable marker of in vivo oxidative
stress. Plasma samples from mice that were sedentary or exercised and subsequently
exposed to PCB 77 were analyzed to determine whether exercise could decrease
toxicant-induced oxidative stress. Plasma F2-IsoP (including 8-isoPF2α, iPF2α-III,
PGF2α-IV, PGF2α-V, and PGF2α-VI) and F2-isoP metabolites (13, 14-dihydro-15ketoPGF2α) concentrations were determined. 13, 14-dihydro-15-ketoPGF2α and 8isoPF2α levels were not detectable within these animals. As seen in figure 4-5, exercise
led to a significant reduction in F2-isoPs including PGF2α-IV and PGF2α-V in mice
exposed to PCB 77, suggesting that exercise has potent antioxidative effects.
4.4.2. Exercise did not lower plasma and liver cholesterol levels
Because PCB 77 administration has been shown to increase plasma and hepatic
cholesterol82,342, we examined whether exercise could mitigate this effect. Acute
administration of PCB 77 did not increase plasma or hepatic cholesterol. Male C57BL/6
are resistant to hypercholesteremia unless dietary manipulation occurs339, thus our
findings support this notion.
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4.4.3. Exercise restores endothelium-dependent vasodilation in PCB 77-treated
mice
To substantiate the PCB-induced dysfunction of the vascular endothelium and
subsequent increase in atherosclerosis, vascular functional studies with isolated vessels
were performed. PCB 77 impaired ACh-dependent relaxation, an endothelial-dependent
event (Figure 7A). Two way ANOVA RM revealed that a statistically significant
interaction between treatment groups and concentration (p=0.002). Further analysis
revealed a statistical difference This reduced relaxation was rescued in vessels derived
from exercised but not from sedentary animals. Pre-incubation with Tempol, a
superoxide dismutase mimetic, was necessary to improve the PCB-induced relaxation
impairment observed in sedentary animals (Figure 7C). Pre-incubation with L-NAME, a
NO inhibitor, significantly reduced endothelium dependent relaxation (Figure 7D). As
previously reported 336, there were no differences in endothelium independent
vasodilation among all treatment groups implicating the importance of the vascular
endothelium and not smooth muscle cells in PCB-induced endothelial dysfunction.
4.4.4. Exercise reduces expression of CYP1A1
Cytochrome P450-1A1 (CYP1A1), a phase I metabolizing enzyme, as well as
several antioxidant enzymes were analyzed in liver samples. Significant CYP1A1
expression was seen in the presence of PCB 77, which has been shown previously,
while exercise attenuated this response (Figure 4-8). Surprisingly, exercise did not lead
to the upregulation of any antioxidant enzymes we analyzed including Nrf2 downstream
targets: GSR, GST, catalase, SOD-1, NQO1, and HO-1. This data suggests that
exercise led to decreased expression of CYP1A1, which could explain the significant
reduction in oxidative stress in exercised animals.
4.5 Discussion
Lifestyle changes such as nutrition and physical activity may modulate
environmental pollutant toxicity. Exercise has been shown to prevent endothelial
dysfunction and subsequent cardiovascular disease184. However, the effects of exercise
on coplanar PCB-induced endothelial dysfunction are unknown. In the current study, we
propose that reduction in oxidative stress and subsequent increased bioavailability of
NO is the main mechanism for the protective effects of exercise against PCB-induced

89

cardiovascular toxicity. To test this hypothesis, male C57BL/6 mice were exposed to
voluntary wheel running for 5 weeks. Our previous work has demonstrated that exercise
can reduce atherosclerotic lesion development within the aortic sinus (Chapter 3 of this
dissertation), thus we isolated aorta from exercised mice to perform vascular reactivity
studies in order to examine the effect exercise and PCB exposure have on endothelialdependent vasodilation.
Endothelial cells play an active role in regulation of vessel tone, blood
coagulation, and permeability. Endothelial dysfunction is a critical step in the
development of cardiovascular disease including atherosclerosis 333,343 . To further
investigate the role of the vascular endothelium in PCB exposure, we performed ex vivo
vascular reactivity studies. Exposure to PCB 77 led to severe impairment of
endothelium dependent vasodilation in sedentary animals. Exercise was able to prevent
the PCB-induced impairment. Reduced NO bioavailability is thought to be a primary
cause of endothelial dysfunction 332. Our data show that ACh-induced relaxation is
blocked in all groups but PCB 77-treated sedentary animals. Because the relaxation
response in exercised and control groups is significantly blunted when treated with the
NO inhibitor L-NAME, one could argue that increased bioavailability of NO is one of the
protective mechanisms of exercise within the vascular endothelium. In fact, preincubation with L-NAME significantly reduced endothelium dependent relaxation in all
groups, except in PCB-treated sedentary animals. Because pre-incubation with LNAME, a NO inhibitor, significantly reduced endothelium dependent vasodilation in all
groups, except in PCB-treated sedentary animals, NO-mediated mechanism may also
contribute to the protective effects of exercise against PCB-induced endothelial
dysfunction. Our work in cultured endothelial cells suggests that PCB can cause
dysfunctional NO signaling and subsequent rise in peroxynitrite 90. Interestingly, our data
did not show exercise modulating several cardiovascular disease risk factors including
plasma lipids or body weight, but there was a significant improvement in vascular
function. A potential explanation for this could be enhanced eNOS activity through
phosphorylation of ser1177344. Other groups have reported that despite changes in body
weight or glucose sensitivity, exercise led to an upregulation of phosphorylation levels of
eNOS following exercise345. Although we did not measure aortic levels of eNOS or peNOS, future measurements would substantiate our proposed mechanism of increased
bioavailability of NO especially since exercise has been shown to increase eNOS activity
in db/db knockout mice190.
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The superoxide mimetic Tempol rescued the impaired vasodilation in PCBtreated sedentary animals, suggesting a relationship between PCB exposure, increased
oxidative stress and dysfunction of the vascular endothelium. Previous publications
have reported rescue of dioxin-induced endothelial dysfunction by Tempol in sedentary
mice 267. This implies that exercise might normalize the redox status within the vascular
endothelium by reducing production of superoxide, thus improving vasodilation. Exercise
did not significantly change the amount of parent PCB 77 within liver or plasma;
however, there was a trend towards an increase of OH-PCB 77 within the liver and lower
plasma levels in these mice. We did not quantify adipose levels of PCB 77, which is a
limitation within this work as it has been reported that PCB 77 accumulates within the
adipose tissue306 and whether exercise affects this storage depot remains unknown.
Despite similar levels of parent compound of PCB 77 among exercise and sedentary
groups, exercise led to a significant downregulation of the phase I metabolizing enzyme,
CYP1A1 (Figure 4-8). This downregulation of CYP1A1 could explain the reduction in
superoxide levels since PCB 77 administration has been reported to lead to the
enzyme’s uncoupling and enhanced production of superoxide. Furthermore CYP1A1
KO mice are resistant to dioxin-induced endothelial dysfunction336. Surprisingly, our
results did not show an antioxidant response in many Nrf2 downstream targets including
HO-1, NQO1, GST, and GSR. Because Nrf2 is redox sensitive, this suggests that a lack
of oxidative stress in exercised animals (Figure 4-4) prevented its activation and
subsequent downstream gene expression. Stimulation of Nrf2 appears to require
induction of oxidative stress by a damaging agent such as PCB 77 which has been
reported in a similar study examining the effect of resveratrol on PCB 77-induced
glucose intolerance346. Because CYP1A1 was downregulated in these animals and less
oxidative stress was present systematically, Nrf2 may not have had the proper stimuli to
become activated. Together this data suggests that exercise attenuates PCB-induced
endothelial dysfunction by reducing levels of oxidative stress through downregulation of
CYP1A1 expression.
Another mechanism of PCB 77-induced endothelial dysfunction could be an
upregulation of Caveolin-1. Our lab has shown that PCB 77 administration increases
formation of caveolae and expression of Caveolin-192. A recent study demonstrated in
ApoE-/- mice that an increase expression in caveolin-1 protein expression is associated
with impaired endothelial dependent vasodilation. Additionally, there was a decreased
ratio of p-eNOS to eNOS in thoracic aortas of these mice suggesting a decreased
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activation of eNOS347. eNOS can directly interact with the scaffolding domain of Cav-1
and become inhibited348. Determining whether exercise could modulate caveolae-and its
associated signaling would be an exciting area of future research since studies are
currently lacking. One study has demonstrated that voluntary exercise can attenuate the
upregulation of caveolae-associated NAD(P)H oxidase subunits p47 and gp91 and
protects against glutathione depletion in mice exposed to methamphetamine through a
Nrf-2 mediated mechanism within cerebral microvessels340. Caveolin-1 can interact with
Nrf2 leading to inhibition of specific antioxidant enzymes as well as suppress its
transcriptional activity349. The recent discovery of Nrf2: Caveolin-1 cross talk is a new
area of research within our lab and whether exercise plays a role in downregulation of
Caveolin-1 thus increasing NO bioavailability through eNOS as well as enhanced activity
of Nrf2 is an exciting area to further explore.
Additionally, the same group has examined the effect of exercise on PCBinduced changes in the gut microbiome. Exercise was able to prevent PCB changes of
gut bacteria including the decreased population of Proteobacteria. PCB exposure can
disrupt intestinal cells and lead to a “leaky” intestinal mucosal barrier by disrupting tight
junction proteins which is likely to increase concentrations of PCBs in the systemic
circulation and lead to enhanced PCB accumulation in tissues350. In addition to
mediating changes of the vascular endothelium, exercise could lead to alterations in gut
microbiome as well as increased metabolism and excretion of these compounds by
preventing intestinal barrier disruption, increasing cholesterol turnover and subsequent
PCB clearance. Future studies are needed to further delineate the beneficial effects of
exercise on PCB-induced cardiovascular disease.
In conclusion, our results indicate that an acute dose of PCB 77 leads to
increased oxidative stress, upregulation of CYP1A1, and impaired endothelialdependent vasodilation in C57BL/6 mice. Voluntary wheel running prevented these
effects and prevented endothelial dysfunction. This study supports a new role for
exercise in preventing environmental pollutant-induced endothelial dysfunction by
decreasing systemic levels of oxidative stress and downregulation of CYP1A1.
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Figure 4-1 Voluntary exercise had no effect on body weight
Body weights were measured weekly. Body weight remained relatively constant in each
experimental group throughout the study. Data represent the mean ± SEM.
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Figure 4-2 Voluntary wheel-running performance
Male C57BL/6 mice were housed singly in cages mounted with a running wheel. Wheelrunning activity was monitored continuously and analyzed using a Clock-Lab Analysis
program. A) Mean daily running distance B) Mean weekly running timeC) Mean running
velocity during the 5 weeks of observation. Data represent the mean ± SEM (n= 8-9).
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Figure 4-3 The effect of exercise on PCB 77 and OH-PCB 77 concentration.
PCB 77 was measured in A) liver and B) plasma by UFLC/MS MS and normalized to
sample volume and IS recovery. Hydroxyl metabolites of PCB 77 were measured in C)
liver and D) plasma. Exercise did not significantly alter the amount of PCB 77 within
liver or plasma; however, there was a trend towards an increase of OH-PCB 77 within
the liver and lower systemic levels. Data are represented as mean ±SEM (n=5).
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Figure 4-4 PCB 77 induced oxidative stress is reduced in exercised animals.
Plasma F2-isoprostane levels were measured by HPLC/MS MS to assess in vivo
oxidative stress induced by PCB 77. Data are represented as mean ± SEM (n=5).
Exercise groups had reduced oxidative stress levels compared to sedentary groups
(*p<0.05).
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Figure 4-5 Exercise does not reduce plasma or liver cholesterol levels
A) Plasma and B) liver cholesterol concentrations were measured at termination through
an enzymatic kit. Data represent the mean ±SEM (n=8-9).
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Figure 4-6 Confirmation of Tissue Viability.
Aortic vessels were pre-constricted with KCl to assess tissue viability. Data represent
the mean ± SEM.
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Figure 4.7 Exercise restores endothelium-dependent dilation in PCB77 impaired
vessels Isolated aortic rings were dilated in response to ACh in a concentrationdependent manner. A) ACh-induced vasodilation was significantly attenuated in PCB,
Sedentary mice. B) No differences in vasorelaxation response to SNP. C) Pre-incubation
with Tempol (10-3M) restored vasodilation in PCB, Sedentary animals. (n=7)
D) Incubation of L-NAME (10-5M) significantly reduced ACh-dependent dilation in mice.
(n=7)
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Figure 4-8 Exercise reduces CYP1A1 and MCP-1 levels in PCB 77-treated animals.
mRNA levels were measured using RT-PCR. Two-way ANOVA revealed a statistically
significant interaction between exercise and PCB77. Data are represented as mean
±SEM (n=5-8). *Significantly different compared to vehicle control, sedentary (p<0.05)
#Significantly different compared to PCB77-treated sedentary mice (p<0.05)
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Table 4-1
Primers used for qRT-PCR
Gene name
Forward Primer
Reverse Primer 5’-3’
Fragment size
______________________________________________________________________________________
CYP1A1
TGGAGCTTCCCCGATCCT
CATACATGGAAGGCATGATCTAGGT
100 bp
MCP-1
GCAGTTAACGCCCCACTCA
CCTACTCATTGGGATCATCTTGCT
63 bp
Nrf2
GAGTCGCTTGCCCTGGATATC TCATGGCTGCCTCCAGAGAA
100 bp
Catalase
CAGAGAGCGGATTCCTGAGAGA CTTTGCCTTGGAGTATCTGGTGAT
100 bp
GSR
TCGGAATTCATGCACGATCA
GGCTCACATAGGCATCCCTTT
100 bp
NQO1
GGCATCCAGTCCTCCATCAA
GTTAGTCCCTCGGCCATTGTT
100 bp
SOD1
GAAACAAGATGACTTGGGCAAAG TTACTGCGCAATCCCAATCA
100 bp
GSTa1
AAGCCCGTGCTTCACTACTTC
GGGCACTTGGTCAAACATCAAA
159 bp
GSTa4
TACCTCGCTGCCAAGTACAAC GAGCCACGGCAATCATCATCA
109 bp
GSTm1
ATACTGGGATACTGGAACGTCC AGTCAGGGTTGTAACAGAGCAT
349 bp
GSTm2
ACACCCGCATACAGTTGGC
TGCTTGCCCAGAAACTCAGAG
118 bp
GSTm3
CCCCAACTTTGACCGAAGC
GGTGTCCATAACTTGGTTCTCCA
208bp
Gpx1
GTGGCGTCACTCTGAGGAACA CAGTTCTCCTGATGTCCGAACTG
125 bp
Gpx2
GTGGCGTCACTCTGAGGAACA CAGTTCTCCTGATGTCCGAACTG
125 bp
Gpx3
CATACCGGTTATGCGCTGGTA CCTGCCGCCTCATGTAAGAC
80 bp
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Chapter Five: General Discussion
5.1 Discussion
5.1.1 Summary
The purpose of this dissertation was to test the hypothesis that voluntary
exercise protects against polychlorinated biphenyl-induced cardiovascular disease and
that this protection is mediated through enhanced nitric oxide (NO) bioavailability and
Nrf2-mediated signaling pathways. The work presented in this dissertation
demonstrates a novel approach of how cardiovascular toxicity due to coplanar PCBs can
be mediated through aerobic endurance exercise. Within the LDLr-/- mouse model,
there is evidence suggesting exercise could reduce PCB-induced atherosclerosis;
however, confounding variables including problems from high-fat feeding and
intraperitoneal injection led us to switch models to the ApoE-/- mouse. Within this
model, we were able to show that exercise improved cardiovascular disease risk factors
including glucose intolerance, dyslipidemia, hypertension, systemic inflammation, and
oxidative stress compared to sedentary, PCB-treated animals. Additionally, exercise
reduced atherosclerotic lesions while upregulating antioxidant enzymes, which are
involved in phase II metabolism of PCB 77 and reduce oxidative stress. However,
exercise did not significantly reduce mean atherosclerotic lesion in PCB-treated animals.
This work suggests that exercise may increase the metabolism; in addition to, excretion
of coplanar PCBs. Exercise was identified as a treatment which prevented impaired
endothelial vasodilation due to acute exposure to PCB 77, our proven model for
coplanar PCB induced endothelial dysfunction. This work demonstrates several
protective properties of exercise within these models.
5.1.2. Effect of Exercise on PCB 77-induced toxicity in LDLr-/- mice
Atherosclerosis is the primary cause of myocardial infarction and stroke and
remains the leading cause of death within in the United States10. Mouse models that
mimic human disease including the LDLr-/- model are useful tools for examining
atherosclerosis157. The LDLr-/- requires feeding of a diet enriched in saturated fat as
well as cholesterol (0.15-1.25%), colloquially known as the “Western” diet because it
mimics the average dietary composition consumed by humans in the Western
hemisphere in order to develop atherosclerosis within the timeframe of our study157.
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Environmental pollutants, specifically polychlorinated biphenyls (PCBs), a type of
persistent organic pollutant, are linked to cardiovascular disease11. Specifically,
exposure to PCBs contributes to cardiovascular-related mortality73 and accelerate
atherosclerotic lesion formation82. Within this dissertation, we identify several risk
factors associated with cardiovascular disease including hypertension, inflammation, and
hyperlipidemia that are accelerated with PCB exposure, as well as provide further
evidence supporting that PCBs contribute to CVD.
There have been several mechanisms proposed to explain how PCB exposure
leads to CVD. Previous studies from our laboratory and others have shown that PCBs
bind to the aryl hydrocarbon receptor (AhR) on endothelial cells which is a transcription
factor that binds to xenobiotic response elements (XREs) within the promoters of
downstream target genes including cytochrome P450 1A1 (CYP1A1) to initiate
endothelial dysfunction, a common first step in CVD83. Once CYP1A1 becomes
uncoupled from the metabolism of PCBs oxidative stress begins within the endothelial
cells68. Elevated levels of oxidative stress (e.g. Reactive oxygen species) can lead to
the activation of redox sensitive transcription factors including Nκ-KB and AP-1 that
upregulate proinflammatory signaling molecules including monocyte chemoattractant
protein-1 (MCP-1) and interleukin-6 (IL-6)285.
Within this dissertation, male LDLr-/- mice were chronically exposed to PCB 77
(170 µM/kg) during weeks 6, 8, 10, 12. The major finding of this dissertation was that 8
weeks of voluntary exercise led to a reduction in plasma and hepatic cholesterol (Figure
2-7) as well as a trend towards reduced atherosclerotic lesions, after PCB exposure
(Figure 2-6). We examined plasma cholesterol levels because cholesterol constitutes a
major portion of atherosclerotic lesions and PCB exposure has been associated with
hyperlipidemia. We hypothesized that exercise would reduce plasma cholesterol levels
within PCB-treated animals. Recently, it has been shown that voluntary exercise
reduces plasma levels of cholesterol including, VLDL and LDL sized lipoproteins,
suggested to be from increased hepatic lipoprotein lipase that lowers hepatic cholesterol
storage in LDLr-/- mice173. Our findings demonstrate that exercise reduced plasma
cholesterol, thus supporting our hypothesis. This study suggests that aerobic exercise
training improves cholesterol clearance that in turn, reduces PCB toxicity, which is
supported by data from other labs173. Several studies have shown that one strategy to
prevent atherosclerosis is to increase cholesterol excretion to the feces because it
reduces plasma cholesterol173,351. Because PCBs are primarily excreted through feces
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upon metabolism into more hydrophilic compounds, a therapeutic approach such as
exercise which has been shown to improve cholesterol clearance through enhanced
biliary excretion is an exciting candidate. Future studies should further investigate the
effects of exercise on cholesterol metabolism and excretion by measuring fecal (e.g.
neutral sterols, bile acids, and PCB metabolites) and biliary secretions (e.g. cholesterol,
bile acids, and bile flow) in addition to jejunal NPC1I1 expression which is a known
cholesterol efflux protein.
A surprising finding was that exercised mice exposed to PCBs had significantly
lower levels of HDL. A review of the current literature suggests that exercise slightly
raises HDL levels with caveats including diet, reduction in body fat, and numerous single
nucleotide polymorphisms (SNPs) in Apo A-I, ABCA1, LPL, CETP, LIPC and GALNT2
that collectively may explain how a person’s HDL-C will response to exercise.
Additionally, we show that exercise leads to an accelerated inflammatory response in
PCB-treated animals and increased liver: body weight ratio compared to sedentary,
PCB-treated animals. Because exercise suppresses the accumulation of lipids within
the liver and reduces liver weight286, our findings indicate that the increased liver: body
weight ratio is due to administration of PCB 77. Our lab has previously reported PCB 77
exposure significantly increased liver-to-body weight ratio in animals on a high fat diet81.
Other groups have reported that exposure to PCB 77 causes lipid peroxidation,
hepatomegaly, and increased oxidative stress within the liver58,287. Although we
observed a reduction in hepatic cholesterol levels, we did not measure total hepatic lipid
content or cirrhosis. Future studies should assess the extent of liver cirrhosis as well as
monitoring changes in biliary excretion and overall body burden. PCB quantification in
tissues reveals elevated levels of PCB 77 in the plasma of exercised PCB-treated mice.
These findings suggest that exercise enhances lipolysis which leads to increased
plasma concentrations of PCB 77 and its metabolites.
Additionally, it should be noted that body weight varies significantly with a highfat diet alone, prior to treatments. This demonstrates that feeding of the Western diet
represents a potential confounding variable within this study; however, we did not
measure how PCB-77 affected appetite. Administration of PCB 77 in conjunction with
Ang II infusion was examined in both LDLr-/- and ApoE-/- mice to assess the extent of
atherosclerosis and abdominal aortic aneurysm (AAA) formation . There was less AAA
formation in the LDLr-/- mice and the authors propose that the Western diet, which
increases adiposity, may be causing the sequestration of PCBs in the adipose tissue. A
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limitation within this study is that we did not quantify PCB 77 within the adipose tissue of
these mice so we do not have the results to determine if Western diet feeding led to a
redistribution of PCB77 within adipose tissue.
Because of the potential confounding factor of the Western diet, future studies
should utilize a different murine model of atherosclerosis, the ApoE-/- mouse. The
majority of in vivo work within the fields of exercise and cardiovascular disease utilize the
ApoE-/- model and demonstrate positive outcomes in exercised animals related to
cardiovascular disease and its associated risk factors159,168,172,175,352. The ApoE-/- mouse
develops atherosclerotic lesions similar to that of humans but does not require high fat
feeding for atherosclerosis to occur338.
5.1.3 The Effects of Physical Activity on PCB-Induced Cardiovascular Disease in
ApoE-/- mice
As pollutant emissions continue to increase (i.e., manufacturing and agriculture),
human exposure to these pollutants will rise, thus leading to the need for buffers to
protect against pollutant-induced adverse health effects such as cardiovascular disease.
The most logical being physiological. Exercise has been shown to improve
cardiovascular disease risk factors including hyperlipidemia, obesity, insulin sensitivity,
hypertension, inflammation as well as the disease itself (reviewed extensively in Chapter
1). In this dissertation, we hypothesized that voluntary exercise protects against PCBinduced cardiovascular disease and its associated risk factors including hyperlipidemia,
glucose intolerance, hypertension, inflammation, and oxidative stress,
We utilized the ApoE-/- mouse model and opted for oral gavage administration of
PCB 77 in order to prevent injection-associated inflammation. Oral gavage of PCB 77
subjects the toxin to intestinal absorption and the microbiome which may have played a
role in metabolism as well. The dosing regimen was modified to a dosage of 170 µM/kg
administered during weeks 1, 2, 9, and 10 based on another colleague’s data that this
paradigm sustained glucose intolerance through week 12306. The exercise intervention
was lengthened to 12 weeks instead of 8 weeks based on the majority of studies utilizing
exercise as an intervention against cardiovascular disease 169,172,173,176,177,279. In this
dissertation, we demonstrate that voluntary exercise prevents several risk factors of
cardiovascular disease including glucose intolerance, hypercholesterolemia,
hypertension, systemic inflammation, oxidative stress, as well as atherosclerosis. Baker
et al. demonstrated that PCB 77 administration leads to impaired glucose intolerance
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that is associated with adipose tissue inflammation306. Although we did not investigate
the signaling pathways associated with adipose tissue or skeletal muscle glucose
uptake, exercise enhances insulin signaling and increases expression of GLUT4, a
transporter that allows glucose to enter the cell from circulation353. We showed that
exercise improved glucose tolerance in PCB-treated animals, Sedentary, PCB-treated
animals had significantly higher levels of hepatic and plasma cholesterol, predominately
in the VLDL and LDL fractions. Our results provide further insight that dietary exposure
to PCB77 significantly increases hypercholesteremia specifically within the VLDL fraction
that is associated with increased atherosclerosis82. Our laboratory previously
demonstrated that PCB77 administration leads to decreased expression of ATP-binding
cassette A1 which is responsible for cholesterol export from the liver as well as,
decreased expression of genes associated with fatty acid metabolism including fatty acid
synthesi and lipid transport/export, 104. There is considerable evidence that exposure to
PCBs leads to lipid changes in both plasma and liver tissues82,104,329,354. Multiple studies
have reported that an increases in liver microsomal lipids (e.g. total lipids, phospholipids,
neutral lipids, and cholesterol) after PCB administration342,354,355.

Voluntary exercise

has been shown to lower hepatic content and within our studies, voluntary exercise
lowered PCB-induced hepatic and plasma increased cholesterol levels. Epidemiological
evidence demonstrates a link between serum PCB level and the prevalence of
hypertension, regardless of age48. Hence, hypertension is an easily identifiable risk
factor for cardiovascular disease. Although we do not specifically investigate
mechanisms of PCB-induced hypertension within this dissertation, Chapter four provides
data that increased bioavailability of NO improving endothelial-dependent vasodilation in
affected vessels may be a possible mechanism.
Atherosclerosis is an inflammatory disorder, leading to the increased expression
of specific inflammatory molecules2. To determine if inflammation is a result of PCBexposure, we next assessed the presence of a diagnostic series of inflammatory
molecules within the plasma of these animals. Significant decreases in interleukin 6 (IL6), monocyte chemoattractant protein 1 (MCP-1), chemokine (C-X-C motif) ligan1 (CXC1
or KC), macrophage colony stimulating factor (M-CSF), and (monokine induced by
gamma interferon) MIG are detected in PCB77-treated, exercised mice compared to
sedentary counterparts (Figure 3-4A-E) suggesting improvements in the inflammatory
state. MCP-1 is a chemokine that attracts monocytes into the subendothelial space in
early stages of atherosclerosis. The recruitment of monocytes into the artery wall
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followed by their differentiation into macrophages and subsequently foam cells is an
early event in the pathology of atherosclerosis. Our lab has shown through in vitro and
in vivo studies that PCB 77 significantly upregulates MCP-1. An exercise regimen of
low-intensity (10,000 steps, 3 times per week for 8 weeks) among healthy human adults
(mean age 45) led to a significant reduction in proinflammatory cytokines IL-6, MCP-1,
and TNF-α. Reduction in circulating levels of MCP-1 could be atheroprotective since less
recruitment of monocytes would occur. KC is C-X-C chemokine that regulates monocyte
arrest (or anchoring to the luminal surface of a vessel) in early atherosclerosis and has
been shown to be reduced in aerobic exercise within several different models including
hind limb ischemia356 and acute lung injury357 further supporting the anti-inflammatory
effects of exercise. M-CSF (macrophage-colony stimulating factor) is a cytokine that
recruits monocytes to the sites of endothelial injury and is found within atherosclerotic
plaques in addition to in the circulation, where it is recognized as a biomarker of disease
progression. Deletion of M-CSF leads to reduced atherosclerosis from a reduction in
circulating monocytes358. The present dissertation provides the first report that aerobic
exercise leads to a decrease in circulating M-CSF. MIG or monokine induced by
interferon gamma is a chemoattractant expressed in the atheroma that recruits T cells to
inflammatory sites359. The data demonstrates that exercise significantly reduces
expression of MIG which supports previous findings that increased laminar flow (such as
during exercise) also reduces MIG expression in endothelial cells360.
PCB 77 exposure has been associated with increased levels of oxidative stress.
To address this, we examined urinary levels of F2-isoprostanes. F2-isoprostanes are
prostaglandin-like compounds formed from a non-enzymatic mechanism of free radical
peroxidation of arachadonic acid361. There are several end products of lipid peroxidation
including thiobarbituric reactive substances (TBARS), gaseous alkanes, and F2isoprostanes; however, measurement of F2-isoprostanes has proven to be a more
accurate marker of oxidative stress in vivo in human and other animals362. Advantages
of mass spectrometry over immunoassays include the high sensitivity and specificity for
molecules, which provides resolution to the picogram range (1 x 10-12). In humans,
levels of F2-isoprostanes are ~4-fold higher in atherosclerotic plaques compared to
normal vascular tissue363. Additionally patients with hypercholesterolemia had 3.4 fold
higher levels of F2-isoprostanes compared to normal controls307 and there was no
correlation with serum cholesterol, triglycerides, LDL-c, or arachadonic acid suggesting
that patients have increased oxidative stress versus increased lipid substrate. A 12
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month random controlled trial that included an intervention of aerobic exercise (60
minutes, 5 days per week) in previously sedentary women demonstrated a decrease in
oxidative stress as measured through urinary F2-isoprostane with little change in body
mass364. Results from this dissertation indicate that exposure to PCB 77 leads to a
dramatic increase in F2-isoprostanes in sedentary mice, whereas, exercised mice have
8-fold lower levels, suggesting that exercise protects against systemic oxidative stress
associated with PCB 77 exposure.
In addition to a reduction in risk factors for cardiovascular disease, we
demonstrate that exercise significantly reduced mean atherosclerotic lesion size in PCBtreated animals compared to sedentary, PCB-treated animals. Our findings are
supported by twenty-three published studies that have examined the effect of exercise
training in mouse models of atherosclerosis. Regardless of exercise intervention utilized
(swimming158–163, treadmill running164–170, or voluntary running171–177), each of these
studies reported a decrease in atherosclerosis following exercise, providing a basis to
test our hypothesis. Our findings are the first to report the beneficial effects of exercise
against atherosclerosis accelerated by an environmental pollutant; however, we are not
the first group to report that exercise can protect against PCB toxicity301.
Within this dissertation, voluntary exercise prevented PCB-induced gut
microbiome changes by preventing decreases in the population of Proteobacteria.
Another group assessed the effects of exercise and dietary supplementation with phytic
acid on Cadium toxicity and suggested that exercise provides a protective effect in
relation to weight loss, cholesterol levels, and liver damage; however CVD parameters
were not investigated365.
Exercised animals have reduced levels of oxidative stress, thus we assessed
several antioxidant enzymes to determine if they provided a potential mechanism of
protection. A growing body of evidence suggests that exercise can activate Nrf2251–254.
Since our lab previously demonstratd the reduction in proinflammatory signaling after
EGCG102 249, a known inducer of Nuclear factor erythroid 2-related factor 2 (Nrf2), we
examined downstream Nrf2 gene targets. Nrf2 is a transcription factor that responds to
increased oxidative stress within the cell. Target genes for Nrf2 include a diverse set of
antioxidant enzymes and cytoprotective genes including heme oxygenase 1 (HO-1),
NAD(P)H:quinone oxidoreductase-1 (NQO1), thioredoxin, and glutathione metabolism
genes including glutathione peroxidase 2 (Gpx2), glutathione S-transferases (GSTs).
Our findings demonstrate downregulation of the inhibitor protein, Keap1. We also see
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an upregulation of several Nrf2 target genes including phase II antioxidant enzymes
Gpx1, GST, and GSR; however, we did not see changes in NQO1 or HO-1 expression.
To confirm that these findings are biologically relevant future studies should examine
antioxidant expression through Western blot analysis. Additionally, Nrf2 nuclear
translocation should be measured to test if exercise increases Nrf2 activation.
Electromobility shift assays could be performed to determine the extent of ARE binding
in exercised animals which would be another indication of Nrf2 activation.
Our results show a downregulation of the phase I enzyme, CYP1A1, which has
been implicated in contributing to oxidative stress in the presence of coplanar PCBs68.
Superoxide can uncouple eNOS320, the enzyme responsible for the production of the
potent dilator nitric oxide, thus producing peroxynitrite and reducing endothelialdependent dilation. We have previously shown in cultured endothelial cells that
exposure to PCB 77 leads to an increase in peroxynitrite.90 In future studies, we will
further test how exercise regulates NO-mediated signaling and endothelial dependent
dilation.
We measured PCB 77 and its hydroxyl metabolites in several tissues to
determine if exercise had an effect on metabolism of PCB77. PCB 77 was not
detectable in any tissues, and OH-PCB 77 was found in the feces of these animals.
Exercised animals had significantly less OH-PCB 77 metabolites in their feces compared
to sedentary animals. Because of the rapid metabolism of PCB77, these results are not
surprising; however, this suggests indirectly that exercise increased drug metabolism
and that most of the PCB 77 may have been metabolized and/or excreted prior to the
time of measurements (at the end of study) since the last dose was during week 10.
Future studies should utilize a different dosing regimen that accounts for PCB 77’s halflife in order to detect potential changes in tissue distribution as well as excretion of PCB
and its metabolites.
With regard to toxicokinetics of PCBs, it has been reported that gastrointestinal
absorption of individual congeners varies from 66-96% in rats366. The distribution of
PCBs in the body depends on the dose as well as, the degree of chlorination.
Hydroxylated PCBs are the major metabolites with others including arene oxides that
highly reactive and converted to phenols, dihydrodiols, and glutathione conjugates which
are excreted. Sulfur-containing metabolites (e.g., methyl sulfones) have additionally
been identified. A major limitation of our current system is the inability to measure a
limited number of metabolites, specifically hydroxylated metabolites. Additional studies
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should examine the above metabolites. This would require collaborations with the
Superfund group at the University of Iowa which have synthesized internal standards for
measuring sulfated metabolites. Excretion of PCB congeners is dependent on their rate
of metabolism to more hydrophilic compounds367. Most congeners show a biphasic
elimination, where the initial half-life is relatively short but the later half-life is much
longer and more structure specific. The half-lives of PCB congeners vary from a few
days to 450 days depending on degree of chlorination. Within ICR mice, the half-life of
PCB 77 was reported at 1.07 days with the majority distributing from serum to adipose,
liver, and thymic tissues368. Within this study, ICR mice received 8 mg/kg every other
day for 10 doses before toxicological endpoints were measured. Because PCB
metabolites are eliminated primarily through the bile and feces, feces should be
gathered at different time points throughout the study in order to quantify excretion rates
between sedentary and exercise animals to determine whether exercise increases
metabolism and subsequent excretion of these compounds.
5.1.4. Effect of exercise on PCB 77-induced endothelial dysfunction in C57BL6
mice
Human exposure to coplanar PCBs has been associated with cardiovascular
disease and its associated risk factors including diabetes77, hypertension48,
dyslipidemia329, and endothelial dysfunction84,313,330. Endothelial dysfunction is an
independent risk factor for cardiovascular disease27 and is an initiating step in the
development of atherosclerosis331. . NO is produced by endothelial nitric oxide
synthase (eNOS) during the conversion of L-arginine to L-citrulline through receptor
activation (e.g., muscarinic receptors) or mechanical force (e.g., shear stress)320. NO
relaxes blood vessels, prevents platelet aggregation and adhesion, limits oxidation of
low-density lipoprotein (LDL) cholesterol, inhibits proliferation of vascular smooth muscle
cells, and decreases expression of proinflammatory cytokines187.

All of these functions

of NO play in role in optimal endothelial health, thus preventing atherosclerosis.
The previous work within this dissertation, specifically Chapter 3, demonstrated
the effects of exercise in PCB-induced cardiovascular disease in an observational
manner. The aim of this dissertation was to determine a mechanism of protection
against PCB-induced CVD within the vasculature. Because our laboratory has shown
that PCB 77 exerts toxicity within the vascular endothelium in an AhR-dependent
mechanism, we examined the role of exercise in PCB-induced endothelial dysfunction
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utilizing the ex vivo vascular reactivity assay. Several studies, in both human and animal
models, have demonstrated that exercise can reverse endothelial dysfunction171,369–371.
We hypothesized that exercise protects against cardiovascular disease by preventing
endothelial dysfunction through increased bioavailability of NO.
We demonstrate that exposure to PCB 77 led to severe impairment of
endothelium dependent vasodilation in sedentary animals (Figure 4-7). Exercise is able
to prevent the PCB-induced impairment. Our data show that ACh-induced relaxation is
blocked in all groups but PCB 77-treated sedentary animals. The NO inhibitor L-NAME
inhibited the relaxation response in both exercised and control groups equally, one could
argue that increased bioavailability of NO is one of the protective mechanisms of
exercise within the vascular endothelium. In fact, pre-incubation with L-NAME
significantly reduced endothelium dependent relaxation in all groups, except in PCBtreated sedentary animals. , NO-mediated mechanism may also contribute to the
protective effects of exercise against PCB-induced endothelial dysfunction. Other
groups have demonstrated that exercise leads to increased activity of eNOS through
phosphorylation of ser1177. A limitation to this study is not confirming aortic expression
of eNOS within these animals to substantiate this finding.
The superoxide mimetic Tempol rescued the impaired vasodilation in PCBtreated sedentary animals, suggesting a relationship between PCB exposure, increased
oxidative stress and endothelial dysfunction. Previous publications have reported
rescue of dioxin-induced endothelial dysfunction by Tempol in sedentary mice 267. This
implies that exercise might normalize the redox status within the vascular endothelium
by reducing production of superoxide, thus improving vasodilation.
Examination of tissue distribution demonstrated that exercise did not significantly
change the amount of PCB 77 or its metabolites within liver or plasma. Measurement of
adipose, skeletal muscle, and fecal concentrations would have allowed us to make a
better estimate to the effects of exercise on metabolism, excretion, and body burden.
Interestingly, exercised animals had a significant downregulation of CYP1A1 which could
explain the reduction of superoxide in these animals. Furthermore, this reduction in
superoxide may explain why Nrf2-mediated antioxidants were not stimulated.
Stimulation of Nrf2 appears to require induction of oxidative stress by a damaging agent
that increases ROS such as PCB 77. A limitation of this work is we did not measure
ROS specifically. This data suggests that exercise attenuated endothelial function may
occur by a reduction in oxidative stress and decreased CYP1A1 expression.
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. The major limitation being this study is the artificial nature of this type of
functional analysis where the experimental conditions do not include the physical
stresses of shear stress and cyclical wall stretch that endothelial cells within the isolated
vessel would normally experience334. Although traditional organ-bath pharmacology is
artificial, we were able to isolate elements of endothelial function by treating with
pharmacological inhibitors including L-NAME and Tempol. Because isolation of aorta to
preserve tissue viability was essential to the success of this experiment, I had limited
time to collect tissue from these animals. In hindsight, a subset of animals or a coworker to assist in weighing of liver tissue as well as harvesting skeletal muscle, adipose
tissue, kidneys, the remaining thoracic aorta and lungs would have enabled more data to
be collected. Additional measurements would include antioxidant enzymes and peNOS/eNOS expression within the aorta as well as measuring tissue levels of PCB 77
and its metabolites to determine the effects of voluntary exercise on metabolism,
excretion and body burden. Fecal collection would have allowed us to compare the
effects of chronic versus acute exercise on PCB excretion rates. An additional limitation
to this study is the acute dosing schedule that is not reflective of human exposure.
Future studies should examine the effect of exercise on endothelial function in mice that
were chronically exposed to PCB 77 (dosing regimen in Chapter 3) to determine if
exercise remains protective.
5.1.5 Implications From Different Mouse Models
The data presented in this dissertation support the hypothesis that exercise
provides beneficial effects within the vasculature particularly in vehicle-treated animals.
Because of the changes in diet, dosing regimen, ways PCBs were quantified, and
differences in animal strains it is difficult to accurately compare results between these
two studies. Because these different aims utilized different mouse models, a further
discussion of differences among strains and recommendations to address these
limitations are discussed below.
Several animal models are available to study atherosclerosis including the
mouse, rabbits, pigs, and nonhuman primates. Due to the well-established murine
models as well as housing costs and feasibility, we utilized the mouse for these studies.
Mice are generally resistant to atherosclerosis due to low cholesterol levels (<100 mg/dl)
which is present predominately as HDL cholesterol274. By genetic and dietary
manipulations, specifically by increasing apoB-containing lipoproteins, mice will develop
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atherosclerosis. The two major mouse models, the ApoE-/- and the LDLr-/-, are widely
accepted within the scientific community. ApoE is mainly produced in the liver and acts
as a ligand on the surface of lipoproteins ultimately for their clearance through uptake by
the LDLr. Genetic deletion of ApoE delays clearance of lipoproteins and raises plasma
levels to 300-400 mg/dl as well as atherosclerosis on a low-fat diet339. Feeding a highfat/high-cholesterol diet can raise plasma cholesterol levels to >1000 mg/dl and
accelerates atherosclerosis. The discovery of the LDLr by Brown and Goldstein while
studying familial hypercholesterolemia led to the honored Nobel Prize in 1985. LDLr
recognizes apoB100 on LDL and apoE on VLDL and chylomicrons for their clearance
from the blood. Unlike the ApoE-/- mouse, LDLr-/- mice require a high fat diet (40%
calories from saturated fat and 0.1-0.2% cholesterol by weight colloquially known as the
Western diet) to develop atherosclerosis and elevated cholesterol levels (>1000 mg/dl).
From a practical standpoint, both models are commercially available and are
backcrossed to the C57BL/6 background.
The lesion stage and timeframe for development of atherosclerosis has been
well-characterized within the literature. LDLr-/- mice fed a Western diet will develop
stage I lesions within 4-6 weeks and present with stage III at 16-20 weeks whereas
ApoE-/- fed a standard diet present with stage I lesions at 1-2 months and do not
develop stage III lesions until 7-9 months of age372. Apoe-/- mice fed a Western diet will
develop atherosclerosis at a similar rate to the LDLr-/- mice. Stages I-III lesions consist
of an abnormal accumulation of lipoproteins, T-cells, and macrophages, which can be
measured through staining techniques. Stage IV lesion is considered as an advanced
lesion because these lesions consist of a lipid core as well as thickening of the tunica
intima. When the lipid core accumulates fibrous material or a cap, this is considered
stage V as the lumen becomes narrowed372.
These discrepancies could explain the differences seen between the two studies.
It is important to note that despite different timeframes, the mean lesion size between
the two studies was roughly similar (in both LDLr-/- mice and ApoE-/- mean lesion sizes
ranged from 0.1-0.3 mm2, refer to Chapter 2 and Chapter 3). Furthermore, a complete
histological analysis of the aortic root was not conducted to better determine which
lesion stage these animals were in and whether exercise could decrease macrophage
infiltration within the lesion. . We did not see a significant change in lesion area, but that
does not necessarily mean that the atherogenic process was the same between PCB,
sedentary, and PCB, exercise groups. Additional studies should quantify the infiltration
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of macrophages within the aortic root especially since differences were seen in the
inflammatory response systemically between the two strains. The amount of technical
skill required to collect all of the serial sections spanning a 400 + μm region of the
ascending aorta is a major limitation within this body of work. Future studies should
utilize an expert with the technical skill to reduce variability and potential human error.
Upon statistical consultation, it has been recommended that this additional study should
utilize a greater sample size (n=15-20) would account for the inherent variability seen in
mean atherosclerotic lesion size and this would allow us to determine if exercise would
be an appropriate therapy for reducing body burden and preventing cardiovascular
disease. Another consideration to this work is that we examined a relatively short time
frame of the disease. Atherosclerosis and body burden of PCBs may be alleviated by
continued voluntary exercise for longer periods of time based on other studies that have
indicated reduction in POP body burden over a 2 year time frame. An additional factor
to account for is the role of diet. Other studies within the literature have demonstrated
that a diet consisting of protein and heart healthy fats was required for exercise to
protect against dyslipidemia, inflammation, and atherosclerosis in ApoE-/-176. Potentially
supplementing rodents with olestra or EGCG may offer protective while PCBs are
mobilized into the plasma for further metabolism and excretion. Although exercise
prevented many of the adverse side effects of PCB exposure, a diet supplemented with
phenols may be required protect against the development and progression of
atherosclerosis.
Specifically within the LDLr-/- study, systemic inflammation was significantly
increased in the PCB, exercised animals. The dosing regimen could account for these
changes since mice were exposed to PCB 77 24 hours before euthanasia. Within the
ApoE-/- study, systemic inflammation was largely attenuated; however the last dose
occurred 3 weeks before plasma was analyzed. To determine the effect of exercise on
PCB-induced inflammation, time course studies that examine inflammatory markers
throughout the duration of the study would provide insight
Within both studies, exercise led to a reduction in hepatic cholesterol despite
increased liver:body weight. This finding suggests that exercise does not fully protect
against PCB-associated liver pathologies; however, we did not quantify total lipids or
fibrosis in either study. Other difficulties that arise for accurate comparison is missing
parameters from the LDLr-/- study including systemic oxidative stress, antioxidant status
and glucose tolerance test that were measured in the ApoE-/- study. Having oxidative
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stress data would help us better assess why the LDLr-/- mice had significantly elevated
CYP1A1 expression which could be merely the result of the dosing regimen but this
remains unknown. It is quite interesting that exercise significantly reduced CYP1A1
expression in ApoE-/- but this could be explained by the dosing regimen as well.
In summary, exercise modulates cholesterol particularly in the VLDL and LDL
fractions, reduces hepatic cholesterol, and reduces adiposity in both strains exposed to
PCB 77. In ApoE-/- mice, exercise reduces systemic oxidative stress, glucose
intolerance, inflammation, and hepatic CYP1A1 expression while upregulating phase II
enzymes including GST and GSR. Exercised animals had lower mean atherosclerotic
lesion size; however, future studies with a larger sample size are needed. The section
below outlines future studies that will further delineate the potential protective role of
exercise against the adverse health effects of PCB exposure.
5.2. Future Directions
The work presented here demonstrates the cardiovascular toxicity of coplanar PCBs and
examines the role of lifestyle modifications including aerobic exercise. Providing
guidelines to humans for physical activity based on this project is not recommended due
to the infancy of this work. In order to provide clear physical activity guidelines for
populations exposed to PCBs and other persistent environmental chemicals, the
following questions should be addressed.
In chapter 3, our data indicates that exercise may have an effect on the
metabolism of PCB 77, which is a novel finding. One unsolved piece of the puzzle are
the pharmacokinetics of the metabolism of PCB 77 and future studies should address it.
To assess the effect of olestra on PCB 77 metabolism, Jandacek et al. utilized radiolabeled PCB 77 and determined absorption and excretion rates through fecal
samples105. Feces should be collected for 48 hours immediately after gavage (if
radiolabeled congeners are available and within a reasonable price range) to measure
initial dietary absorption (reported as % of dose in 48 hours) and then for an additional
48 hours 7 days after administration to measure enterohepatic circulation. At this
endpoint, tissues should be collected to measure distribution of PCB in adipose, plasma,
and liver tissue. If radiolabeled congeners are not available, concentration within the
adipose tissue could be utilized as an estimate of body burden. This would allow the
researcher to make a more thorough report on the potential role of exercise in increasing
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metabolism and excretion of PCB 77 through interrupted enterohepatic circulation and
enhanced excretion of these compounds.
More recently, Jandacek et al. administered olestra potato chips (15 g
olestra/day) to reduce PCB body burden in Anniston residents for 12 months in a
double-blind placebo-controlled, 1 year trial. Results from this pilot study demonstrate
elimination rate of 37 non-coplanar PCBs to be faster in olestra-consuming patients than
before the trial373. This study is very important because it demonstrates a dietary
intervention that can safely reduce body burden of PCBs. These findings support the
need to continue a larger intervention trial to determine whether reduction in PCB body
burden will improve metabolic parameters such as hypertension, cardiovascular disease,
and diabetes. To date, there is a single case study that reports metabolic improvement
(hyperlipidemia and hyperglycemia) in a patient whose PCB body burden was
reduced374.
Additional in vivo studies should examine the effects of chronic exposure of PCB
77 on endothelial dependent vasodilation. Walker and Kopf measured the effect of
dioxin exposure (35 days which was the amount of time required for C57BL/6 mice to
become hypertensive) on vascular reactivity and found significant impairment267. A
group of Spolana plant workers in the Czech Republic were heavily exposed to dioxin
and vascular function was examined by laser Doppler fluxmetry. Workers were found to
have significant endothelial dysfunction in four of the six parameters of microvascular
reactivity within the brachial artery (maximal perfusion during hyperemia, time needed to
reach maximal perfusion during hyperemia, velocity of perfusion increase, and thermal
reactivity)375. We hypothesize that chronic exposure of PCB 77 will lead to impaired
vasodilation based on our findings regarding increased atherosclerosis, oxidative stress,
and inflammation but that exercise will prevent this endothelial dysfunction.
Previous work in our laboratory provides strong evidence that PCB transport
requires functional caveolae and its associated scaffolding protein Caveolin-1 (Cav-1),
enhancing its toxicity. PCB 77 administration in endothelial cells increases caveolin-1
and PCB 77 accumulates within the caveolae fraction92. Because caveolae play a role
in the development of atherosclerosis, therapies that decrease caveolae and modulate
its associated inflammatory signaling are attractive targets. We did not see changes in
Cav-1 expression within the liver of exercised mice; however, future studies should
examine expression of caveolin-1 in aorta of exercised mice to determine if exercise
reduces its expression. Because eNOS is bound to caveolin-1 in its inhibitory state348, a
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potential scenario is that the lipid bilayer undergoes a conformational change due to
mechanotransduction, thus increasing NO bioavailability by freeing eNOS from Cav-1.
This hypothesis remains untested and would be an exciting mechanism to explore.
Because shear stress is a potential mechanism with which exercise exerts its
cardioprotective effects, porcine endothelial cells should be cultured and exposed to a
newly developed system that exerts “physiological” flow instead of the traditional models
that apply a controlled level of fluid shear stress. Uzarski et al. have developed a
hemodynamic flow model that mimics complex and variable shear fields based on shortterm changes in blood flow that were observed in vivo. They compared physiological
flow (PF) to static culture and steady flow (SF) that was set at a consistent pulse
frequency of 1.3. Hz. Their findings demonstrate that PF led to a significant
upregulation of eNOS, upregulation of atheroprotective genes including SOD-1 and
downregulation of MCP-1. Additionally these endothelial cells had a lower TNF-α
induced HL-60 leukocyte adhesion376. This flow model mimics atheroprotective flow and
may be a suitable model to mimic flow seen during exercise. Quantification of shear
stress in human pulmonary arteries reports that shear changes 19.8 +/- 4.0 to 51.8+/6.7 dynes/cm2377.

If this collaboration cannot occur, a suitable alternative would be

collaborate with Hainsworth Shin to utilize his micropipette shear device to administer
shear stress to cultured endothelial cells. His work has previously shown that
membrane cholesterol influences mechanotransduction of shear stress by PMNLs by
affecting membrane fluidity378 which has implications for testing whether or not exercise
can modulate caveolin-1 (a membrane protein) and its associated signaling during PCB
administration. These cells then should be exposed to doses of PCB 77 to determine if
PF flow (or shear stress representing laminar flow) can prevent proinflammatory
signaling mediated by NF-κB and potentially upregulate anti-inflammatory signaling
molecules.
5.3 Conclusions
In conclusion, this dissertation demonstrates that voluntary exercise protects
against PCB-induced cardiovascular disease risk factors including glucose intolerance,
dyslipidemia, hypertension, systemic inflammation, and oxidative stress. Additionally,
exercise reduced atherosclerotic lesions while upregulating antioxidant enzymes. This
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work suggests that exercise may increase the metabolism and excretion of these
compounds as well.
Acute exposure to PCB 77 led to impaired endothelial-dependent dilation, an ex
vivo measure of endothelial function; however, exercise was able to prevent this PCBimpaired endothelial dependent vasodilation. The mechanisms involved in PCB-induced
endothelial dysfunction involve production of superoxide and reduced bioavailability of
NO; however the mechanisms involved in eNOS regulation should be studied in further
detail including the role of Cav-1.
Lifestyle modifications such as physical activity have been shown to protect
against cardiovascular disease. This dissertation provides evidence that exercise can
modulate several adverse health effects of PCB 77 but additional studies are required
before exercise recommendations can be made for groups residing in Superfund
hazardous waste sites.
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PCB77

Exercise

Keap1

GSHPCB77
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Figure 5 -1. Proposed signaling pathway for PCB detoxification in vivo.
PCB 77 is an AhR ligand and causes CYP1A1 upregulation, which when in the presence
of PCB 77 leads to superoxide production. Exercise effectively upregulates the
antioxidant response in the presence of PCB77 which allows for a more efficient
antioxidant response to environmental insult. (Adapted from Newsome et al JNB, 2013)
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Appendix A: Vascular Reactivity Protocol
Tissue Force Analysis
Before tissue harvest
(Modified)Krebs buffer preparation:
- For 2 liters:
~ 1650mls of diH20
-add NaCl dry chemical and stir ;add dextrose dry chemical stir
-add 60 mls KCl, KH2PO4, MgSo4-7H20 and NaHCO3 stocks and stir for 5
min
- q.s. with diH20
- pour into reservoir; turn on heater and O2/CO2 tank to aerate the buffer. Let buffer
aerate ~ 20 mins
- drain solution, add CaCl2-2H20 and re-stir 5 min
- return to reservoir and aerate additional 10 mins before using
80mM KCl solution preparation:
- For 500 mls :
~ 300 mls of diH20
- add KCl dry chemical and stir; add dextrose dry chemical stir
- add 15 mls KH2PO4, MgSo4-7H20 and NaHCO3 stocks and stir for 5 min
- q.s. with diH20
- pour into reservoir; turn on heater and O2/CO2 tank to aerate the buffer. Let buffer
aerate ~ 20 mins
- drain solution, add CaCl2-2H20 and re-stir
- return to reservoir; aerate an additional 10 mins prior to use.
Balance and calibrate each transducer
1234-

Turn on analyzer: the screen will be in the set up mode and read as follows:
SET
bASE
CAL
[0.00]

To balance -from set up menu
Press 2 - bASE
Balance/baseline menu will appear as follows:
1
bASE
2
BLANK
3
[current force]
4
[baseline force]
Press 2 - a red light will appear next to button 2, when the red light goes out the
transducer is balance. The screen will read as follows:
1
bASE
2
BLANK
120

3
[0.00]
4
[0.00]
Press button 1 to return to set up mode.
To calibrate - In set up mode
Press 3 - CAL
The calibration menu will appear as follows:
1
CAL
2
[20]
3
BLANK
4
[2.0]
Place the 2 gram weight on the transducer
Press button 3 - a red light will appear next to button three, when the red
out the transducer is calibrated
Press button 1 (mode) to return to set up Menu
From set up Menu press Button 1 to enter pre-stimulation mode

light goes

The display should read as follows
1
[2.0]
2
BLANK
3
BLANK
4
[00:01]
Remove the 2 g weight
The value in display box 1 should return to zero
(If this value exceeds 0.02g than repeat calibration)
Open up DMSI software on computer; choose “all”, then “force”
- In “window”, choose “tile horizontally” and arrange windows to preference
- When ready to begin experiment, hit “start experiment” to record
Tissue Harvest
1.
Anesthetize mice with IP injection of ketamine/rompun/saline cocktail
2.
Perform a thoracotomy, drain blood and perfuse the aorta with mod. Kreb’s buffer
3.
Carefully remove the entire aorta, with or without the heart, being careful to
create no tears in the vessel.
4.
Place whole aorta in fresh Kreb’s buffer and remove all adventitia under a
microscope
5.
Measuring sections of interest:
Arch- 3mm section superior starting from the ascending arch at the base of the heart
Thoracic- 4mm section inferior to the left subclavian artery
Suprarenal- 4mm section from the superior mesenteric artery toward the superior end of
the aorta
Infrarenal- 4mm section from left renal artery toward the bifurcation
6) After each segment has been cut, mount the rings on the isometric triangles.
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Mounting Tissues in Baths
1. Fill reservoirs with fresh Kreb’s buffer.
2. Using the mounting wires, secure each tissue segment to its transducer and fixed
point within the glass baths.
3. Create minimal tension (0.5-0.6 g) after tissue segment is successfully mounted
4. When all tissues are mounted, increase tension to 1 g, drain baths and refill with
fresh buffer
5. For the next 30 min, readjust tension to 1 g and replace with fresh Kreb’s buffer
every 10 min to equilibrate tissue segments
Administering Agonists/antagonists
KCL, if being used, should be given first to establish tissue viability and a baseline vasoreaction for future relaxation trials
**our protocol adds KCL as a solution, so the entire bath is drained of buffer then filled
with 80mM KCL for this step. Other drugs/agonists are usually added to the buffer in the
baths
The first time a drug dose is added to the chamber, hit “contract” or “relax” (whichever
applies) and record the reference force. At each subsequent addition, repeat and record
the max. force for that time interval
Tissue should be ”washed” at least 3 times after each agonist by filling the baths and
draining them
Tissue should be allowed to equilibrate for at least 30 min after the washes (replacing
with fresh buffer every 10 min) between agonists
If using antagonists, administer these first and allow equilibrating 30 min before adding
the secondary drugs

Drug calculations:
*All drugs dissolved in dH2O unless otherwise noted
*All drugs diluted with fresh Kreb’s buffer
*Stocks are good at 4 C for 2-3 days (5HT and PE are light sensitive)
*Aliquots may be frozen for up to 12 weeks - do not freeze/thaw more than once
5HT (serotonin)

MW=212.7

PE (phenylephrine)

MW=203.7
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AngII (angiotensin II)

MW=1166

Ach (acetylcholine)

MW=181.66

Cbl (carbachol)

MW=182.6

L-NAME

MW=269.7

Ind (indomethacin)

MW=357.8 *dissolve in ethanol, dilute in dH2O
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